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Summary 
The family of Enterobacteriaceae is comprised of Gram negative bacteria found in a variety 
of natural environments as well as in the gastrointestinal (GI) tracts of humans and many 
animals including diverse mammals, birds and reptiles. Three species of the enteric bacteria 
are largely responsible for causing infections both in humans and animals worldwide; these 
are Escherichia coli, Salmonella enterica and Klebsiella pneumoniae; β-lactams are 
antimicrobials commonly prescribed to treat uncomplicated as well as severe infections 
caused by these Enterobacteriaceae and other Gram negative and also Gram positive bacteria. 
In particular, aminopenicillins, cephalosporins and carbapenems found broad application in 
treatment of infections caused by the aforementioned enteric species. Recently however, 
increasing levels of resistance to β-lactams is observed in these key infectious agents as well 
as in many other previously susceptible species. This phenomenon has become a major public 
concern.  
Antimicrobials including β-lactams have been often used in heavy amounts in farming, not 
only to treat the diagnosed infections in individual animals but also as prophylaxis, 
metaphylaxis and growth promotion. It is believed that these practices lead to the generation 
of reservoirs of antimicrobial resistance genes in the GI tracts of intensively reared food -
production animals like pigs, poultry and cattle. Moreover, it has been previously shown that 
the bla genes (e.g. genes encoding resistance to β-lactams) could be transmitted between 
different bacteria on mobile genetic elements (MGEs) like plasmids and variety of 
transposons. Evidences were also published indicating that zoonotic bacteria like E. coli or  
S. enterica resistant to diverse antimicrobials and harbouring plasmids might have been 
transmitted from farm animals to humans (farm workers, animal caretakers etc.). It has been 
therefore speculated whether the plasmids with the bla genes found in Enterobacteriaceae in 
humans could actually originate from the animal sources.  
The overall aim of this thesis was to verify if indeed related resistance plasmids can circulate 
between enteric bacteria from humans and food production animals; and if so, then which of 
these plasmid species are specifically associated with the epidemic types of blaTEM genes in 
Enterobacteriaceae. Furthermore, the association of the plasmid encoded blaTEM genes with 
transposable elements is also studied in order to get a broader perspective of which MGEs are 
involved in mobilization and spread of these bla genes in the diverse reservoirs. Finally, an 
attempt is made to encompass ecological aspects of plasmid driven transmission of resistance 
among the enteric bacteria.   
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In the first study the relationship between plasmids harbouring blaTEM-52 genes isolated from 
humans, poultry and also meat products was examined. Twenty- two plasmids from a 
collection of E. coli and different serovars of S. enterica were characterized. The study 
delivered molecular evidences that epidemiologically related plasmids circulated in the 
diverse species of enteric bacteria and between humans and animals, and the possible 
transmission route could have been contaminated food products like meat. Two types of 
epidemic plasmids were detected in isolates of E. coli and S. enterica; namely 
undistinguishable IncI1 blaTEM-52 plasmids were found in human and poultry isolates of E. 
coli and S. enterica;  also undistinguishable IncX1 plasmids were isolated from E. coli and  
S. enterica from human infections, poultry and meat products (from poultry, broiler and 
beef). The strains harbouring these plasmids were confirmed not to be clonally related, hence 
indicating the transmission of the plasmids between the different bacteria from humans and 
animals rather than isolation of the same bacterial clones from the different reservoirs.  
With relation to the study I, a range of other observations was made. On majority of the 
examined plasmids, the blaTEM-52 genes resided on the Tn3-related transposons. Further 
analysis of the genetic environment of these blaTEM genes resulted in the conclusion, that it 
was a defined type of Tn3-like element that harboured the blaTEM-52, namely the Tn2 
transposon. This knowledge was later used in the second study to design more discriminatory 
PCR method that would allow for distinction of which transposon types (Tn1, 2 or 3) or 
insertion sequences (IS26) could be linked to the blaTEM genes of interest. Moreover, the 
initial typing of – as realized later the IncX1 –blaTEM-52 plasmids with the use of available 
standard PCR-based methods for replicon typing (PBRT) was unsuccessful. In the course of 
this study the whole plasmid from E. coli 2161 was sequenced and deposited in GenBank as 
plasmid pE001. It became apparent that the standard PBRT method targeted another group of 
IncX family of replicons, namely the IncX2 plasmids, which so far have been rather rarely 
detected in humans or animals. The replicon of the pE001 was designated in the published 
Manuscript I as an IncX1A. The reason to that was the discovery of dissimilarities between 
the replicon of pE001 and the replicon of an IncX1 plasmid called pOLA52. The latter was 
published before pE001 and was considered to carry a classical IncX1 replicon. In the study 
I, an incompatibility assay for the pE001 and the pOLA52 (variant with the deletion in blaTEM 
gene) was performed. The two plasmids turned out to be compatible, which was surprising 
considering the high degree of overall similarities between the two sequenced scaffolds. 
Based on these results it was concluded that the standard incompatibility assays may in some 
cases give a false reflection of the real relatedness of the examined plasmids. Combining this 
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experience with the knowledge that the PBRT method is often sensitive to the sequence 
substitutions within the replicon scaffolds, another idea was generated. It was previously 
reported that the plasmids from Klebsiella pneumoniae often escaped the detection by the 
classical PBRT methods, which was originally designed based on E. coli replicons. Therefore 
in the third study, which will be described later in this summary, a novel method was 
elaborated for rapid detection and sub-classification of plasmids from this species.  
The blaTEM-52 genes that were the focus of the first sub-project are in fact evolutionary 
descendants of blaTEM-1 genes. The second study aimed therefore at verifying on which 
plasmids scaffolds these blaTEM predecessors are usually located in Enterobacteriaceae found 
in humans and food production animals like pigs, poultry and cattle. In this sub-project the 
focus was stated on the plasmids from E. coli, which is known to be either an indicator 
organism colonizing (as a commensal) both the human and animal GI tracts; or it may cause 
infections to its hosts. Evidences were found in the study II that either undistinguishable or 
similar blaTEM-1 plasmids circulated in different E. coli from humans and from animal sources 
in Denmark. Possibly epidemic blaTEM-1 IncI1 and IncB/O plasmids were found in humans 
and the diverse animals (pigs, poultry and cattle). Moreover, a larger variation of the 
transposable elements linked to the blaTEM-1 genes was detected on plasmids in the second 
study compared to blaTEM-52 plasmids. In the second study usually specific alleles of the 
blaTEM-1 genes resided on either the Tn2 (blaTEM-1b and blaTEM-1c) or Tn3 (blaTEM-1a) 
transposons. In many cases the insertions of IS26 elements upstream of the blaTEM-1 genes 
were detected by PCR. These results gave important clues not only regarding which plasmids 
but also which specific transposons might have served as platforms for mobilization and 
evolution of the blaTEM-1 to blaTEM-52 genes.  
In the third sub-project plasmids from K. pneumoniae from human infections and from 
surface waters (designated as environmental isolates) were typed. In this study the strains 
were not pre-selected based on the defined resistance markers. The results allowed for 
evaluating if there are differences in the replicons normally found on plasmids from humans 
and from the environment in this bacterial species. Additionally, these potentially host 
specific replicons could have been compared to the replicons of plasmids previously shown 
to be specifically associated with the resistance genes in the clinically relevant K. 
pneumoniae.  
At the time when this project was initiated the standard PBRT method often failed to detect 
the replicons from K. pneumoniae. Therefore a novel multiplex PCR (mPCR) was designed 
for detection of these otherwise untypable plasmids. While this was pursued, updated 
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protocols for PBRT were published by other authors and many of the sequenced plasmids 
from K. pneumoniae used as references for designing of the mPCR turned out to be the 
IncFIIk types. However, an interesting observation was made. Namely, in one of the 
previously sequenced K. pneumoniae strain MGH78578 apparently multiple plasmids with 
the similar incompatibility determinants IncFIIk were detected; this was opposing to the 
theory that the plasmids from the same incompatibility groups typically would not be able to 
co-exist in the same bacterium. In fact, a similar pattern was seen in study III  in some of the 
examined K. pneumoniae strains from human infections and from the environment, where 
also multiple IncFIIk plasmids were present in the same isolates simultaneously, but these 
plasmids harboured diverse secondary replicons detected by the mPCR. The conclusion from 
the third study was that plasmids may acquire secondary replicons in order to persist in the 
given bacterium and to overcome the incompatibility phenomenon and this seems to be fairly 
common in K. pneumoniae. Analysis of literature data against the data from the study III 
resulted also in a conclusion, that the same replicons that are generally predominant in  
K. pneumoniae (IncFIIk, likely also IncR and yet unknown replicons) are often associated 
with a variety of the bla genes in the clinical strains of this species. 
In summary, the combined data from the three studies suggested that often the blaTEM 
plasmids are generally host specific to the species they were detected in. This is exemplified 
by IncFII, IncFI, IncB/O and IncI1 replicons in E. coli, IncI1 and likely IncX1 in S. enterica 
or IncFIIk in K. pneumoniae. Many of the broad host range replicons (IncP, IncA/C, IncR, 
IncL/M, IncN) were found rather occasionally in these hosts. Although some exceptions were 
seen, namely the IncP were often found with blaTEM-1 genes in particular in cattle, while 
IncA/C were often associated with blaTEM variants encoding Extended Spectrum β- 
Lactamases in the diverse reservoirs. Evidences presented above indicate that the 
transmission of plasmids between animal and human Enterobacteriaceae is possible and it is 
likely that in some cases the resistance plasmids might have been delivered from animal to 
human strains via food chain. 
Further studies are needed to determine the chromosomal progenitors of the resistance genes 
like blaTEM-1. Determination of the very origins of resistance genes is crucial if further 
mobilization of these genes from the given source is to be prevented. Plasmids undoubtedly 
play a major role in transmission of bla genes also across the reservoirs. Solutions like whole 
genome sequencing should be preferentially applied in the future in order to efficiently 
detect, classify and tract the epidemiology of resistance plasmids in populations of 
Enterobacteriaceae. 
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Dansk Sammendrag 
Escherichia coli, Salmonella enterica og Klebsiella pneumoniae tilhører familien 
Enterobacteriaceae og er vid udstrækning skyld i infektioner hos både mennesker og dyr; β-
lactamer og i særdeleshed aminopenicilliner, cephalosporiner og carbapenemer er antibiotika, 
som ofte bruges til behandling af denne type infektioner. I den senere tid har der været en 
bekymrende stigning i resistens over for β-lactamer, dels i infektionsgivende bakterier, og 
dels i tidligere følsomme bakterier. Tidligere studier indikerer, at zoonotiske bakterier 
resistente over for forskellige antimikrobielle stoffer, samt indeholdende mobile genetiske 
elementer (MGEer), som f.eks. plasmider, kan overføres fra husdyr til mennesker 
(landarbejdere, dyrepassere osv.). Det overvejes derfor, om plasmider med bla-gener (gener, 
som koder for β-lactam-resistens) i enterobakterier hos mennesker, muligvis kan stamme fra 
dyrekilder.  
Målet med denne Ph.d. afhandling var, at se om nært beslægtede resistens plasmider kan 
cirkulere mellem enterobakterier fra mennesker og fra produktions dyr; og hvis det er 
tilfældet, hvilke af disse plasmidtyper der kan være associeret med epidemiologiske typer af 
blaTEM gener i Enterobacteriaceae (blaTEM-1 and blaTEM-52). Endvidere er der i denne Ph.d. 
afhandling kigget på sammenhængen mellem blaTEM gener og transposable elementer for at 
få et bredere perspektiv af hvilke MGEer, der er involveret i mobilisering og spredning af 
disse bla-gener i diverse reservoirer.  
I det første delprojekt blev relationen mellem plasmider med blaTEM-52 gener isoleret fra 
mennesker, fjerkræ og fødevarer undersøgt. Toogtyve plasmider fra en kollektion med E. coli 
samt forskellige serotyper af S. enterica blev karakteriseret. Der blev fundet to typer af 
epidemiologiske plasmider, nemlig de gængse IncI1 blaTEM-52 plasmider fundet i E. coli og S. 
enterica isoleret fra mennesker og fjerkræ; samt de gængse IncX1 plasmider fundet i E. coli 
og S. enterica isoleret fra humane infektioner, fjerkræ samt fødevarer (fjerkræ, slagtekylling 
og oksekød)  
Det andet delprojekt var rettet mod verificering af, på hvilket plasmidskelet (scaffold)  
blaTEM-1 sædvanligvis er lokaliseret i E. coli fra mennesker og produktions dyr såsom svin, 
fjerkræ og kvæg. Syvoghalvtreds blaTEM-1 plasmider fra mennesker og mere end hundrede 
blaTEM-1 fra dyr (svin, kylling og kvæg) blev undersøgt. Der blev fundet to typer af 
epidemiologiske plasmider, IncI1 og IncB/O, i flere isolater fra både mennesker og dyr.  
I studie I og II blev blaTEM genet ofte fundet på Tn3-familie transposoner, og Tn2 
transposoner var det mest udbredte.  
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I det tredje delprojekt blev plasmider fra halvtreds K. pneumoniae isolater fra humane 
infektioner samt fra overfladevand (betegnet som miljøprøver) typebestemt. Udvælgelsen af 
plasmiderne skete tilfældigt og var ikke baseret på definerede resistens markører. En ny 
multiplex PCR (mPCR) blev designet til typebestemmelse af replikaser af plasmiderne fra K. 
pneumoniae. Denne metode blev anvendt sammen med standard PCR-baseret replikon 
typning (PBRT). IncFIIk, IncR og den nye type replikon repIV blev oftest fundet. Generelt set 
fandt man forskelle i udbredelsen af de forskellige replikaser fundet med mPCR i mennesker 
i forhold til dem fra miljøprøver. Et højt antal af repII og repIV positive og ikke-typebare 
blev fundet i isolater fra blod, repIV og repV så ud til at være karakteristisk for plasmiderne 
fra miljøprøverne. 
 
Den samlede data fra de tre studier tyder på, at blaTEM ofte er placeret på et værtsspecifikt 
plasmid såsom IncFII, IncFI, IncB/O og IncI1 replikoner i E. Coli, IncI1 og IncX1 i S. 
enterica and IncFIIk i K. pneumonia; eller i mindre grad på de mindre værtsspecifikke 
plasmider tilhørende replikoner såsom IncP, IncA/C, IncR, IncL/M og IncN. Overordnet set 
har denne Ph.d. afhandling givet vigtig evidens for, at relaterede blaTEM plasmider kan 
cirkulere mellem enterobakterier fra både dyr og mennesker. BlaTEM plasmider kan være 
udvekslet mellem bakterier fra mennesker og dyr enten in vivo, i mave-tarm kanalen eller i 
ydre omgiverlser.  
 
 
Translated by Lisbeth Andersen with assistance of Berith E. Knudsen 
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Objective of the study and outline of the thesis 
 
Elaboration of the technique allowing for mass-production of penicillin in 1940-ties opened a 
new antibiotic era in the history of medicine and microbiology 
120
. It became a common 
belief that bacteria causing infections could be easily eradicated with proper antimicrobials 
designed against them. However, it soon became obvious that bacteria are capable of 
developing various mechanisms to resist or overcome the actions of many antimicrobials. 
Bacteria belonging to the family Enterobacteriacae can function both as true and 
opportunistic pathogens. The most common Enterobacteriaceae causing infections in humans 
and animals are E.coli, K. pneumoniae and serovars of S. enterica. The majority of these 
infections have so far been treated with β-lactam antimicrobials. This is believed to be the 
reason of selection for the bla genes in Enterobacteriaceae. 
Antibiotics are produced by microorganisms present in the natural environments. It has been 
therefore suggested that the genes encoding also resistance to these natural compounds have 
been present in the environment long before the introduction of antibiotics in treatment.  
Nowadays it is a known fact that the genes encoding resistance to antibiotics (and as 
explained later also to other antimicrobials) often reside on platforms composed of diverse 
mobile genetic elements. Resistance genes can be part of transposable elements and the latter 
might integrate onto a variety of self-transmissible or mobilizable plasmid scaffolds. In view 
of this it is not surprising that the selective pressure imposed by the use of antimicrobials 
might have stimulated mobilization of the resistance genes from the environment to the 
animal and human reservoirs. Gaining an inside knowledge about the molecular platforms 
driving that transmission is essential if one would like to predict the evolution and 
distribution pathways of the resistance genes. An ultimate goal is to apply the basic 
knowledge gained in studies like this one in order to control and possibly prevent the further 
spread of resistance among the key infectious bacteria. 
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This work aimed at verifying the diversity of resistance plasmids originating primarily from 
E. coli and also from K. pnaumoniae and S. enterica. The following questions were raised: 
 
i) What is the diversity of and relationship between plasmids with blaTEM 
genes circulating in Enterobacteriaceae, in particular E. coli from humans and 
from food production animals or meat products (Manuscripts I and II) 
 
ii) Could the blaTEM genes have been transmitted from the animal sources 
to Enterobacteriaceae causing infections in humans; or were the blaTEM genes 
acquired from independent sources by plasmids endogenous to humans and 
animals (Manuscripts I and II) 
 
iii) How plasmid host range, host specificity and incompatibility influence 
the potential of these MGEs to spread the blaTEM genes among the key enteric 
species like E. coli, S. enterica and K. pnaumoniae (Manuscripts I, II and III) 
 
iv) What is the diversity of transposable elements harbouring blaTEM genes 
found on plasmids in E. coli and other key enteric bacteria in humans and animals 
(Manuscripts I, II and III) 
 
The thesis is divided into three main sections. Section I gives an overview of β-lactams and 
their application against key infectious bacteria belonging to the Enterobacteriaceae family. 
The origins and spread of resistance to β-lactams and the role of mobile genetic elements in 
that spread are discussed. Details on the relevant mobile genetic elements involved in HGT 
and in the transmission of β-lactam resistance are introduced. Primarily, the attention is given 
to plasmids as the main actors in the resistance transmission (in particular resistance mediated 
by β-lactamases). Principles of plasmid biology, ecology and typing/classification methods 
are presented. Role of transposable elements in transmission of bla genes is accentuated. A 
large fraction of the theoretical background refers to E. coli, as this is a well studied model 
organism as well as a common pathogen of humans and animals. In section II the theories are 
plotted against the results obtained in this study. Evidences observed in this study suggesting 
plasmid transfer between animals  and humans are highlighted. An attempt is made to point 
out which plasmid platforms -and why these - are particularly involved in the transmission of 
blaTEM genes in Enterobacteriaceae from humans and from food production animals. The role 
13 
 
of plasmids in transmission and evolution of genes encoding the TEM type β-lactamases is 
discussed. Factors like plasmid host specificity and host range in relation to transmissible 
resistance and dynamics of microbial ecosystems is also commented. Section II is finalized 
with the overall conclusions from the study and the suggestions for the future studies.  
Section III is composed of the three manuscripts produced during this study: 
 
I. Bielak,E., Bergenholtz,R.D., Jorgensen,M.S., Sorensen,S.J., Hansen,L.H., Hasman,H., 
2011. Investigation of diversity of plasmids carrying the blaTEM-52 gene. J. Antimicrob. 
Chemother., 66, 2465-2474. 
 
II. Bielak, E. ,Knudsen, B. E.,  Haugaard, E. , Andersen, L., Hammerum
, 
A. M., 
Schønheyder, H. C., Porsbo, L. ans Hasman
 
H. Characterization of plasmids carrying blaTEM-1 
gene from humans, poultry, cattle and pigs – manuscript in preparation 
 
III. Bielak, E., Struve, C. and Hasman, H. Typing of plasmids from Klebsiella pneumoniae 
from human infections and from the environment with a novel multiplex PCR - manuscript in 
preparation 
 
Manuscript I was reproduced with permission of the publisher (according to publication 
policies of Oxford Journals: ‘the authors retain rights to include the [previously published] 
article in full or in part in a thesis or dissertation, provided that this not published 
commercially’). 
 
 
 
 
 
 
 
14 
 
SECTION I.  
1. ANTIMICROBIALS AND ORIGINS OF ANTIMICROBIAL RESISTANCE IN 
ENTEROBACTERIACEAE 
Bacterial infections due to opportunistic and true pathogens were the cause of morbidity and 
mortality in humans and animals probably since the very beginnings of their existence. 
However, many of the microorganisms like fungi and certain species of bacteria turned out to 
naturally produce small molecules that can kill or inhibit the growth of other bacteria. These 
natural compounds were termed antibiotics. All compounds with bacteriostatic or bactericidal 
properties including the semi- and fully synthetic compounds are termed antibacterials, or 
more generally antimicrobials 
53
. 
Currently a whole range of antimicrobials is available for treatment of infections caused by 
both the Gram negative as well as Gram positive bacteria. Some of the major families of 
antimicrobials are β-lactams, aminoglycosides, chloramphenicols, ketolides, lincosamides, 
macrolides, oxazolidinones, streptogramins, tetracyclins, rifamycins, sulphonamides and 
trimethoprim, quinolones, nitrofurans and nitroimidazoles, glycopeptides, fosfomycin, 
bacitracin, polymyxins and recently recognized colistins 
66
. The compounds within the given 
families share some common molecular structures and they usually act against the defined 
targets within the bacterial cells. These targets are usually the key steps of biochemical 
pathways in bacteria (nucleic acids replication, transcription and translation, protein 
synthesis, metabolism) or the key structural components (cell wall and cytoplasmic 
membranes). Owing to some structural differences between Gram positive and Gram 
negative bacteria and the diverse properties of individual species (fermenters vs non-
fermenters, aerobic vs anaerobic, intracellular vs extracellular etc.) diverse antimicrobial 
families might be more or less effective against particular infectious agents. The different 
families of antimicrobials, their mode of action and specificity against given bacteria are 
reviewed elsewhere 
66
. In this study the attention is given to β-lactams as they are one of the 
most commonly prescribed antimicrobials in human and animal chemotherapy in the world.  
1.1 Structure and mechanism of action of β-lactams 
In terms of organic chemistry a lactam is a cyclic amide and its name originates from the 
combination of lactone and amide. Prefixes in a form of Greek alphabet letters (β, γ, δ etc.) in 
front of the lactam’s name inform about the number of carbon atoms present in the lactam 
ring in addition to the carbonyl moiety. The β-lactam is a ring composed of two carbon atoms 
15 
 
in addition to the third carbon in the carbonyl group. The simplest example of such β-lactam 
is presented on the Figure 1a. The β-lactam family of antimicrobials is comprised of several 
groups of compounds, namely penicillins (covering also a subgroup of aminopenicillins), 
penems and carbapenems, cephalosporins and cephamycins often collectively named as 
cephems, monobactams and β-lactam inhibitors. All of these compounds contain the β-lactam 
ring in their core structures (Figures 1b -f) 
66
. 
a) β-lactam  
  
b) penicillins 
 c) cephalosporins 
  
d) carbapenems 
  
e) clavulanic acid 
f) monobactams 
Figure 1. Chemical structures of the main groups of β-lactam family of antimicrobials; a- the β-lactam ring; b- 
general structure of penicillins; c- general structure of cephalosporins; d- general structure of carbapenems; e- 
example of β-lactamase inhibitor (clavulanic acid); f – core structure of monobactams 
 
The targets for β-lactam antimicrobials are located within the bacterial cell walls. The 
organisation of the cell envelopes in Gram negative bacteria differs from the one found in 
Gram positive bacteria and this will be discussed further in this section (Figure 2). 
Nevertheless, in both cases the cell walls are composed of peptidoglycan layers (murein) 
177
. 
To understand the mechanism of action of β-lactams it is first necessary to look at the 
composition of the peptidoglycan and how the latter is synthesised in bacteria. Each 
peptidoglycan layer is composed of two types of disaccharides, the N-acatyloglucosamine 
(NAG) and the N-acetylmuramic acid (NAM) 
177
.  An individual peptidoglycan layer can be 
imagined as a set of parallel glycan chains that are cross linked to each other. The individual 
chains are made up of NAG and NAM connected via amide bonds in a ‘head-to-tail’ fashion. 
These amide bonds are formed in a transglycosylation reaction catalysed by enzymes called 
penicillin binding proteins (PBPs). The cross- linkage of the parallel glycan chains occurs as 
a result transpeptidation reaction which is another reaction catalysed by the PBPs enzymes.  
Each of the NAM is also associated with a pentapeptide chain; these pentapeptides are termed 
stem peptides. In the transpeptidation reaction the stem peptides attached to the NAM 
16 
 
moieties belonging to the neighbour glycan chains are made to form bridges. In E. coli before 
any processing (e.g. the transpeptidation) the five stem peptides are usually the following:  
L-Ala(1)–DGlu(2)–m-A2pm(3)–D-Ala(4)–D-Ala(5), where the numbers in the subscripts indicate 
the position on the pentapeptide counting from the NAM 
177
.  In this case the bridge is formed 
between the D-Ala(4)  of one of the stem chain with m-A2pm(3) of another stem chain attached 
to the NAM on the neighbor glycan chain
177
(Figure 3). In this way a layer of crosslinked 
glycan chains can be formed. The chemistry of crosslinking in some bacteria may differ from 
the one described here for E. coli 
177
.  However, in any case the multiple peptidoglycan layers 
form the final peptidoglycan grid called the cell wall. 
PBPs own their names due to the ability to bind penicillin and as it has been shown later they 
also have affinity to other β-lactam antimicrobials. There exists a range of different PBP 
enzymes in the different microorganisms and usually several types of PBPs are 
simultaneously present in the given bacterium 
177
. The β-lactam antimicrobials resemble 
structurally the chemical substrates utilized by the PBPs enzymes in the transpeptidation 
reaction. The mechanism of action of the β-lactam antimicrobials is as follows: the PBPs bind 
the β-lactam antimicrobials instead of their own substrates. However, the bond formed has a 
covalent nature resulting in inactivation of the PBPs. The cell wall synthesis is stalled and 
bacterium undergoes destruction during its growth or upon the cell division. This means also, 
that β-lactams are bactericidal only to these growing or dividing cells 177. Efficacy of the 
given β-lactam against the bacterium depends on the ability of the compound to reach its 
target PBPs. In the Gram positive bacteria, the cell envelope is composed of only one plasma 
membrane and the thick outer cell wall comprised of many layers of peptidoglycan that are 
directly accessible for β-lactam antimicrobials (Figure 2). In Gram negative bacteria (among 
others Enterobacteriaceae) the cell envelope consists of the plasma membrane, the cell wall 
made up of a thinner peptidoglycan matrix and then the outer cellular membrane (Figure 2). 
 
 
Figure 2. Schematic comparison of the cell envelopes 
in Gram positive and Gram negative bacteria. For 
explanation please refere to the text above. 
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Figure 3. Schematic overview of the arrangement of 
cross-linked peptidoglycan chains within the bacterial 
cell wall. 
 
The classical penicillins G and V are are not active against Gram negative bacteria due to the 
natural impermeability (or rather very low permeability) of their outer membranes 
180
.  
Addition of an amine group to the classical penicillin G and synthesis of aminopenicillins 
makes the latter compounds able to penetrate through the outer membrane of the Gram 
negative bacteria (Figure 4). This phenomenon is related to the porins that are the proteins 
forming channels located in the outer membranes of Gram negative bacteria 
180
. The porin 
channels might be composed of a variety of protein subunits (monomers or multimers) and 
might allow for transport of only certain types of molecules to the inside of the bacterial cells. 
Semi-synthetic descendants of penicillin G, namely the aminoampicillins as well as many 
cephalosporins and other β –lactams readily traverse through the porin channels and can 
therefore be used in chemotherapy against many of the Gram negatives like E. coli, K  
pneumoniae, S. enterica and others not listed. The ability of the β –lactams to penetrate the 
pores was shown to be related to the size of the molecule (smaller molecules penetrate more 
easily), the charge of the given β –lactam (positive charge increase the penetration rate of the 
β –lactams through the certain types of porin channels) and the hydrophobicity of the given 
β-lactams (hydrophilic compounds penetrate faster through the pores)180. 
1. 2 General applications of β-lactams in human and animal chemotherapy and 
implications in mobilization and spread of bla genes in Enterobacteriaceae 
1.2.1 Enteric bacteria -their significance for human and animal health and zoonotic 
potential 
Enterobacteriaceae is a family of Gram negative bacteria covering large number of genera 
found in humans, animals, insects as well as different environmental niche including plants, 
a  b  
Figure 4. Structure of penicillin G (a) and example of aminopenicillin (ampicillin, b); in the circle indicated is 
the amino group (b) 
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soil, surface waters etc.
97
 Among others the three most clinically significant 
Enterobacteriaceae are E. coli, S. enterica and K. pneumoniae 
79
;  E. coli and K. pneumoniae 
are largely responsible for nosocomial infections as well as community acquired infections in 
humans. S. enterica is one of the most common food-borne pathogens of humans especially 
in the developing countries 
77
.  Among others in humans these bacteria typically cause UTI 
(K. pneumoniae and E. coli), gastroenteritis (E. coli, S. enterica), typhoidal fevers 
(S. enterica) and pneumonia (K. pneumoniae) 
77
 
;79
. 
Zoonotic bacteria are those that can be transmitted from animals to humans and vice versa 
and can cause infection to the recipient organism 
42
.  E. coli and S.enterica are known for 
their zoonotic potential. In fact, both are particularly problematic agents causing infections in 
many of the food production animals like poultry, cattle and pigs 
10;65;91
. 
In this thesis a bacterium that can live in natural environments will be termed ‘free living’. 
E.coli is not a free living bacterium  and is almost exclusively associated with human or 
animal GI tract, which is the reason why this species is a suitable indicator of possible faecal 
contaminations of waters or food products 
96
. E. coli can be either normally found as a 
commensal in the human and animal GI tracts, where it may occasionally cause infections in 
immuno-compromised individuals or when the inoculums size is large. Commensal GI flora 
of humans and animals was shown to be composed of resident and transient populations of E. 
coli strains 
96
. The first ones may persist even up to years; the diversity of the transient strains 
may vary over the day. Some of the E. coli strains may function as true pathogens and these 
are generally classified as diarrheagenic (or intestinal pathogenic) or as extraintestinal 
pathogenic strains (Ex-PEC)
28
; the latter may cause infections in variety of sites in the 
affected organisms 
99
.  Six types of the diarrheagenic E. coli (EC) were recognized based on 
the detected virulence factors, serotypes and symptoms of the infections, namely 
enteropathogenic (EPEC), enteroinvasive (EIEC), entrotoxigenic (ETEC), Shiga toxin 
producing (STEC; variants of the latter are the enterohemorrhagic- EHEC and 
verocytotoxigenic- VTEC strains), enteroaggregative (EAEC) and diffuse adhering 
(DAEC)
96
. 
Well described zoonotic agent is E. coli O157:H7 that is known to be often shed by cattle and 
may cause EHEC type infections in humans (actually antimicrobials are not part of the 
treatment of EHEC diseases as this may increase the risk of subsequent development of  life 
threateing haemolitic uraemic syndrome- HUS) 10.  It has also been suggested that the UTIs in 
humans due the E. coli can be in fact zoonotic infections 
55;94;95
.  Jacobsen et al.
94;95
 found 
clonally related E. coli isolated from meat and from the UTI in humans. In another study  
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E. coli isolates from UTI in humans were shown to share similar patterns of resistance genes 
with isolates from pigs, broiler chickens and meat products from these two types of 
animals 
79
.
 
Food production animals may be reservoirs of Ex-PEC strains that may cause 
infections in humans 
89
. Although, in some cases it can be difficult to unequivocally 
determine the clonal relationship of the Ex-PEC isolates from the given animal or meat 
sample with the particular isolate causing infection in human. This is due to the frequent 
remodelling of the genomes in E.coli and horizontal acquisitions of genetic elements from 
other bacteria 
10
. 
S. enterica is not considered as a part of normal flora in humans despite some serovars (Typhi 
and Paratyphi) may specifically colonize and infect humans
77
; non- typhoidal Salmonella 
(NTS) serovars are found in GI tracts of diverse animals, in particular birds and even reptiles 
often without causing infection to these hosts 
77;80
.  NTS are known to cause zoonoses in 
humans and the classical example  of such NTS is the S.Typhimurium DT104 which is the 
most frequently detected serovar in animals and humans 
128
. 
K. pneumoniae is not the classical zoonotic bacterium; however, it is a common inhabitant of 
soil, surface waters and plants and can be also found in GI tracts of mammals 
159;178
.  It 
produces number of virulence factors but is considered an opportunistic pathogen of humans 
and animals 
159;178;217
.  
Because of the ability of the above described enteric bacteria to circulate between humans 
and animals and also in the environmental niches they are considered as vehicles potentially 
transmitting resistance genes between these reservoirs. As discussed in further sections the 
virulence of and resistance to antimicrobials in these key infectious Enterobacteriaceae is 
often related to the presence of plasmids 
99
. 
1.2.2 β-lactams in human and animal chemotherapy and implications in mobilization 
and spread of bla genes on plasmids in Enterobacteriaceae 
Often the same or similar classes of compounds are used in human and animal chemotherapy 
to treat infections caused by the same species of bacteria. Namely, amplicillin, amoxicillin 
(more often amoxicillin combined with clavulanate) and first generation cephalosporins are 
commonly prescribed to humans and companion animals to treat among others UTI  
(typically caused by Enterobacriaceae like E. coli,  K. pneumoniae and Proteus species), 
salmonellosis and diverse types of diarrhoea, also infections caused by other than enteric 
bacteria, examples being lyme disease caused by Borrelia burgdorferi (borreliosis; often 
treated with amoxycillin), infections caused by Haemophilus influenzae (one of the most 
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common agents causing otitis media) and Listeria monocytogenes (listeriosis), Neisseria 
gonorhoe (diversity of infection types), skin infections etc.
9;209
 In animal food production 
aminopenicillins have found application in treatment of the common diseases like bovine 
respiratory disease, mastitis and footrot in cattle, infections common for farrowing pigs 
(metritis, agalactia), collibacillosis and salmonellosis (in particular in poultry and pigs) 
126
. 
Currently four classes of cephalosporins are available on the market. 1
st
 and some of the 2
nd
 
generation cephalosporins have similar spectrum of activity to aminopenicillins 
9
; the 3
rd
 and 
higher generations of cephalosporins are valuable drugs with broad application in treatment 
of severe, often hospital acquired infections in humans; 4
th
 generation cephalosporins are the 
drugs of choice in treatment of infections caused by Enterobacteriaceae resistant to other β-
lactams and importantly, they are the first group of cephalosporins active against 
Pseudomonas aeruginosa 
9
. The classical 3
rd
 and 4
th
 generation cephalosporins used in 
humans are cefotaxime, ceftazidime (3
rd
) and cefepime (4
th
). Rather limited range of 
cephalosporins is approved to be used in food production animals. The 3
rd
 generation 
cephalosporin designed strictly for veterinary use is ceftiofur 
90
. This compound has different 
pharmacokinetic properties compared to other cephalosporins 
90
. Carbapenems and 
monobactams are reserved mainly for human chemotherapy to treat severe infections caused 
by Gram negatives like K. pneumoniae and E. coli resistant to other classes of β-
lactams 
166;210
. 
As illustrated above, β-lactams have broad application in human and animal chemotherapy. 
Intense and often inappropriate usages of antimicrobials lead to the development of resistance 
in bacteria 
126
.  Antimicrobials are -or rather should be - prescribed to humans in the cases 
when a bacterial infection was diagnosed or as prevention when a high risk of bacterial 
infection exists, for example prior or after surgeries in hospitals 
115
.  In acute cases 
antimicrobials can be prescribed before the laboratory results arrive to the physician, if there 
are indications of bacterial infection 
115
.  In animals antimicrobials typically are administered 
to treat diagnosed infections but also as prophylaxis, metaphylaxis and as growth  
promoters (no longer in Europe, discussed below) 
167;181;185
.  Because of the practical reasons 
the treatment of livestock often involves administration of the antimicrobials in feed or water 
given to the whole herd of animals. This is especially valid for intensively reared animals like 
pigs and poultry 
181
. It is believed that mainly these practices lead to the generation of 
reservoirs of resistance genes in food- production animals 
181
 . 
There are various hypotheses explaining how the resistance was acquired by previously 
susceptible Enterobacteriaceae. The occurrence of the new resistance genes (or new variants 
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of existing resistance genes) may be related to the temporary increase in mutation rates in 
bacteria exposed to stress conditions; these bacteria were called transient hypermutators 
3
. 
Another hypotheses points out on so called persister cells present in bacterial populations 
119
.  
Persisters may enter a dormant stage during which they do not grow or divide compared to 
the remaining population (which would be especially effective way to avoid the action of 
antimicrobials like β-lactams) 98; in exchange they may survive the temporary higher 
concentrations of antimicrobials and they may reverse later to the normal growth stage. If 
exposed to sub-inhibitory levels after antimicrobial treatment round or to repetitive usage of 
antimicrobials these persister bacteria might have developed mutations or acquired resistance 
genes on the MGEs like plasmids 
119
.  Persisters have been previously described in E. coli 
and in P. aeruginosa 
98;119
. It is actually a common phenomenon that resistance is detected in 
individuals re-currently treated with antimicrobials or treated with low doses for a prolonged 
time 
126;156;216
. The latter especially applies to usage of antimicrobials as growth promoters in 
animals 
126
. Because of these reasons the use of antimicrobials as growth promoters is no 
longer allowed in Europe 
37;62
.  
In practice resistance to each of the above mentioned classes of β-lactams have been observed 
in Enterobactertiaceae 
154
.  In majority of reported cases the most problematic resistances 
resided on self-transmissible or mobilizable MGEs like plasmids
33;154
 . 
1.2.3 Evidences of transmission of antimicrobial resistance from animals to humans 
The main point of discussion is currently whether the resistance bacteria and hence resistance 
plasmids could have been transmitted to humans from animals 
32;126;181;188
.  Introduction of 
the antimicrobials in livestock production was previously shown to be followed by the 
occurrence of the resistant bacteria in the treated animals as well as in humans (caretakers, 
their family members etc.). Evidences exist that the transmission of resistance might have 
taken place from animals to humans. Many of these evidences were not direct and were based 
on the similarities between the resistance profiles of bacteria (among others indicatory 
E. coli) isolated from animals (poultry, pigs, cattle) and from humans having contact with 
these animals (farm workers, animal caretakers, their family members) 
2;117;168;203;203
.  Direct 
evidences have been based on the molecular methods allowing for detection of either clonally 
related, resistant zoonotic bacteria in humans and animals
108
 or related resistance plasmids 
isolated from humans and animals 
126
.  Studies dated back to 1970s and 1980s reported the 
following cases: transmission of the same resistant E. coli (harbouring a plasmid known 
currently as  IncFII ) was demonstrated from chickens to farm workers and their family 
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members by Levy et al.
118
; similar plasmids conferring resistance to ampicillin and 
tetracycline were described by Holmberg et al. in diverse S. enterica from beef and from 
infected humans with diagnosed salmonellosis 
89
; similar plasmids encoding  resistance to 
aminoglycoside- streptothricin were detected in different  E. coli from pigs fed with this 
antimicrobial and also in farm workers and their families in the study of Hummel et al. 
93
. In 
1990s a range of similar plasmids conferring resistance to gentamycin and apramycin was 
detected in E. coli and S. enterica from cattle and E. coli from diseased humans in Belgium
38
.  
More than a decade later Cloeckaert et al. described an epidemic IncI1 blaTEM-52 plasmid 
(now known to be ST5/CC5
71;100
) in various serovars of S. enterica from human (France) and 
poultry (Belgium)
43
. Recently, a range of E. coli isolates from humans and from poultry 
harbouring the same IncI1 blaCTX-M-1  (mainly ST7/CC5) and IncI1 blaTEM-52 (ST10, ST36/ 
CC5) plasmids were reported in the Netherlands by Leverstein-van Hall et al.
116
  
Madec at al. 
124
 demonstrated that the IncFII (F31:A4:B1
205
 /IncFII and F2:A-:B-/IncFII) 
plasmids harbouring the blaCTX-M-15 genes and IncI1 (CC31) circulated between diverse 
clones of E. coli from humans and animals in France.  
1.2.4 Routes of resistance transmission between animals and humans and evidences of 
in vivo plasmid transfer between Enterobacteriaceae in the GI tract 
Transmission of the resistance may occur either via direct contact with the animal harbouring 
the resistant bacteria or via food chain (consumption of contaminated food or drinking  
water) 
126
.  It has been suggested that the resistant bacteria may reside on the particles 
suspended in the air which may then be deposited on the skin of or inhaled by the exposed 
individuals 
86
. Contamination of agricultural products, in particular sprouts, with coli form 
bacteria  resistant to multiple antimicrobials was also reported 
17
.  In passing, Shiga-toxin 
producing E. coli causing an outbreak in Germany in May 2011 resulting in fifty reported 
deaths was shown to harbour a large blaCTX-M-15 plasmid 
169
; the probable source of this 
bacterium were sprouts likely contaminated with faeces (curiously, as indicated later  
blaCTX-M-15 gene is considered to be typically associated with humans rather than animals) 
24
. 
Contamination of meat products was described among others by Wu et al.
214;215
 (tetracycline 
and sulphonamide resistant E. coli were detected in pig carcasses in Denmark) and Zhao et 
al.
218
 (E. coli resistant to divers antimicrobials were detected in retail meat in USA). 
Bortolaia et al. isolated CTX-M producing E. coli from chicken egg in Denmark, in this case 
interestingly the sample originated from organic farm with no history of antimicrobial  
usage 
18
. 
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Resistant bacteria transmitted from animals to humans or vice versa may either cause 
infections (zoonoses) or the resistance genes may transfer to bacteria colonizing the gut of the 
recipient host organism. There exist experimental evidences that the transmission of plasmids 
between diverse Enterobacteriaceae may take place in vivo in the gut of animals and humans. 
Transmission of an IncR blaTEM-1 pKPN5 plasmid from K. pneumoniae MGH78578 (human 
isolate) to E. coli recipient in the gut of mice
179
  and transmission of plasmids between 
diverse E. coli isolates in the guts of  human infants treated with antimicrobials 
107,
 
15
 was 
previously demonstrated. Trobos et al. demonstrated transfer of sulphonamide and ampicillin 
resistance on a plasmid from animal E. coli isolate to another E. coli recipient in the intestine 
of adult humans 
201
;  in her study the transfer was not stimulated by the presence of selective 
pressure (the human volunteers participating in that study were not ingesting antimicrobials 
for a month prior and then during the study). 
Resistance transmission most probably occurs also outside the human reservoirs. Resistant 
bacteria originating from animal faeces
109
 may contaminate fruits and vegetables (possibly 
via faecals-containing fertilizers), soils and the surface waters and from these sources may be 
picked up by other animals transmitting the resistance (likely on plasmids) genes further 
1;5
.  
Enterobacteriaceae resistant to the ESBL-antimicrobials were detected in wild birds on the 
most remote inhabited island in the world, The Easter Island where the usage of 
antimicrobials on this island is suppose to be limited mainly to the local hospitals
1
. Increased 
attention recently was given also to the travellers who are  suspected of transmitting the 
resistant bacteria from so called high prevalence countries to the countries where the 
occurrence of resistance in humans has been so far low (like Denmark or generally 
Scandinavian countries) 
211
. Swedish study from 2010 demonstrated that 24 of 100 human 
volunteers previously not colonized by E. coli producing ESBLs came back from their travels 
outside the northern Europe and they were colonized by E. coli producing CTX-M, TEM or  
SHV ESBLs 
196
. 
In summary to the above sections, isolates with the same resistance patters (in some cases 
confirmed to be clonally related) were reported in humans and in animals, typically following 
the introduction of an antimicrobial to the livestock production. Moreover, the same 
resistance plasmids were found in the diverse isolates from animals and humans; some of 
these plasmids were self-transmissible. Transmission of plasmids between enteric bacteria in 
human an animal guts was demonstrated. Considering these data, it seems likely that 
resistance plasmids found in humans may originate from animal sources. 
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1.3 Mechanisms of resistance to β-lactams in Enterobacteriaceae 
There are four general mechanisms that bacteria utilize to resist the action of antimicrobials. 
These mechanisms are i) alteration of the outer-membrane permeability ii) over-expression of 
efflux pumps iii) antimicrobial target alteration and iv) enzymatic deactivation of the 
antimicrobials 
154
.  
They will be briefly introduced below. More details will be described regarding the origins of 
and resistance mechanisms by β-lactamases as this is the mechanism typically utilized by  
E. coli, K. pneumoniae,  S. enterica and also many of the other Enterobacteriaceae. Particular 
attention will be given to the TEM- type β-lactamases that are plasmid encoded enzymes 
dominating in ampicillin resistant E. coli of humans and animals 
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52;146;157;160
. 
1.3.1 Impermeability to antimicrobials 
Alteration of the permeability refers mainly to mechanisms found in Gram negative bacteria 
due to the presence of the outer lipopolisaccharide membrane in these microorganisms. As 
indicated above, the efficacy of the given antimicrobial against the bacterium largely depends 
on the ability of the compound to reach the proper target. While in Gram positive bacteria the 
PBPs are readily available targets for the β -lactam antimicrobials, it has been shown that the 
diverse β -lactams present different efficacy in penetrating the outer membranes of the Gram 
negatives 
180
.The resistance mechanism via the membrane permeability alteration is based on 
the regulation of the expression of the specific porins and this influences the uptake of the β –
lactams from the outside of the cell to the periplasmic space in the Gram negative bacteria. In 
some cases the porins specific for the bacterium can be even lost thus preventing the uptake 
of the given β –lactam 208. The genes coding for the major porin proteins and their regulators 
are typically located on the chromosomes in bacteria 
67
. Resistance to higher generations of 
cephalosporins and carbapenems via porin deficiency was observed in number of bacteria 
including K. pneumoniae and E. coli 
162
. 
1.3.2 Resistance due to the active efflux systems 
Once the antimicrobial reached the cytosol or the periplasmic space it is still possible for 
some bacteria to actively pump out the compound via the efflux pumps systems. An active 
efflux pump requires an energy for its action and therefore the ejection of the antimicrobial 
from the cell is coupled either with the hydrogen proton movement into the cell or with the 
hydrolysis of the ATP. There are five major classes of efflux systems in bacteria. These 
families are the Major Facilitator Subfamily (MSF, widely distributed in bacteria and often 
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plasmid and further transposon encoded; often involved in resistance to antiseptics), the 
Small Efflux Regulators (SMR), Resistance/ Nodulation/ Cell Division system (RND, very 
efficient efflux system widely distributed on chromosomes of Gram negative bacteria), ATP- 
Binding Cassette (ABC system, often chromosomally encoded by the antibiotic producing 
bacteria) and the Multidrug and Toxin Extrusion system (MATE) 
162
. Typically the resistance 
problem in Gram negative bacteria is associated with the mutations causing the over-
expression of the efflux systems, thus allowing the bacterium to efficiently pump out a wide 
range of the small molecules including antimicrobials like β-lactams 162. In E. coli and also in 
N. gonorhoeae and P. aeruginosa mainly RND type systems were described conferring the β-
lactam resistance 
138
.  
1.3.3 Resistance by target alteration  
In terms of β -lactam resistance the target alteration could be the modification of PBPs in a 
way that they lose the affinity to these antimicrobials. This was achieved in many Gram 
positive bacteria due to chromosomal mutations within the genes encoding the PBPs 
176
. 
Currently, methicillin and oxacillin resistant S. aureus (MRSA/ORSA) are the common 
problem not only in the health care units but also in the community. In Enterobacteriaceae 
mutations in the blaTEM genes causing the resistance of the encoded TEM enzymes to β-
lactamase inhibitors could be considered as target alteration mechanism (author’s comment).  
1.3.4 Resistance due to enzymatic modification of the antimicrobials 
Bacteria can produce enzymes capable of deactivating some of the antimicrobials. The 
enzymes may catalyze different reactions to chemically modify antimicrobials; examples of 
these reactions are acetylation, phorsphorylation, nucleotidylation and many others that are 
studied in details elsewhere 
213
. The enzymatic hydrolysis is the mechanisms utilized by 
enzymes β-lactamases to degrade the β-lactam compounds both in Gram positive and Gram 
negative bacteria (usually β-lactamases are found in Gram negative bacteria). In Gram 
positive bacteria β-lactamases are often extracullar, while in Gram negative they are typically 
retained in the periplasmic space 
121
. β-lactamases and their mechanism of action will be 
explained in more details below. 
1.3.4.1 β- lactamases in Enterobacteriaceae- classification and mechanism of action 
β- lactamases are probably the most common reason of resistance to β- lactams in Gram 
negative bacteria. There exist a range of different enzymes β- lactamases. Following the 
Ambler structural classification it is possible to group the majority of these enzymes found in 
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Enterobacteriaceae into four classes, A, B, C and D 
170
. A, C and D classes have serine in 
their active sites. Otherwise, these three groups do not seem to share common primary 
structures. This indicates that they are probably distantly related with each other (which may 
be a result of convergent evolution) 
170
. The B class enzymes have the metal ion in the active 
centre, although the general mechanism of hydrolysis of the β- lactam ring is similar to the 
one utilized by A, C and D enzymes.  
β- lactamases can also be classified based on their substrate specificity. Bush and Jacoby 26 
proposed an updated classification scheme combining the substrate specificities and structural 
similarities of the diverse β- lactamases. According to the Bush classification class A and D 
of β- lactamases belong to the group 2 of serine β- lactamases, class C enzymes correspond to 
group 1 cephalosporinases and class B correspond to group 3 metallo- β- lactamases (MBLs).  
In clinical settings and also in animals the most commonly encountered in Enterobacteriaceae 
are class A enzymes: TEM, SHV and CTX-M 
20
.  Class A comprises β- lactamases like 
penicilinases, Extended Spectrum β-lactamases (ESBLs) or inhibitor resistant β- lactamases. 
The first ones hydrolyze penicillins and also some of the early generations of cephalosporins. 
TEM-1 and its derivative TEM-2 and also SHV-1 are the most commonly detected 
penicillinases in E. coli. Overall, in E. coli class A β-lactamases are almost exclusively 
located on transferable plasmids. 
ESBLs are defined as β-lactamases capable of hydrolysing oxyimino-cephalosporins and that 
that are inhibited by clavulanic acid 
27;122
.  Oxyimino-cephalosporins are β-lactams 
harbouring oxyimino-aminothiazoyl side chains. Oxyimino groups are found on the third and 
fourth generation cephalosporins and the monocyclic β-lactams (for example azerotram). The 
SHV and TEM ESBLs are believed to be evolutionary descendants of the TEM-1 and SHV-1 
penicillinases. The first ESBLs of SHV and TEM types have been described in E. coli and K. 
pneumoniae already in 1980s 
122
. Since then almost 200 variants of TEM enzymes and more 
than 180 variants of SHV-type enzymes have been described. Many if not a majority of these 
are ESBLs. In the mid-1990s the TEM-52 ESBLs was first detected in a K. pneumoniae  
isolate 
163
. Due to its stability and spectrum of activity TEM-52 became one of the most 
commonly detected TEM type ESBLs in E. coli, S. enterica and K. pneumoniae 
147
. The most 
commonly detected SHV types ESBLs are SHV-2 and SHV-5 
50
. 
In 1990s the CTX-M ESBLs began to infiltrate the clinically relevant Enterobacteriaceae 
137
. 
Possibly due to their higher efficacy against β- lactams like cefotaxime ( this antimicrobial 
have high speed of penetration of the bacterial outer membranes
51
)  the divers CTX-M in 
practice replaced the TEM and SHV β- lactamases. Nevertheless, the two latter enzymes are 
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still considered to significantly contribute to the resistance in the Enterobacteriaceae. 
Currently five major groups of CTX-M β- lactamases have been recognized, namely CTX-M-
1, CTX-M-2, CTX-M-8, CTX-M-9 and CTX-M-25 
29
. Interestingly, the different groups are 
often highly prevalent in the specific geographical locations. CTX-M-14 (CTX-M-9 group) 
was shown to be most prevalent in Spain, while CTX-M-15 (CTX-M-1 group) was shown to 
be most prevalent in United Kingdome 
29
.  There seem to be also a reservoir bias, namely 
blaCTX-M-15 genes are more frequently detected in humans 
124;137;152
 while blaCTX-M-1 are more 
frequently detected in animals 
137
. 
Some of the class A TEM and SHV β- lactamases evolved resistance to the inhibitors 20. The 
TEM inhibitor resistant β- lactamases (IRTs) are often detected in E. coli isolates from 
urinary tract infections (UTIs). This is probably the side effect of the common application of 
amoxicillin-clavulanate in chemotherapy against these infections 
30
. 
The B class covers the Metalo- β- lactamases (MBLs) and these enzymes have usually a zinc 
ion at their active site, although it is not always the case. Classical examples of MBLs are 
VIM and IMP type enzymes. 
140
  Class C β- lactamases is generally comprised of enzymes 
termed AmpCs which are typically encoded chromosomally; recently however increasing 
occurrence of plasmid encoded AmpC enzymes (class C) is being reported 
155
. Class D is 
comprised of so called OXA –type enzymes. The class B- MBLs and class D- OXA enzymes 
are currently the major cause of resistance to caprbapenems mediated by β-lactamases in 
clinically relevant Enterobacteriaceae and also in P. aeruginosa and Acinetobacter baumanii, 
in which these enzymes are also typically associated with plasmids 
140;154
. 
Reference sequences of the diverse variants of β- lactamases mentioned above are collected 
in the Lahey Clinic database at http://www.lahey.org/Studies/.  
 
The mechanism of action is similar for all the β- lactamases 63;213. These enzymes hydrolyse 
one of the bonds within the core β-lactam ring between the carbon and the nitrogen atom. 
Once the β- lactam ring is broken the molecule loses its activity as it is no longer recognized 
as a substrate by the bacterial housekeeping PBPs. The following steps are included in the 
chemistry of the β- lactam hydrolysis. The active serine residue of the A, C or D class 
enzymes nucleophilically attacks the carbonyl atom of the β- lactam ring. This generates a 
covalent but unstable enzyme- β- lactam intermediate. The covalent bond between the serine 
and the β- lactam is rapidly cleaved at the presence of water. As a result the enzyme is 
regenerated while the β- lactam ring is left degraded 63;213.  MBLs employ a different 
mechanism to open the β- lactam rings. They use the metal ion (typically zinc ion) to activate 
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the water molecule. A hydroxide ion is generated that attacks the β- lactam ring. Again the 
hydroxyl- β- lactam intermediate is unstable and falls apart producing the inactivated 
antimicrobial  
63;213
.  
β- lactamases inhibitors are compounds having the β- lactam ring but with some exceptions 
they do not inactivate the PBPs in bacteria like the usual β- lactam antimicrobials.63 Instead 
inhibitors inactivate β- lactamases and when combined with other β- lactam antimicrobials, 
the later are free to interact with their targets on PBPs. As indicated above some β- 
lactamases became or are resistant also to the inhibitor compounds 
20;63
.  
1.3.4.2 Origins of the β- lactamases 
The first reports of the enzymes penicillinases in E. coli are dated back to 1940-s, which 
corresponded to the start up of production of penicillin on a commercial scale 
63;120
. The 
majority of the known β- lactamases probably evolved from the PBPs. PBPs own their names 
to the ability to bind penicillin and -as it has been shown later- they also had affinity to other 
β-lactam antimicrobials. There exists a range of PBP enzymes and usually several of these 
enzymes are present in diverse organisms 
81;190
. They are found both as membrane-bound 
enzymes and as periplasmic proteins. Purified enzymes have been shown to function among 
others as D-alanine carboxypeptidases, peptidoglycan transpeptidases, and peptidoglycan 
endopeptidases. In all bacteria in which PBPs have been studied, these enzymes have been 
shown to catalyze more than one of the above reactions 
190
.  It has been shown the PBPs have 
the penicillin-insensitive transglycosylase domain at their N-terminal (involved in formation 
of linear glycan chains) and a penicillin-sensitive transpeptidase domain at the C-terminal 
(involved in cross-linking of the stem peptides) 
8
 . The serine is the key amino acid at the 
active site of transpeptidase domains and it is conserved in all members of the PBPs family 
8
. 
This has implications into understanding of the occurrence and evolution of the resistance to 
β -lactams mediated by β-lactamases. The exact details on the structures of the different β- 
lactamases will not be given here. However, the A, C and D β-lactamases despite some 
overall differences at the amino acid sequence levels they all share the serine in their active 
sites. They could thus have evolved from the different PBPs. Moreover, it has been deduced 
that the substitution of one of the amino groups in the active centre of PBPs to water 
molecule changes the enzyme function from transpeptidase (PBPs) to a hydrolase (β-
lactamases) 
110;111
. Only the class B metalo- β-lactamases use another mechanism for 
hydrolysis of their β –lactam substrates, namely the metal ion instead of the serine in the 
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active site, as described above. Hall et al.
82
 suggested that MBLs had their very origins in 
Archea. 
The PBPs are encoded by chromosomal genes in bacteria. In contrast, currently the most 
clinically problematic are the β-lactamases encoded by genes located on mobile elements like 
plasmids and transposons. On the other hand, it is now known that a number of these plasmid 
located bla genes have their analogs located on the bacterial chromosomes. Many of the 
Gram negative bacteria naturally produce the chromosomally encoded β-lactamases 20;155. 
The most obvious evidence of the chromosomal ‘very origins’ of some of the plasmid 
encoded  β-lactamases are illustrated by the cases of the AmpC β-lactamases (class C), the 
CTX-M type (class A) and the SHV β-lactamases. Species like Enterobacter cloacae, 
Citrobacter freundii, Serratia marcescens, and Pseudomonas aeruginosa were shown to be 
able to overproduce their chromosomal AmpC as a result of mutations in the promoter region 
of the gene 
155
. However, over time these ‘foreign’AmpC β-lactamases were detected in 
Klebsiella pneumoniae, Escherichia coli, Salmonella and in other species and they were 
shown to be encoded from plasmids 
155
. That clearly indicated the mobilization of the ampC 
genes (blaAmpC) from the bacterial chromosomes onto plasmids. Conversly, the CTX-M β-
lactamases (class A) have been observed on plasmids in the clinical isolates of diverse 
Enterobacteriaceae but have been later shown to have their equivalents chromosomally 
encoded in Kluyvera species.In fact, the specific types of blaCTX-M  genes found on plasmids 
originated from the different Kluyvera species. The blaCTX-M -9 & 25 probably originated from 
K. georgiana 
161
, while bla CTX-M-1 & 2 from K. ascorbata 
92;139
. 
1.3.4.3 Origins and evolution of the TEM type β-lactamases 
The chromosomal progenitor to the TEM β-lactamases was not yet revealed. The first record 
on TEM-1 β-lactamase is dated back to1963, when an E. coli strain harbouring a plasmid 
encoding β-lactamase was isolates from a Greek patient Temoniera, hence the abbreviation 
TEM 
20;175
. TEM-1 is currently the most dominant transferable β-lactamase found worldwide 
mainly in E. coli, but also in other Enterobacteriaceae, in P. aeruginosa, Haemophilus 
influenzae and N. gonorrhoeae 
20
. The blaTEM-1 genes were the predecessors for numerous 
variants that encode the TEM type β-lactamases presenting diverse spectrum of activity 
against the different β-lactam antimicrobials. The variants of TEMs described in the Lahey 
reference data base (www.lahey.org/Studies/temtable.asp) correspond to proteins differing at 
the amino acid level between each other. These variants resulted from the miss-sense 
mutations (mutations within the nucleotide codon sequence resulting in the change of the 
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encoded amino acid)
3
. However, also silent point mutations are observed within the given 
blaTEM genes coding for the specific TEM variants. Until now nine alleles of the blaTEM-1 gene 
have been detected on plasmids deposited in the public databases (GenBank). These alleles 
are designated with one letter suffixes, currently from blaTEM-1a to blaTEM-1j and they differ 
from each other by one to several nucleotide base pairs, although they all encode the same 
TEM-1 protein (the allele ‘i’ was not officially annotated on previously published sequences 
in GenBank, however the blaTEM-1 gene found on pHCM1 - AL513383 probably constitute 
the tenth ‘i’ allele according to anlaysis performed in this study). In some cases the blaTEM-1 
alleles were defined not only for the blaTEM-1 open reading frames, but also the mutations in 
the promoter regions were considered (e.g. blaTEM-1d and blaTEM-1f)
199
. So far three alleles (a, b 
and –c) of the blaTEM-52 variant of the gene encoding the TEM-52 β-lactamase were observed. 
Both the mis-sense and the silent point mutations are useful in tracing the pathways of 
evolution of the blaTEM genes. 
Initially, the TEM-1 β-lactamases did not seem to present a major treat from a clinical point 
of view, as it should have be possible to use other classes of β-lactams to treat the infections 
caused by ampicillin resistance bacteria. However, it has been deduced that in some cases 
only one nucleotide substitutionin the blaTEM-1 may result in an enzyme product called 
Extended Spectrum β- Lactamase (ESBLs)20.  This is exemplified by blaTEM-135 whcih differs 
by one nucleotide compared to blaTEM-1b. Higher generations of cephalosporins harbouring 
the large side chains were initially simply too big to enter the active centres of the early TEM 
β-lactamases (as well of the early variants of SHV β-lactamases). Extensive usage of higher 
generations of cephalosporins most probably influenced the mutations and recombination 
frequency in some of the blaTEM genes
3;88;135;193
. As a result the active centre of the encoded 
enzymes underwent enlargement enabling the entrance of the different, more complex β-
lactam substrates resulting in production of ESBLs TEM enzymes. 
Certain amino acids within the TEM enzyme sequence play a critical role for the activity and 
stability of TEM β-lactamases enzymes 20;175. Substitution of these amino acids was shown to 
result in either the ESBLs or the inhibitor resistance (IR) phenotypes conferred by the 
enzymes. The list and positions within the TEM-1 sequence of the amino acids whose 
substitution results in the ESBLs or IR phenotypes is given in the review of Bradford et al.
20
  
Among the numerous TEM-type ESBLs observed in bacteria one of the most predominant 
types became the TEM-52 enzymes. Three substitutions are present in the TEM-52 compared 
to the TEM-1. Namely the glutamic acid at position 104 was substituted by lysine (E104K), 
methionine at 182 was changed to threonine (M182T) and glycin at 238 was substituted by 
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serine (G238S)
147
. It is suspected, that the substitutions E104K and G238S occurred as first 
ones resulting in the enlargement of the TEM active centre
147
. This is observed on the TEM-
15 enzymes that differ from TEM-1 by the two substitutions, E104K and G238S. The last 
substitution M182T conferred the increased stability of the final TEM-52 structure 
147
. It 
would actually be enough for the TEM-1 enzyme to receive a substitution at position G238 to 
significantly increase the size of the active centre and allow the enzyme to bind and 
hydrolyze the 3
rd
 generation cephalosporine like cefotaxime 
175
. The important lesson from 
the studies on the TEMs β-lactamases evolution was that the degree of ‘success’ of this 
evolution is the resultant of the enzyme stability and hydrolytic activity, like in the case of 
TEM-52. It is possible that the novel enzyme products may have increased activity against 
the higher classes of β-lactams but due to the instability of the protein structure they may in 
fact not be capable of conferring their function in the bacterium; or opposite, further 
mutations in the enzyme may be detrimental for the ESBL phenotype 
147
. On the other hand 
the evolutionary potential of the TEMs as well as other classes of β-lactamases have not yet 
been fully utilized and there is still space for occurrence of new variants 
147
.  Interestingly, for 
many years no enzyme has been observed that would display the inhibitor resistance and 
ESBL phenotype simultaneously. Recently however, complex mutant TEM β- lactamases 
(CMTs) were described 
30
. These enzymes combine the mutations typical for IRTs and 
ESBLs.  
It is highly possible that the recombination between different alleles of the blaTEM genes that 
may be present in the same cell or on the same plasmid (possibly due to gene duplication
88
) 
contributes to the increasing variety of these genes. It has been previously suggested that 
gene conversion and homologous recombination might have played a critical role in the 
blaTEM evolution 
88;135
. Evidences exist that allelic recombination most probably shaped the 
evolution of the blaSHV genes as well 
7
.  
2. HORIZONTAL GENE TRANSFER, MOBILE GENETIC ELEMENTS AND 
SPREAD OF ANTIMIROBIAL RESISTANCE 
Attention has been given above to the origins of the β-lactamases in bacteria. It has been 
pointed out that the bla genes are often associated with mobile platforms, which is the 
probable reason for their worldwide distribution. This section will focus on the basic biology 
of plasmids from Enterobacteriaceae (in particular E. coli) and their role in the transmission 
of antimicrobial resistance. Also other MGEs and the mechanisms of HGT will be discussed. 
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2.1 Modes of acquisition of resistance genes in bacteria- HGT 
Some bacterial species are naturally insensitive or in other words intrinsically resistant to 
certain antimicrobials. This may be due to the lack of the antimicrobial target in the given 
species or due to the natural impermeability of the outer membrane to the given  
antimicrobial 
197
.  For example Gram negative bacteria like E. coli or K. pneumoniae are 
intrinsically resistant to penicillin G due to their low permeability to this antibiotic.  
Acquired resistance refers to the resistance that appeared in the previously susceptible 
bacterial population as a result of mutation or as a result of acquisition of genes from 
exogenous DNA in the process of HGT 
197
. There are three generally recognized mechanisms 
of HTG: transduction, transformation and conjugation. An accessory mechanism termed 
conduction has been recently described that is linked with conjugative transfer of DNA 
74
. 
2.1.1 Transformation  
Transformation is an uptake of the linear or circular double- stranded DNA by the bacterium 
directly from its surroundings 
83
.  Some bacteria are naturally competent which means they 
are naturally capable of uptake of DNA in this mode. Bacillus subtilis and Streptococcus 
pneumoniae are classical models of natural competence in Gram positive bacteria; the natural 
competence was described also in Gram negative bacteria like H. influenzae and Neisseria   
species 
40
.  
2.1.2 Transduction 
Transduction is a process of DNA transfer between bacteria mediated by bacteriophages 
(bacteria specific viruses) 
83
.  Upon infection the bectrophage first attaches to the receptors 
found on the bacterial surface (these receptors could be lipopolisaccharides, teichoic acids, 
pili and other surface antigens). Subsequently the bacteriophage injects its DNA to the 
bacterium. At this stage the bacteriophage can either undergo the lytic state or the lysogenic 
state. During the lytic pathway bacteriophage replicates itself and this is usually finalized by 
breakage of the bacterial cell and releasing the multiple new copies of the bactriophage 
83
.  If 
the bacteriphage enters the lysogenic state, it integrates into the bacterial chromosome as an 
inactive prophage. The prophage can be again activated and then enter the lytic pathway 
when induced by different stress factors, for example by means of UV light or other DNA 
damaging agents.   
Two types of transduction mechanism have been described, the generalized and the 
specialized transduction. The generalized transduction refers to the situation, when only the 
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bacterial DNA is by a mistake packed into the phage capsid instead of the viral DNA 
83
.  In 
generalized transduction it is also possible that a whole plasmid, plasmid elements or a 
transposon DNA can be packed to the viral envelope. Upon the subsequent infection and 
injection of the DNA content to another host, the new genes can be inserted into the new host 
DNA by means of homologous recombination or transposition, if the transposon was initially 
packed. If a plasmid replicon was packed it can re-establish itself in the new host 
83
.  
Specialized transduction refers to the situation, when the genes in the close proximity of the 
phage integration site on the bacterial DNA are accidentally excised and packed together with 
the viral DNA upon activation of the prophage.  If the DNA incorporated into the phage is 
stable, the virus can replicate and infect other bacteria. Otherwise, it is also possible that the 
DNA fragment mobilized by the phage recombines with the DNA of the new host 
83
. 
There are some evidences that the transduction might have been evolved in the transmission 
of the bla genes in Enterobacteriaceae. Study of Muniesa and co-workers showed that 
bacteriophages harbouring blaOXA and blaPSE type genes were present in sewage 
136
. Colomer-
Lluch et al. detected blaCTX-M and high prevalence of blaTEM on DNA of bacteriophages 
isolated from poultry, pigs and cattle faecal wastes 
48; 49
. A sequence of a Phage 7 is deposited 
in GenBank (AF503408 from an unpublished study). According to the description available 
in GenBank this phage was isolated from human faeces and according to an in silico analysis 
(this study) it represents IncY group of replicons 
130
. Its sequence contains the transposon 
Tn2 linked with blaTEM-1b gene (this study).  Nevertheless, the literature data regarding the 
impact of transduction in the transmission of bla genes is still scarce. 
2.1.3 Conjugation  
Conjugation and the related mechanisms are believed to be main contributors to the spread of 
antimicrobial resistance in Enterobacteriaceae .Conjugation is the direct transfer of one of the 
strands of a plasmid DNA (or another conjugative DNA molecule) from one bacterium to 
another 
83
. The transfer is followed by the synthesis of the complementary DNA strands in 
the donor and in the recipient bacteria. Conjugation of integrative conjugative elements and 
conjugative transposons would be followed by the integration of such elements into host 
chromosome as these elements cannot self replicate. The transfer usually requires 
establishment of cell to cell contact and the expression of a conjugative channel through 
which the DNA could traverse from the donor bacterium 
83
. 
There are in general two types of transferable plasmids: conjugative (self-transferable) 
plasmids and mobilizable plasmids 
76
. The latter do not encode the full machinery required 
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for conjugation but they harbour as a minimum requirement their own conjugal transfer 
origin (oriT). Thus they can utilize for transfer the remaining protein machinery encoded by 
other plasmids present in bacterium. This phenomenon is called mobilization 
76
. 
Conjugation was generally better studied in Gram negative bacteria due to the difficulties 
with establishing which factors are responsible for achiving the cell to cell contact in Gram 
positives; in Gram negatives this contact is mediated by conjugative pili 
78
. The majority of 
the conjugative plasmids from Enterobacteriaceae encode the transfer systems that resemble 
the bacterial type IV secretion system (T4SS) 
113
. Similar conjugation systems are also 
encoded by mobile elements like ICEs or conjugative transposons. The transfer regions of the 
self- conjugative plasmids (or ICEs) are comprised of three main elements encoding the 
relaxases, mating pair formation components (MPF) and the coupling protein 
113
. Relaxases is 
a collective name describing family of enzymes catalysing site and strand specific nicking of 
a double- stranded DNA. In plasmids there are two types of relaxases, the replication 
initiatior proteins (Rep proteins) and the transfer initiator proteins (MOB proteins) 
59;76
.  In 
conjugation or mobilization the specific MOB protein binds to its specific site within the 
plasmid oriT 
113
. MOB relaxase catalyses the nicking of one of the DNA strands at the nic 
site and initiates the transfer. A range of helper proteins is involved in the initiation of the 
transfer. Together with the MOB relaxase they bind to plasmid DNA at the initiation site and 
the resultant nucleoprotein complex is termed relaxosome 
113
. The model explaining the 
conjugation mechanism of plasmids suggests that the relaxosome contacts the coupling 
protein that is linked to the channel formed within the donor cell envelope. The outer 
extension of the channel is termed a sex pilus and it contacts the recipient bacterium.  The 
channel and the pilus are part of the transfer apparatus encoded by the MPF region on the 
plasmid. The coupling protein directs the relaxosome to the channel and the single stranded 
DNA is pushed through the channel. Experimental evidences suggest that the MOB relaxase 
traverses to the recipient together with the plasmid singe stranded DNA (ssDNA)
59;113
. When 
the ssDNA is fully transported to the recipient probably the MOB relaxase catalyses the 
recircularization and the host factors initiate the replication of the complementary plasmid 
DNA strand in the recipient
113
. The latter is now called transconjugant. The complementary 
strand of the plasmid DNA in the donor is being synthesized already while the transfer of the 
other strand is in progress. 
Importantly, conjugative plasmids in Enterobacteriaceae can be either liquid maters capable 
of conjugation in liquids (typically with the T4SS like conjugation systems) or surface maters 
that require solid surfaces to conjugate
59
. The first type is represented by the IncF plasmids, 
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the example of latter type are IncW plasmids 
173
. Regions allowing for conjugation both on 
the solid surfaces and in liquids were described on IncI1 plasmids 
100
. 
Conjugative plasmids may also form co-integrates with another plasmids. If the co-integrate 
is not resolved prior the conjugation the two plasmids would be transported together to the 
recipient cell. This process is termed conduction 
74
.  
2.2 Mobile genetic elements participating in the transmission of antibiotic resistance 
The vehicles of the HGT in bacteria can be phages, plasmids, ICEs, conjugative transposons 
and transposable elements like insertion sequences (IS), transposons, integrons and other 
variants of these elements. Resistance genes might be associated with any of these elements 
and often the smaller transposable elements (IS-es, transposons) are integrated onto larger 
self-transmissible platforms like the ICEs, plasmids and finally chromosomes 
189
. Below a 
broader introduction will be given to plasmids and in particular plasmids found in the family 
of Enterobacteriaceae. Also the MGEs specifically related with blaTEM genes will be 
described with more details. 
2.2.1 Plasmids - basic biology, classification and diversity in Enterobacteriaceae.  
Plasmids are usually double- stranded circular DNA molecules found in a wide range of 
Prokaryotes (Bacteria and Archaea) and to lesser extend in some Eukaryotes. The linear 
plasmids have been described among others in Streptomyces and Borrelia species and some  
fungi 
105
.  The key property of plasmids is that they can replicate autonomously from their 
host chromosomes 
34
.  Similar to viruses, plasmids require the host proteins and substrates in 
order to express their own genes. Often the term replicon is used when describing a plasmid. 
In genetics, a replicon refers to a DNA or RNA molecule (or a region on that molecule) that 
can replicate from a single origin of replication. In case of a plasmid the term replicon refers 
to the minimal region that is indispensable for plasmids to replicate. In this thesis the replicon 
will be used to collectively describe the minimal region required for plasmid to replicate and 
to maintain itself at a characteristic copy number per host cell (replication, control and 
partitioning functions) 
34
.  Plasmids might be simple structures whose only functions seem to 
be their own replication. Such plasmids are designated as cryptic; or they can be sophisticated 
and complex systems encoding a variety of accessory functions in bacteria. Such complex 
systems are believed to be products of a continuous interplay between plasmid DNA acting 
like a selfish molecular parasite and selective pressure imposed by the changing external 
environment 
189
.  Perceiving a plasmid as a form of ‘living’ molecule makes it easier to 
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understand, that the evolution and spread of resistance to antimicrobials discussed further in 
the text is not only a matter of survival for bacteria exposed to those antimicrobials. It is 
actually a matter of survival for plasmids which in a way resemble leaving creatures willing 
to persist and replicate in a given niche and whenever possible to colonize other niches in 
order to increase their chances for survival 
189
.  Possibly as a result of this strive for survival 
the simple cryptic plasmids acquired some genes via DNA rearrangements (insertions, 
deletions) and homologous recombination events. Products of these genes either enabled 
plasmids to transfer to other bacterial hosts (plasmids developed transfer region), or offered 
the host bacterium some selective advantages to be able to persist in or colonize otherwise 
unavailable niche (evolution of accessory functions region) 
189
. 
It has been deduced by researchers that acquiring more functions by plasmids and thus 
increasing in size might have become too much of an energetic burden for the host 
bacteria 
164;204
.  The latter might have therefore been more prone to lose such large plasmids 
upon the cell division, especially if the plasmid did not confer any selective advantage at the 
given time point. This imposed a need for plasmids for developing more stringent systems for 
control of their own replication and copy number (to diminish the energy requirements for the 
hosts)
204
 and then active partitioning to daughter cells upon host replication (to assure stable 
inheritance on the cost of lower copy number) 
19
.  In some cases plasmids developed 
addiction systems assuring themselves that the bacteria would not lose the plasmid even if the 
function conferred by it is no longer essential for host survival 
171
.  Usually such addition 
systems are based on toxins and anti-toxins that at the presence of plasmid encoding both of 
them neutralize each other; upon loosing the plasmid the more stable and longer lasting toxin 
would kill the host 
171
. 
Plasmids can be seen as the resultant products of the selective forces acting upon them and 
leading to DNA rearrangements. Acquisition of the new features and clustering of the core 
functions shaped by the plasmid-host- environment interactions resulted in modularity of 
plasmids structures 
189
. Three basic modules were proposed for plasmids: the replication 
module (containing the control of replication elements), the transfer module and the 
accessory functions module. One could add to this list also the partitioning and maintenance 
units (covering respectively the active partitioning systems and the host addition systems) as 
well as host adaptation module related to the host range 
189
 . 
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2.2.2 Plasmid replication  
Three modes of replication have been described in circular plasmids: the theta replication, 
strand displacement and rolling circle replication (RC) 
60
. In the RC mode the replication 
initiation protein catalyses the nicking of the leading strand of the double-stranded plasmid 
DNA. The leading strand is then unwound while in the same time the new complementary 
leading strand is being synthesized on the lagging strand template. The unwound leading 
ssDNA is circularized and serves as template for the new complementary lagging strand 
60
. 
RC plasmids were so far described primarily in Gram positive bacteria.  
Strand displacement mechanism was described with most details in IncQ family of plasmids. 
This mode of replication involves three plasmid encoded replication proteins RepA 
(helicase), RepB (primase) and RepC (replication initiator). The region on the plasmid where 
the initiation of replication occurs is composed of the series of iterons followed by the GC 
rich region and then the AT rich region, downstream of the latter there are found two single 
stranded origins of replication, ssiA and ssiB located on the opposite DNA strands. The 
strands are termed respectively L and R. The RepC proteins bind to the iterons and together 
with RepA probably induce the opening of the two DNA strands downstream of the AT rich 
region. This results in exposition of the two ssi origins that are now available for priming by 
the RepB. The replication is conducted by the host polymerase and may proceed in one 
direction from one of the ssi-s or in both directions from both ssi-s simultaneously 
58;123
 
(Figure 5) .The DNA strand that is not serving as the template for replication is being 
displaced by the newly synthesized one, thus the name of this mechanism of replication 
60
. 
The lack of Okazaki fragments during the DNA replication is the unique feature of the strand 
displacement mechanism described in the IncQ replicons 
123
. 
E. coli chromosome as well as many replicons of the large plasmids found in 
Enterobacteriaceae replicate via theta mode. In plasmids the theta replication may be initiated 
from one or from multiple origins and can be uni- or bi-directional, although in most cases 
the replication is unidirectional 
60
.  In the majority of plasmid families the initiation of the 
theta replication involves the replication initiator Rep proteins. The plasmid encoded 
replication initiator protein as well as a number of host and plasmid encoded helper proteins 
are assembled at the origin. This enables the opening of the doublestranded DNA. Similar to 
the strand displacement, the primase protein is synthesizing a short primer at the exposed 
single strand origin for the leading strand synthesis. The helicase protein is unwinding the 
doublestranded DNA at the newly initiated replication forks. However, contrary to the strand 
displacement, in theta replication also the laggings strand is synthesized simultaneously with 
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the leading strand following the same replication forks (Figure 6). The lagging strand is 
synthesized in a discontinuous fashion from the Okazaki fragments. During the plasmid theta 
replication a product resembling the Greek letter θ can have been observed under the electron 
microscope, which gave the origin to the name of this mechanism 
60
. In some plasmids like 
those with ColE1 type replicons replication initiator protein is not required. Instead, a long 
RNA pre-primer designated as RNA II is constitutively transcribed by the host RNA 
polymerases 
206
. The pre-primer is processed to achieve proper conformation and cleaved by 
host encoded RNaseH in the maturation process; after cleavage the pre-primer fragment that 
remains hybridized with the template plasmid DNA serves as the primer for plasmid DNA 
synthesis by host polymerases. 
 
 
Figure 5. Replication by strand displacement (replication can 
occurs from one or from both ssi origins; the example is not 
drawn to scale) 
 
     
 
Figure 6. Replication by θ mechanism (example for bi-directional replication; uni-directional replication would 
occur in a similar fashion only with one replication forks proceeding in one direction) 
2.2.3 Control of plasmid replication and its implications in plasmids incompatibility 
A plasmid is thought to be an energetic burden for a bacterium as it requires the building 
blocks and assembly of the protein machinery for expression of its genes 
69;164
. Therefore in 
the absence of selective pressure the bacterium may lose the plasmid during cell division. 
Plasmids developed strategies to assure themselves progression to daughter cells upon 
bacterial division. They may rely on random distribution to the daughter cells but are then 
usually present in higher copy numbers (such plasmids tend to be smaller as larger plasmids 
present in high copy are expected also to become unstable in bacterial cells) 
69
. This increases 
the chances that at least one plasmid copy will be distributed further upon the cell division. 
On another hand, there is always a probability that when the host bacterium divides some of 
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the daughter cells will not receive the copy of the plasmid, while some cells will receive 
many copies 
204
. This inequality in the distribution of plasmids to the daughter cells may lead 
to the increasing number of plasmid free cells in the populations and thus losses of even high 
copy number plasmids at the absence of selection against them 
204
. It is proposed that an 
alternative strategy is active partitioning utilized by many plasmids. This mechanism is 
assuring them more stable inheritance to daughter cells. These plasmids are often present in 
lower copy number but are larger due to the additional DNA load 
164
.  
Regardless the assumed partitioning strategy, plasmids need to be able to control their 
replication in order to assure that there is always a proper number of copies available for 
partitioning and also to be able to increase the replication rate if too low number of copies 
was received by the daughter cell after division 
204
.  Conversely, uncontrolled runaway 
replication would also lead to plasmid instability in the host 
69
. Control of replication and 
copy number is thus essential for a plasmid stable inheritance. That implies plasmids need to 
be able to ‘count themselves’ and to control and adjust their replication frequency in order to 
achieve the desired copy number. Every plasmid replicon in the given host (and physiological 
conditions) has its characteristic, inherent copy number 
206
 . The copy numbers for different 
plasmids can vary from just one up to several hundreds 
144
. The actual number of plasmid 
copies per cell can also fluctuate over time in the population in bacteria. This is normally 
corrected by the plasmid replication control systems. The copy counting can be imagined as 
counting of defined targets detected upon the plasmid replication initiation events. Finally, 
the control of plasmid replication is usually by one of two mechanisms based on the negative 
feedback loops, namely the iteron binding or by inhibitor-target circuit 
206
. 
2.2.3.1 Replication control by iterons 
Replicons controlled by this mode have a series of tandem repeats called iterons present 
within or/and in the close proximity of their origin of replication. Inverted repeats are often 
also present upstream the promoter for the rep gene encoding the Rep initiator protein 
39;60
. 
These inverted repeats as well as the iterons contain a sequence ‘code’ recognized by the Rep 
protein. Some models indicated that Rep proteins can either be present as active monomers 
which can bind to the iterons; or Rep can be present in a form of dimers which, with some 
exceptions, are not capable of binding to iterons but they can bind to the inverted repeats 
inhibiting the transcription of Rep mRNA from its promoter. In the current models explaining 
the control by iterons, the Rep monomers bind to the origin iterons in the proximity of AT 
rich region and promote replication initiation. In some plasmids iterons are only present in 
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the origin region, while in other plasmids there exists a second set of regulatory iterons 
present further away from the key oriV. In the latter case the Rep monomers bind both to the 
origin iterons and to the regulatory iterons located away from the origin iterons. The origin 
iterons can thus participate both in the initiation of replication and the copy control. It is 
believed that the main copy control mechanism involves handcuffing of two plasmids via 
iterons to which the Rep proteins are bound. The iterons-Rep-iterons nucleoprotein 
complexes located on the two individual copies of plasmids can interact by locking the two 
origins together. The oriV-iterons-Rep complexes can also be locked together with the Rep 
bound to the regulatory iterons located further away from the oriV iterons. In the latter case 
the locking of the oriV-iterons with the other regulatory iterons mediated by the Rep 
complexes can occur within the same molecule or as handcuffing of individual plasmid 
molecules. Handcuffing of the origins prevents the initiation of replication. The process is 
reversible allowing for restoring of the replication when the copy numbers are too low. 
Classical examples of iteron controlled replicons in E. coli are among others IncP family 
plasmids, IncFIA and IncFIB replicons 
39
. 
2.2.3.2 Replication control by inhibitory countertranscribed RNAs (ctRNAs) 
Replication of the plasmid can be controlled by binding of an inhibitory molecule to a 
defined target on the replicon. Inhibition of the target results in the decrease of the replication 
rate 
144
.  One of such examples is control by antisense RNAs termed also ctRNAs. In 
plasmids whose replication is initiated by the Rep proteins, antisense RNAs are transcribed 
from the same DNA segment as the mRNA for the Rep proteins but in an opposite direction 
than the Rep mRNA. Antisense RNA has a short half life and it is always present in excess 
compared to its target 
141;206
. This is due to the transcription of the ctRNA proceeds from a 
constitutive promoter, while the Rep mRNA promoter is normally under a transcriptional 
control. Antisense RNAs are complementary to the 5’ end of the Rep- mRNAs and the two 
molecules interact with each other to form duplexes 
141;206
. 
The initial contact is made via loops (hair-pin loops) which are structures formed on both the 
mRNA and the ctRNA 
164
. After the initial complex is made further duplex formation occurs 
and it prevents the translation of the Rep proteins from their mRNAs which results in the 
decrease of the initiator protein concentration 
141
. This is followed by the decrease in the 
initiation of plasmid replication rate. In Enterobacteriaceae such control mechanism were 
described in IncFII , IncI- complex (IncI1, IncB/O, IncK , IncZ) and ColE1 replicons 
164
. The 
details of how the duplex formation prevents the translation of the Rep protein may differ 
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between the various types of replicons. The general mechanism is similar to all of the 
aforementioned replicons; the key elements in these types control systems are the base pairs 
located in the loops of ctRNA and the loops of Rep mRNA that are interacting with each 
other and where the formation of the duplexes is initiated. Also the secondary structures 
called bulge-loops present on the ctRNA and the Rep mRNA (in addition to the 
aforementioned hair-pin loops) are of the key importance, as the formation of the inhibitory 
duplex is not only a matter of the exact complementary 
141
. It is also necessary for the two 
molecules to properly align in the space (topologically) with respect to each other. Initially 
only the single stranded loop regions of the two RNAs interact. Then the target and inhibitor 
molecules need to be located in space in a way that the remaining complementary sequences 
on these two RNA molecules are also made to form further duplexes 
141;144;206
. 
In ColE1 replicons which do not require the Rep protein for replication, the ctRNA forms 
duplex with the pre-primer RNAII preventing it from maturation and thus inhibiting the 
initiation of plasmid DNA replication
206
. 
Mutations in the DNA segment encoding the ctRNA and the Rep mRNA will not affect the 
complementarily of the two RNA molecules. They may however, affect the formation of 
secondary structures assumed by the transcribed RNA molecules as well as the composition 
of the key base pairs located in the interacting loops 
141
. This in turn may result in decrease of 
the interaction strength between the target and the inhibitory loops, or decrease in speed of 
formation of the duplex after the initiation step. Overall, mutations may decrease the 
inhibition by the ctRNA of its corresponding target mRNA and as explained later, this may 
lead to the increases in copy numbers of such replicons. This may also influence the 
incompatibility properties of replicons with mutations affecting the ctRNA encoding  
region 
144;164
. 
Certain proteins can play accessory roles in the control of plasmids replication driven by the 
ctRNAs. In a plasmid R1 which belongs to the IncFII family of replicons, the Rep protein can 
by translated from two types of mRNA transcribed from two promoters. In wild type 
conditions a long mRNA transcript containing the copB and rep genes is constitutively 
expressed from the copB promoter 
60
. The Rep is normally translated from this long mRNA. 
There is a second promoter downstream of the copB from which only the Rep mRNA can 
also be transcribed. The second promoter is usually suppressed by the CopB protein product 
that binds to this promoter. This promoter is released in emergency situations at very low 
copy levels detected 
206
. The main control of Rep translation is still by the ctRNA that is 
complementary to the 5’ rep regions on mRNAs transcribed from both types of promoters. 
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Although important, the control by CopB plays the secondary role 
144
.  In ColE1 plasmids the 
Rom (or Rop) protein was shown to influence the replication rate by stabilizing the initial 
complex between the ctRNA and its target on the pre-primer. In this case the Rop (Rom) 
proteins also have an accessory role in control 
206
. 
2.2.3.3 Incompatibility of plasmids 
If two plasmid replicon types cannot be stably maintained and replicated in the same cell line 
at the absence of selective pressure to maintain both plasmids, they are said to be 
incompatible 
141;144
. Incompatibility (Inc) is therefore considered a measurement of plasmids 
relatedness. This property was used as a basis for typing and classification of plasmids to Inc 
groups  (described in the next section) 
36;54
.  Incompatibility is a complex phenomenon and it 
may be either a result of a random selection of only one type of the two similar plasmids for 
replication and partitioning during bacterial division, which may lead to inequalities in 
replicons distribution and later dominance of cells harbouring only one type of plasmids in 
bacteria population (partition incompatibility 
19
); or it may be due to the expression by 
plasmids of certain incompatibility functions  (for example copy number control factors) that 
cause the instability and finally loss from the bacterial population of the other similar 
plasmids. The later scenario will be highlighted with more details further in this subsection in 
order to explain i) the basics behind plasmid classification to incompatibility families and  ii) 
what are the shortcomings of grouping of replicons based on the incompatibility assays 
54;144
. 
As underlined above replication control is critical for plasmid maintenance and inheritance. 
Plasmid replication and stability may be influenced by presence of other types of replicons in 
the same cells. In practice, three simplified scenarios are possible 
144
. In the first scenario an 
external plasmid p1 with resistance marker r1 (p1
r1
) may arise to a bacterium that already 
harbours a plasmid with an identical replicon to p1, but different resistance marker r2 (p1
r2
). 
The loci encoding the replication and control functions of the two replicons are 
undistinguishable so their inherent copy numbers are also the same. In such situation the two 
plasmids would ‘see’ each other as additional copies of the same replicon p1. They would be 
able to ‘count’ each other as additional copies and the replication of both plasmids would be 
set up to adjust to the overall copy number equal to the inherent copy number of either of the 
replicons. The loss of one of the plasmids at the absence of selection for any of them would 
be due to a random selection for replication and partitioning 
144;206
. 
Second scenario assumes that two different replicons would arise to the same cell. If the 
difference would be enough for plasmids not to ‘see’ each other’s replicons for counting, 
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replication control machineries of the two different replicons would not recognize the foreign 
targets for copy ‘counting’. The two plasmids would probably not influence each other’s 
control circuits and be able to co-exist with each other. They would be compatible 
141;145
. 
The third possible situation would be, when two plasmids with similar but not identical 
replicons would arise in the same cell. Although the two plasmids would have their own 
replication and control circuits it would be possible that they would be somehow sensitive to 
the similar replication control functions expressed by the other co-residing replicons (due to 
the similarities in the targets being under the control of these controlling factors). It is 
probable that one of the replicons could be more sensitive to the replication inhibitors 
(iterons, ctRNAs and possibly other factors) expressed by the other replicon type. In this 
situation the replication rate of the (more) sensitive plasmid would be more strongly 
repressed. As there are always fluctuations in the total plasmid copy numbers obtained by the 
daughter cells, it is possible that at some point the bacterium would receive less copies of the 
more strongly repressed plasmid. Since the replication of this plasmid would be continuously 
repressed by the presence of the additional control factors expressed by the second similar 
replicon, this plasmid would not be able to correct its copy numbers during the next rounds of 
bacteria division 
141
.  Such plasmid would become unstable and lost from the population. In 
this case the two plasmids would be incompatible because of the similarity in their copy 
control elements.  
It needs to be underlined that the above cases are simplifications and the details behind the 
mechanisms of plasmids incompatibility are not yet fully elucidated 
19;144
.  Any element of 
the plasmid replicon participating in the replication, copy number control and also in 
partitioning may in fact contribute to the incompatibility properties displayed by the given 
plasmid 
19;144
. 
2.2.3.4 Drawbacks of incompatibility assays and development of replicon typing 
methods  
In 1970s Datta and Hedges proposed classification scheme for plasmid based on their 
incompatibility properties 
54
. The incompatibility assay requires introduction of two plasmids 
with different selective markers into the bacterium. Subsequently the double transformant 
selected initially to contain both replicons needs to be propagated for a number of generations 
in selection free conditions. Finally the transformants are plated out onto media containing 
the individual selections for the respective plasmids and also on the media with selections for 
both plasmids. The ability of plasmids to co-exist is assessed based on the frequency of 
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occurrence of the transformants harbouring the two plasmids. Development of 
incompatibility assays was a step forward in studies on plasmids classification and hence 
epidemiology. The major Inc groups in Enterobacteriaceae, i. e.  IncFII, IncFI, 
IncI1(IncI1=Iα=Iβ) and IncIε (IncIγ was established later195), IncX, IncO (= Inc B/O, IncN, 
IncA (=IncA/C), IncT, IncW, IncP and IncL (=IncL/M), have been defined in early 1970ies 
by this method 
85
.  However, the procedure is time consuming 
144
. Also, the obstacles here are 
that many wild type plasmids harbours more than one replicon on the same scaffolds and they 
can utilize the different replicons if needed. This makes it possible for them to overcome the 
incompatibility problem. Therefore preferably a vector containing only the replicon of 
interest and the selective marker should be produced and used in such incompatibility assays. 
Moreover, the output of the assay may not always give the real overview on the relatedness 
of two replicon sequences. This is especially truth for the ctRNA controlled replicons 
141;144
. 
Few bases pair mutations in the region encoding the key inhibitor may in this case result a 
new incompatibility group compared to the wild type replicon. Although the two replicons 
would be closely related, they might give a compatible phenotype 
144
. Partial incompatibility 
(or partial compatibility) and one-side incompatibility might also be observed which makes 
the results of the assays difficult to interpret in a straightforward manner 
144
.  
Finally, phenomenon’s like surface and entry exclusion were shown to interfere with the 
interpretation of the incompatibility assays 
75
. Some of the F-like plasmids described in E. 
coli were shown to encode surface proteins that prevented formation of stable co-aggregates 
between the mating cells already harbouring the similar F-like plasmids. This phenomenon 
was called surface exclusion. It was also shown that plasmids sharing the similarities in their 
transfer regions may also exclude each other’s entry to the given recipient cell harbouring 
such plasmids even if the mating co-aggregate required for conjugation was formed between 
the donor and the recipient cell. In this case another factor was shown to prevent the entry of 
the plasmid from the donor to the recipient cell with the similar plasmid. Namely, it was 
proposed that a host plasmid encoded protein which is located in the periplasm of the 
recipient cell (harbouring this plasmid) probably prevents setting-up of the initiation 
machinery for donor plasmid DNA transfer at the recipient inner membrane. This was termed 
entry exclusion (EEX) 
75
. The EEX functions were described for the variety of conjugative 
(IncF-family, IncI, IncP, IncN, IncW, IncX, IncHI ) as well as mobilizable (ColE1) plasmids 
and even ICE’s 75. Surface and entry exclusion may result in miss-interpretation that the two 
replicons examined in incompatibility assay are incompatible, despite in this case the real 
feature being tested would be the transfer module.  
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At the end of 1980ies the hybridization probes have been designed by Couturier an co-
workers 
54
. The probes corresponded to the known or putative incompatibility loci of nineteen 
plasmid replicons from E. coli, namely repFIA, -FIB, -FIC, FIIA, -9 (of com9 Inc group),-I1, 
-B/O, -K, -HI1 and -HI2,-L/M, -N, -P, -O, -T, -U, -W- X and –Y.  The method was a 
breakthrough as it allowed for relatively rapid detection and classification of plasmid 
replicons to Inc groups. This methodology was still laborious if large sample number was to 
be screen. Over a decade later, in 2005 a rapid RCR based replicon typing method (PBRT) 
was published by Carattoli et al.
35
. Again the targets for the PBRT were preferentially the key 
incompatibility determinants found on the diverse replicon sequences. Eighteen of the 
aforementioned rep groups (further termed Inc groups) were targeted by the PBRT (the rep9 
was not included as target in the PBRT). This method was originally designed based on 
replicons of plasmids described in E. coli. Later in time owing to the increasing number of 
sequences available in public databases replicon variants characteristic for other species, like 
Salmonella, K. pneumoniae and Yersinia  were added to the PBRT scheme 
72;205
. 
2.3 Classification of plasmids 
Classification of plasmids is essential if one would like to be able to study their 
epidemiological relationships 
56
. The reference point for classification of plasmids can be any 
of the modules described in previous section. In this section the relevant classification and 
typing schemes of plasmids in Enterobacteriaceae will be described.  
2.3.1 Classification of replicons to Inc families 
Currently there are 27 Inc groups recognized in Enterobacteriaceae by Plasmid Section of the 
National Collection Type Culture, Colindale, London 
34;54
. The groups are designated with 
alphabet letters from IncA to IncZ 
189
.  In practice there more than 30 replicon groups were 
described in the literature and also subgroups were recognized in this family of bacteria. This 
number will probably change along with the increasing number of replicon sequences 
available through next-generation sequencing. The terminology may sometimes be confusing. 
Overall, an assumption can be made that Inc families are comprised of Inc groups and the 
latter may be further divided into Inc subgroups (family>group>subgroup). As indicated 
below, plasmids within the given family and group may in some cases be compatible with 
each other. 
The first Inc group (that later became a family) was described in 1960ies; this family is 
known today as IncF and is composed of IncFII, IncFIA, -B and –C replicons ans well as 
other F-like replicons which have been rather rarely detected in E. coli 
56
.  Within the F-
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family IncFIC group, although similar to is compatible with the IncFII replicons 
13
. In many 
cases the different groups within the same families were distinguished based on the DNA 
sequence comparison, although the representatives of these different groups were still 
incompatible with each other. This is exemplified by the IncX family, where IncX1 R485 
plasmid was shown to be incompatible with IncX2 R6K plasmid, despite an appreciable 
amount of differences in the two replicon sequences and also in the remaining key plasmids 
components 
104
.  Within the IncI-complex family of replicons, the IncB/O replicons are 
incompatible with the IncZ replicons, but both of these replicons are compatible with the 
family members IncI1, IncIγ and IncK replicons (the three latter replicons are incompatible 
with each other) 
164;165
. 
Currently available PBRT methods target a selected range of the classical Inc groups listed in 
the above section 
36
. The novel types of replicons like IncFII host specific variants (FIIk, FIIs, 
FIIy) and IncFIB Salmonella –specific variant (IncFIBS), IncR, IncQ, IncU and IncX1 can be 
detected by the updated PCR protocols as described by Garcia-Fernandez et al.
72
,  
Villa et al.
 205
 and in Manuscript I in this study
16
 (here two PCRs were described targeting the 
replicator protein of IncX1A plasmid pE001 and the repA of IncN-like plamids). 
Some of the Inc groups are not ‘real’ plasmids; IncY group covers the bacteriophages that in 
the lysogenic cells are circular and can self replicate just like plasmids do 
130
. The IncJ group 
covers the Integrative Conjugative Elements (ICEs) related to SXT/R391 
212
. These elements 
were initially miss-interpreted as plasmids. As explained further in the text, ICEs can 
conjugate but cannot self –replicate 212. 
Furthermore, some of the Inc groups from Enterobacteriaceae overlap with the plasmid Inc 
groups of Pseudomonas (designated IncP-). Namely, IncA/C group corresponds to IncP-3, 
IncU corresponds to IncP-6, IncP corresponds to IncP1 and IncQ corresponds to IncP-4, 
respectively 
189
.  
2.3.2 Classification of plasmids based on the characteristics of transfer module 
The plasmid encoded pili may serve as attachments sites for bacteriophages 
44-47
.  Phages can 
attach to the shafts on a pilus (these are usually very specific phages), or to the tip of the pilus 
(less specific filamentous and tailed phages) 
186
.  In the early history of plasmid classification 
in E. coli it was shown that certain bacteriophages could bind specifically to the conjugative 
pili of plasmids from the particular Inc families. The C type phages bound specifically to pili 
encoded by the IncC family plasmids (later this family was renamed to IncA/C-complex)
186
; 
the M bacteriophages were shown to be specific for pili of IncM (later IncL/M) plasmids
46
, X 
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bacteriophages were shown to attach to pili of IncX plasmids
44
, also phages specific for pili 
of IncI1α and IncI2 plasmids were described45. In 1980s it was further shown that these 
conjugative pili encoded by plasmids from the diverse Inc groups determined for E. coli 
could be grouped to three morphological types: thin flexible, thick flexible and rigid pili. The 
thin flexible pili were encoded by the I- complex plasmids, the thick flexible pili were 
encoded by IncC (currently IncA/C), IncD, IncF, IncHI1 and IncHI1, IncJ, IncT, IncV and 
IncX plasmids; the third type was encoded by IncM (later IncL/M), IncN, IncP and IncW 
plasmids 
21
.  In fact, in some of the literature sources it has been proposed to group plasmids 
into four major incompatibility groups based on their genetic relatedness and structures of 
pili. These major groups were IncF (covering IncF, -S, -C, -D and –J replicons), IncI 
(covering the IncI, -B/O and –K replicons), Ti-plasmid group (IncX, -H, -N and –T) and the 
IncP (IncP, -M, -W and –U) 31;207. 
Recent studies of Francia et al. and Garcillan-Barcia et al. pointed out that both the 
conjugative and mobilizable plasmids could actually be classified based on other than the 
above mentioned characteristic (i. e. pilus) of their transfer regions 
68;74;76
.  Garcillian-Barcia 
and co-workers proposed an alternative classification scheme for transferable plasmids based 
on the similarities of the key MOB relaxases encoded by both the self-conjugative and the 
mobilizable plasmids 
74;76
. Available sequences of plasmids from the public data bases 
(GenBank) were grouped to seven MOB families. Six of these were major MOB families 
MOBF, MOBH, MOBC, MOBQ, MOBP and MOBV 
74;76
.  Phylogenetic trees have been 
produced for each of the MOB groups using the available sequenced plasmids as references. 
It appeared that plasmids were generally grouped into branches of the MOB trees according 
to the Inc groups of their replicons and also according to the genes encoding coupling 
proteins.  In other words, plasmids from the same Inc group usually belonged to the same 
branches within the given MOB family tree
59
. This implied that there is a strong correlation 
between the replicon and the transfer region on the plasmids. Possibly in the early 
evolutionary history plasmids had more conserved backbones composed of one type of the 
replicon and the specific transfer system. Later acquisition of new replicon modules and 
rearrangements in the plasmid scaffolds resulted in the larger replicons diversity observed to 
date. Overall, the mob genes seemed to be more conserved  than the replicons on 
plasmids
59;74
. Diagnostic signatures representing the conserved and characteristic motifs of 
the MOB relaxases  have been deduced for each of the MOB families 
59;74
.  The proposed 
method for screening and classification assumes an amplification of the mob targets with the 
use of degenerate primers, sequencing and then allocation of the sequences into the MOB 
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phylogenetic trees. Based on the position of the obtained sequence within the tree and its 
clustering pattern with the reference plasmids, further information could be deduced 
regarding the plasmid transfer system and also the corresponding replicon. Multireplicon 
transferable plasmids harbour typically only one transfer region
59
. Thus if other replicons 
than the one deduced from the tree would be detected on the multireplicon plasmid, it could 
be suspected that the other replicons have been acquired later in the evolution of such 
plasmid. Swapping of the whole transfer module between plasmids is also possible, although 
it is believed to be rather a rare event 
59;74
. 
The mob genes seem to be suitable targets for typing species for screening and possibly 
epidemiological purposes. The method is still being elaborated and suffers from drawbacks as 
well. The main one being that some plasmids may not harbour the MOB relaxases at all; or 
the plasmid may encode relaxase that was previously not characterised thus it may be omitted 
by the detection based on signatures designed initially only for the known relaxases 
74
. 
Although the MOB based method have undobtedely a good potential, it is currently not used 
in the classical plasmid screening and characterisation studies. Replicon typing continues to 
be the most commonly applied method. 
2.3.3 Classification of plasmids based on function  
Based on the accessory region, termed also an adaptation module, plasmids can be designated 
as i) resistance plasmids, when they encode resistance to antimicrobials ii) the ColE plasmids 
encoding colicins 
87
; the latter being compounds with killing activity against other bacteria 
iii)  degradative or catabolic  plasmids, when they harbour genes for degradation of organic 
compounds or toxins  and iv) virulence plasmids 
189
. The different groups will not be 
described with details here. Many of the virulence plasmids found in Enterobacteriaceae have 
been shown to be associated with the resistance genes. Especially IncF plasmids and also 
IncI1 plasmids usually harbour the virulence genes and they are also among the predominant 
types associated with the resistance genes among others in E. coli, S. enterica, K.pneumoniae 
and other Enterobacteriaceae 
33;34;99
. The virulence plasmids described in the literature 
typically encoded colonization factors (CF) like adhesins (plasmid encoded pili and 
fimbriae), aggregation factors (auto-aggregative adherence factors of EAEC), toxins 
(enterotoxins in ETEC strains), haemolysins (plasmids in majority of STEC and EHEC 
strains), iron sequestering  systems (encoded by diverse virulence plasmids), invasion of the 
host cells factors (encoded by plasmids in EIEC and Shigella), colicins and necrotizing 
factors (exemplified by cytotoxic necrotizing factor CTN encoded by Vir plasmids in  
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E. coli) 
99
 . 
2.3.4 Plasmids Multilocus Sequence Typing (pMLST) 
The classical method for analysing the epidemiological relationship between plasmids is  the 
RFLP 
198
. This fingerprint-based method is not a classification or detection procedure for 
plasmids, however it allows for direct comparison of plasmids and their relatedness.  Recent 
advances in sequencing methods allowed for development of another typing/classification 
method for plasmids that simultaneously allows for tracking down the epidemiology of these 
MGEs, namely the pMLST. The general procedure involves PCR amplification of the 
selected ‘housekeeping’ genes present on the backbones of plasmids belonging the given 
family or group; sequencing of these selected genes and then blasting the sequences against 
the corresponding reference data base. Reference allele types are pre-defined for the specific 
genes in the corresponding reference databases based on previously sequenced and annotated 
plasmids 
158
. Sequence types are then defined for each of the genes on the analysed plasmid 
and combination of these STs defines the plasmid species (pMLST type) and hence its 
relationship to other plasmids from the same family. pMLST is currently available for IncF 
family of plasmids (in this case only the target locus or loci on the replicon/s are required for 
sequencing thus the abbreviation RST, i.e. replicon sequence typing), IncN, IncI1 and IncHI1 
and -2 (here the term double locus sequence typing was applied by the authors) 
70;71;73;205
.  In 
the near future such method should also be available for IncX family of plasmids (personal 
communication with Alessandra Carattoli, Istituto Superiore di Sanità, Rome).  
The drawback of these kinds of PCR /sequencing based methods is a large workload related 
to handling of multiple samples. Simplex PCR amplifications of multiple genes per one 
plasmid need to be initially set up. Subsequent purifications of the PCR products and 
sequencing of each sample is still a costly procedure when large number of samples needs to 
be analyzed. Generation of an excessive number of new STs due to the occurrence of novel 
alleles might also become a problem. On the other hand the main advantage of pMLST is 
obtaining valuable information regarding the plasmids backbones without necessity for 
sequencing of the whole plasmid. Single nucleotides polymorphisms can be tracked down for 
the selected genes. Rapid comparison of sequences from the distant geographical locations is 
also possible without the need for sending out the DNA preparations or the whole strains.  
2.4 Other MGEs involved in the transmission of resistance genes  
Plasmids may serve as mobile platforms onto which other MGEs can integrate or be excised 
from. Mobile DNA elements which movement is catalysed by so called transposases are 
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collectively termed as transposable elements. There exists a whole variety of such mobile 
elements and some of them like ICEs can in fact encode their own transfer systems to move 
between bacteria just like conjugative plasmids do. Unlike plasmids, these MGEs do not 
replicate autonomously 
212
.  
2.4.1 Insertion sequences (IS) and composite transposons 
The simplest in structure are class I transposons and this group in practice is comprised of IS 
elements 
189
. They are composed of the genes encoding the transposases typically flanked by 
the characteristic end sequences, usually the inverted repeats (IRs) 
189
. These end sequences 
are specifically recognized by the transposase upon the initiation of transposition. ISs usually 
utilize the mechanism termed ‘cut and paste’ to transfer to different DNA locations. This 
means that the IS is excised from the donor DNA strand and inserted into the recipient DNA 
strand. The hallmarks of such insertion are direct repeat sequences (DRs) at the target DNA 
flanking the incorporated IS 
189
. Two IS sequences can also flank a region containing the 
gene(s) encoding resistance to antimicrobials. Such structures are called composite 
transposons. Often the genes encoding resistance to kanamycin, tetracycline and streptomycin 
are contained on the composite transposons.  Classical examples are Tn5 and Tn10. 
Composite transposons can be translocated either as a whole unit, or only one of the IS parts 
can transpose 
189
. 
IS elements are believed to play essential role in integration of some of the plasmids into the 
bacterial chromosomes in the high frequency recombination cells (Hfr cells) 
83
.  Especially 
IncF plasmids harbouring the IS-es homologous to the targets on the bacterial chromosomes 
have been reported be able to recombine with and integrate into the chromosomal  
locations 
133
. This phenomenon may lead to mobilization of chromosomal genes upon 
conjugation of such integrated plasmid to another host 
83
. 
2.4.2 Class II transposons 
Class II family transposons are generally composed of a transposase gene tnpA, a resolvase 
gene tnpR and are flanked by the IRs. Class II transposons often harbour additional genes 
encoding traits like antimicrobial resistance or degradation of organic compounds. According 
to Sota
189
 Class II elements are currently grouped into five families, namely IS1071, Tn3-
types, Tn21-types, Tn4651-types and Tn5393-types. The terminology used in the literature 
may be confusing; some authors collectively term the class II as Tn3-like transposons. In the 
following section, the Tn3-like or Tn3-type will refer specifically to only one of the five 
families of the class II elements. Transposons from the Tn3- family have been shown to be 
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predominant carriers of the blaTEM genes in Enterobateriaceae 
6;151
. Three subgroups were 
defined within the Tn3 family, namely Tn1, Tn2 and Tn3 transposons. Tn3- family of 
transposons display transposition immunity. That means that once the Tn3-type transposon is 
integrated into the plasmid scaffold, the plasmid becomes immune to the subsequent 
insertions of the similar Tn3-related element. The characteristic end sequences (IRs) are 
believed to confer the immunity to the reinsertion of the Tn3 -like transposons
106
. It is 
common however, that other transposable elements like IS-es paste themselves into regions 
within the Tn3-like transposons. Typically IS26 elements inserted within the tnpA regions of 
Tn3 –related transposons were previously detected 6;152. 
Class II elements typically transpose by the replicative mechanism 
189
.  In this process 
enzymes resolvases catalyse resolution of cointegrates at the res sites. In some cases 
resolvases may be substituted by integrases that catalyse not only the cointegrate resolution, 
but also the intra- and intermolecular recombination between the defined att  
attachment sites 
189
 .These may generally lead to an increase recombination rates for example 
between plasmids harbouring resistance genes located on the transposable elements. 
Examples of other classes of transposons are Tn7-like and Tn402-like transposons 
189
.  It is 
probable that when more sequences will be characterized more classes and families will be 
defined. 
2.4.3 Integrons and ICEs  
Integrons constitute another individual class of transposable elements. They consist of the intI 
gene and the gene cassette or sometimes number of gene cassettes. IntI integrase catalyses 
site specific recombination of integrons. Upstream the intI there is typically located an attI 
recombination site, while gene cassettes harbour the attC site at their 3’ end. Integrons can 
accept multiple insertions of other gene cassettes. The gene cassettes can encode resistance to 
a whole range of antimicrobials, including β-lactams. The cassettes can be transposed onto 
plasmids or onto the chromosomal DNA 
189
. Another group of transposable elements are 
conjugative transposons discussed typically together with the ICEs group. ICEs of the SXT 
(conferring sulfamethoxazole-trimethoprim resistance) type were initially detected mainly in 
Vibrio cholera 
25
. Recently it was proposed that some genetic elements initially classified as 
genomic islands and found in Salmonella (SPI-7) and other  Enterobacteriaceae may in fact 
be a class of ICEs 
183
. 
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SECTION II.  
3. SUMMARY OF THE RESULTS AND DISCUSSION 
E. coli, K. pneumoniae and S. enterica are the most common Enterobacteriaceae causing 
infections in humans and animals
153
. Increasing occurrence of plasmid encoded resistance to 
β-lactams is being reported in these bacteria33;34;36;126. Plasmid encoded TEM β-lactamases 
were shown to be particularly prevalent in E. coli; blaTEM genes were previously detected not 
only in pathogenic strains but also in normal faecal flora of humans and animals
33;55;149;184
. In 
this study the diversity of plasmids with blaTEM genes (Manuscripts I and II) as well plasmids 
not selected based on the resistance (Manuscript III) was examined. The overall aim was to 
study the possible connection between plasmids from human and non-human sources like 
livestock animals, meat or natural environment (Manuscripts I, II and III). In manuscripts I 
and II the relationship between plasmids harbouring blaTEM genes from humans and from 
animals or food products from animals is examined. The plasmids originated primarily from 
E. coli (Manuscript I and II) and also from S. enterica (Manuscript I). Relationship between 
transposable elements harbouring blaTEM genes residing on the plasmids backbones is also 
discussed. In Manuscript III plasmids from K. pneumoniae are examined, namely plasmids 
from human infections are compared to plasmids from environmental samples (surface 
waters). A novel plasmid typing method was developed in this study for typing of plasmids in 
K. pneumoniae and the utility of this method as well as other available methods applied to 
study epidemiology of plasmids are discussed in relation to Manuscript III. Influence of 
plasmids host specificity and host range on the evolution and transmission of blaTEM genes is 
discussed with relation to all three monographs. 
3.1 Limited range of Inc types is found on blaTEM plasmids in Enterobacteriaceae from 
humans and from animals  
More than 27 Inc groups have been described in Enterobacteriaceae 
54;72;205
. Resistance 
plasmids with blaTEM genes (blaTEM-1, blaTEM-30, blaTEM-40, blaTEM-135, blaTEM-52) examined in 
this study represented only a limited range of these Inc groups, namely  IncF-complex (-FI 
and -FII), IncI1, IncX1 variant called IncX1A, IncA/C, IncL/M, IncK, IncHI1, IncY,  IncP, 
IncR and the non-typable replicons (Manuscripts I-II; summarized below in Table 1).  As 
explained in Manuscript I the blaTEM-52 IncX1A plasmid pE001 overall shared many 
similarities with other IncX1 scaffolds, therefore these plasmids from study I will be 
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generally designated IncX1 in the following sections. In a previous study of Bergenholtz and 
Jørgensen
11
 replicons IncI1, IncA/C and NT were also detected on blaTEM-15, blaTEM-19, 
blaTEM-20 and blaTEM-63 plasmids.  
Similar replicons to the aforementioned range were previously described in the literature on 
plasmids encoding the TEM-1 enzymes
33;85;129;172
; additionally, plasmids with IncS, IncT, 
IncW (mainly in Providencia spp
83
.) and also ColE replicons were shown by other authors to 
encode TEM-1 β-lactamases in diverse enteric hosts33;85;129. Combining data available in the 
literature with this study it can be concluded that the above listed replicons associated with 
the blaTEM genes are also frequently found with other  epidemic types of bla genes encoding 
class A β-lactamases, namely blaCTX-M and blaSHV
172;174
. 
This raises the question whether the aforementioned replicons are generally specific for the 
examined entero-bacterial hosts and therefore are found in the various reservoirs with or 
without the resistance genes; or some of these are host/ reservoir ‘non-specific’ replicons 
acquired from external reservoirs (natural environments, other bacteria families etc.) and 
accommodated in E. coli and other examined Enterobacteriaceae (K. pneumoaniea and S. 
enterica) because of the selective pressure for the resistance traits of these particular 
plasmids. This question will be further reviewed below. 
3.2 Different Inc types are typically associated with blaTEM-1 compared to blaTEM 
variants encoding ESBLs  
Based on the data collected in Manuscript I and –II  it can be concluded that plasmids with 
blaTEM-1 and other blaTEM variants encoding IRTs (blaTEM-30, blaTEM-40) typically belonged to 
IncF-family (FII, FIB, FIA), IncI1, IncB/O or had non-typable (NT) replicons (Table 1 
below). In contrast, IncB/O and IncF-family replicons were not found on plasmids encoding 
TEM-ESBLs (plasmids with blaTEM-135, blaTEM-52; Manuscripts I and –II). In the latter case 
mainly replicons IncI1 and IncX1 were detected in E. coli and S. enterica and also less 
frequently cases IncA/C, IncL/M and IncN-related. In the studies of Bergenholtz and  
Jørgensen
11
 and Carattoli et al.
33
 the blaTEM-1 and blaTEM encoding IRTs typically resided on 
IncF- family, IncB/O, IncI1 or NT replicons, while genes encoding ESBLs (blaTEM-15, blaTEM-
19, blaTEM-20 , blaTEM-63, blaTEM-3, blaTEM-10, blaTEM-21, blaTEM-24, blaTEM-52)  were localized 
mainly on IncA/C and IncI1 replicons. Apparently there are differences in the replicon 
distribution among plasmids encoding TEM-1 genes compared to plasmids encoding TEM-
ESBLs (Figure 7).  
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Table 1. Summary of the replicons detected in study I and II on the blaTEM plasmids  
blaTEM variant blaTEM-1  blaTEM-30 or blaTEM-40 
( IRT  encoding) 
blaTEM-135, blaTEM-52,  blaTEM-15, -19, -20, -63
a 
 (ESBLs encoding) 
Reservoir Human                Animal  Human          Animal  Human Animal Meat 
Individual plasmids 
from the specified 
reservoir 
           57 92 2         2                      14                                              9
b
 4 
Replicon(s) detected 
on the  plasmids          
   
IncA/C     1 blaTEM-52, 1 blaTEM-19,  
1 blaTEM-63 
  
IncB/O 10 10 1 blaTEM-30     
IncB/O & IncP 3 3      
IncFIB  2 1 blaTEM-40     
IncFII 7 13  1 blaTEM-30    
IncFII & IncFIB 14 15      
IncFII & IncFIB & 
IncFIA or  IncFIB & 
IncFIA   
2 7 
     
IncFII & IncFIB & IncP 2 5      
IncFII & IncP  1      
IncFIB & IncY 1       
IncI1 3 18   1 blaTEM-135, 5 blaTEM-52 2 blaTEM-52, 1 blaTEM-20 
IncI1 & IncP 1 2      
IncI1 & IncFIB &IncFIC  1      
IncHI1  1      
IncK 1       
IncL/M     2 blaTEM-52   
IncN  or IncN-related 1 2    2 blaTEM-52  
IncP  2      
IncR  1 [IncFII &IncR]   1  blaTEM-52   
IncX1A 1    1  blaTEM-52 4  blaTEM-52 4 blaTEM-52 
NT 11 9  1 blaTEM-30 1  blaTEM-52    
        
 
a- plasmids  with these blaTEM alleles originated from the study of (Bergenholtz and Jørgensen, 2008) and they  were part of the collection covering also the blaTEM-52 
plasmids characterized in Manuscript I; these additional data was included here in order to obtain a broader overview of the replicons associated with blaTEM-ESBLs variants 
b
- Cloeckaert TC was considered as poultry isolate; IRT- Inhibitor resistant TEM- β- lactamase 
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Figure 7. Distribution of replicons on plasmids with different variants of blaTEM evaluated based on combined 
data from this study (Manuscripts I and II) and from Bergenholtz & Jørgensen and Carattoli et al. 2009 12;33; 
ESBLs encoding variants were blaTEM-3, blaTEM-10, blaTEM-135, blaTEM-15, blaTEM-19, blaTEM-20, blaTEM-21, blaTEM-24, 
blaTEM-52 and blaTEM-63;  blaTEM-1 plasmid with IncI1&IncFIB &IncFIB (study II) was counted as IncI1 replicon;  
blaTEM-1 plasmids with IncFII &IncR and with IncFIB & IncY replicons  (study II) were considered as IncR or 
IncY replicons. 
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The explanation to (and implication of) this distribution is more clear when looking on data 
reported by Johnson et al.
100;102
 and data reported in Manuscript II (the latter summarized on 
Figure 8). In the two cited studies of Johnson, he examined diversity of plasmids not selected 
based on the resistance. In his studies mainly IncF plasmids, in particular IncFII and IncFIB, 
were found in pathogenic and commensal E. coli  in humans and poultry, IncB/O plasmids 
were the second most abundant in humans  (both pathogenic and indicator), while IncI1 were  
the second most abundant  in pathogenic and indicator E .coli from poultry; in poultry there 
were also a notable fractions of IncN and IncP replicons present. In pathogenic avian strains 
IncB/O were often detected 
102
;  IncI1 replicons were frequently detected in pathogenic E. 
coli from pigs
100
. According to Manuscript II similar pattern was observed among plasmids 
with blaTEM-1 genes from faecal indicator and diagnostic/clinical E. coli from humans, cattle, 
pigs and poultry. Namely, IncFII and IncFIB were frequent in all examined reservoirs 
(human and animals); IncB/Os were the second most abundant in humans, cattle and pigs but 
were not detected in poultry; IncI1 were dominating in poultry, to lesser extend were found in 
pigs and humans and were not detected in cattle; often broad-host range (BHR) IncP
194
 
replicons were found on the same blaTEM-1 plasmids with IncB/O, IncFII, -FIA, FIB and IncI1 
mainly in E. coli from animals (Figure 8).  
In summary, the following statements can be made based on the above data: 
a) IncF-family plasmids are found in commensal and pathogenic E. coli both in humans and 
animals and hence are well adapted to this bacterium in these reservoirs 
 b) IncB/O are likely to be adapted specifically for E. coli from humans, cattle and pigs 
(found both in pathogenic and commensal isolates), but were also found among pathogenic 
E. coli in the avian reservoir 
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Figure 8. Distrubution of the 
replicons detected on  
blaTEM-1 plasmids from faecal 
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or clinical E. coli from 
humans and food-produciton 
animals (summary of study 
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c) IncI1 are well adapted for commensal and pathogenic E. coli from poultry and are also 
often found in pathogenic E. coli from pigs  
d) blaTEM-1 genes usually reside on the same plasmids that are generally predominant in 
E. coli  from the given reservoir
57
  
e)  blaTEM encoding TEM-ESBLs  are often found on BHR plasmids like IncA/C and NHR 
plasmids like IncI1 and IncX1 
f) IncP are the most common BHR plasmids with blaTEM-1 and were detected mainly in cattle 
and often as co-integrates with IncF-family, IncI1 and IncB/O  replicons in different 
examined reservoirs. 
 
Marcade et al.
125
  previously suggested that the blaTEM-1 genes were able to evolve only to 
some extend (typically producing IRT variants) on the IncF-family and IncB/O replicons in 
humans; the blaTEM genes encoding ESBLs might have evolved outside of the human 
reservoirs, possibly on the IncA/C,  IncI1 or IncX1 scaffolds. This implies that the plasmids 
encoding ESBLs like TEM-52 (Manuscript I) were probably acquired at least by human  E. 
coli strains (typically not populated with IncI1, IncX1 or IncA/C plasmids) from external 
sources; possibly from poultry or pigs where especially high prevalence of IncI1 replicons 
was detected or on the IncX1 replicons from other bacteria species as discussed below.  
Regarding IncA/C, these replicons were not detected in the faecal indicator or in the 
diagnostic/ clinical E. coli of humans and food production animals (study II); as it is 
explained in the next section these plasmids have generally broad host range and likely this is 
the reason why such a diversity of blaTEM variants was found on these scaffolds by other 
authors.  
Only one case IncX1 replicon was detected with blaTEM-1 (in human E. coli) in study II. Based 
on that it can be deduced that, contrary to IncF- and IncI-complex replicons, IncX1 replicons 
are not really prevalent in the E. coli from healthy individuals; hence must have been 
transmitted to E. coli of humans and animals (like pigs, cattle or poultry) probably from other 
bacteria. Among others S. enterica could be the source (or at least the important carrier) of 
IncX1 replicons. This species is found in humans almost exclusively because of consumption 
of contaminated foods of animal origin (excluding S. Typhi and S. Paratyphi which are 
specifically human-associated but these two serovars do not seem to be the problem in the 
western countries). In European countries the IncX1 and IncI1-encoding TEM-52s were 
mainly detected (study I); also the detection of TEM-52 in other countries was typically 
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limited to non-typhoidal Salmonella species
43;84;114
 thus likely originating from animal 
sources.  
Above findings suggest that IncA/C, IncI1 or IncX1 plasmids with blaTEM-52 (Manuscript I) 
might indeed have been acquired by the human E. coli from the animal sources. This also 
raises the question about the origins of the blaTEM-1 genes found apparently in E. coli 
originating both from humans and animals like pigs, cattle and poultry often on the same  
E.  coli host adapted plasmids; an attempt to answer this question is made in further sections. 
3.3 Molecular evidences that diverse Enterobacteriaceae from humans and animals may 
share similar or undistinguishable blaTEM plasmids. 
Still little is known regarding the transmission of mobile genetic elements between bacteria 
from the diverse reservoirs like animals, natural environments and humans. This study 
delivered several evidences that either undistinguishable or at least closely related plasmids 
with either blaTEM -1 or blaTEM-52  circulated in E. coli and S. enterica from humans, animals 
and meat (Manuscripts I and –II). Moreover, some of the replicons detected in humans and 
associated with the blaTEM-135 and blaTEM-52 encoding genes (IncI1, IncX1 and IncA/C) were 
deduced not to be typical for human associated E. coli (the latter are normally dominated by 
IncF and IncB/O plasmids) suggesting acquisition of these ESBLs encoding plasmids 
possibly from food-production animals. 
3.3.1 IncX1 plasmids with blaTEM-1 and blaTEM-52 
In study I epidemic blaTEM-52b IncX1 plasmids were found in E. coli and various serovars of S. 
enterica from human, poultry, beef and broiler meat. One case of blaTEM-1 IncX1 (p1413-
CO3) plasmid was detected in a human E. coli isolate from Denmark in the II
nd
 study. 
Additional RFLP profiling (not published in the manuscripts) demonstrated that the two types 
of IncX1s, namely the epidemic blaTEM-52 plasmids and the plasmid with blaTEM-1, were not 
epidemiologically related (data not published). Interestingly, the epidemic IncX1 blaTEM-52 
plasmids from human and animal/meat isolates from Denmark and The Netherlands 
(Manuscript I) shared many similarities with pOLA52 isolated from swine manure from 
E. coli 
142
 as well as with pOG670
23
 from S. enterica (data not published). A variant of 
pOLA52 (e.g. pOLA52 blaTEM-1:ntp, kan
R
), was initially used in the incompatibility assay 
with the pE001 plasmid (Manuscript I). The pOG670 was originally isolated from 
humans/cattle (exact source not specified) in Scotland in 1917. The epidemic IncX1 blaTEM-52 
plasmid from study I, pOLA52 and pOG670 may possibly belong to the same similarity 
cluster compared to the blaTEM-1 IncX1 plasmid from study II. It is possible that only a certain 
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clone or clones of IncX1 plasmids might have been responsible for the spread of the blaTEM-52 
genes in animals and humans at least in European countries. However, such hypothesis needs 
to be further investigated.  
3.3.2 IncI1 plasmids with blaTEM-1 and blaTEM-52 
By analogy to the IncX1 replicons, two types of epidemic IncI1 plasmids were found in this 
study harbouring blaTEM-1 (pMLST ST36/CC5, paper II) and blaTEM-52 (pMLST
71;100
 
ST5/CC5, paper I). Interestingly, Leverstein-van Hall et al.
116
 demonstrated that the 
ST36/CC5 blaTEM-52 plasmids were circulating in animals and humans in also in The 
Netherlands (described in section 1.2.3). 
Despite the differences in their STs the two plasmids belonged to the same CC5; the CC5 is 
currently comprised of four ST-types (ST5,-10,-21 and -36) which are represented by IncI1 
plasmids mainly with blaTEM-52 and blaTEM-20 
100;158
. These data suggest that these CC5 
scaffolds might have been the original platforms for the evolution of the blaTEM-1 to blaTEM-52 
genes.  
TEM-52 was initially described in K .pneumoniae from stool sample taken from a Greek 
patient (Athens) in a French hospital (Paris) in 1996
163
. In the reference study it was 
determined that the blaTEM-52 gene resided on a small plasmid (<10 kb; replicon was not 
identified) harbouring Tn3-like element. Other reports of the blaTEM-52 informed about rather 
large plasmids (>40 kb); blaTEM-52  were found on plasmids with not determined replicons 
from Shigella spp. isolated betwen 1991-2000 in  Korea 
182
; on IncA/C, IncN, IncI1, IncL/M, 
IncR and  IncX1 plasmids from K. pneumoniae, E. coli and different serovars of S. enterica 
originating from diverse European countries as well as Canada and  Korea, isolated from 
humans, poultry and meat between 1995-2000 (Bergenholts & Jørgensen
11
 and Manuscript I); 
More recent reports located blaTEM-52 on IncA/C plasmids form clinical E. coli from Tunesia
41 
(isolation years not specified) and IncN plasmids from clinical isolates of  P. mirabilis 
collected in 2008 in Korea
180
. Much of the of data regarding the replicon typing of blaTEM 
plasmids (as well as plasmids with other bla types) come from after 2005 when the PBRT 
was published and also when already more attention was given to  surveying of the resistance 
and its genetic background in animal reservoirs. In this case it is not possible to state whether 
this ‘first’ blaTEM-52 in human originated from animal sources or not.  
3.3.3 IncB/O and IncK plasmids with blaTEM-1  
In the II
nd
 study a range of either undistinguishable or at least closely related blaTEM-1 IncB/O 
plasmids designated as RFLP ‘p’ was detected in E. coli from healthy human, human clinical, 
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diseased pig and cattle as well as  from healthy cows. Another group of IncB/O plasmids 
sharing similarities with each other was found among several human isolates of E. coli from 
(RFLP ‘m’ in Manuscript II).  Here, the E. coli isolates from each reservoir have been 
compared with each other by XbaI PFGE. The strains were shown not to be clonally related 
which suggests that these similar IncB/O RFLP ‘p’ and ‘m’  plasmids were indeed circulating 
in the diverse E. coli isolates. Overall, the blaTEM-1 IncB/O plasmids from the different 
reservoirs seemed to share many similarities based on their RFLP patterns. Currently no 
pMLST or similar method exist for IncB/O plasmids; therefore the relationship of these 
epidemic IncB/O ‘p’ and ‘m’ scaffolds with the previously published plasmids like 
pR3521
150
( from clinical E. coli in Greece), pO26-vir (FJ386569; from STEC, USA) or 
pHUSEC41-1
112
 (from STEC from Germany) or other not listed plasmids from isolates 
originating from countries other than Denmark remains to be elucidated in the future studies.  
 
One case of a blaTEM-1 IncK plasmid was detected in human E. coli isolate (Manuscript II). 
Due to the similarity of the IncB/O and IncK replicons it will also be mentioned in this 
subsection. The IncK replicons have been rather rarely detected in Enterobacteriaceae from 
humans and from food production animals. Although, this replicon was recently shown to 
drive the spread of blaCTX-M-14 gene in E. coli from humans in Spain
202
. 
3.3.4 IncFII and/or IncFI plasmids with blaTEM-1 
In study II the selected IncF-family plasmids underwent the replicon sequence typing 
(RST
205
). In three different diagnostic cattle E. coli isolates similar multireplicon plasmids 
IncFII & IncFIB with blaTEM-1c were found; they shared the same RFLP profiles and 
according to the FAB formula (each letter representing IncFII, IncFIA and IncFIB, 
respectively) they were of F2:A-:B1 types. A plasmid from another cattle isolate and 
harbouring blaTEM-1b gene was only verified by RFLP in study II but shared similar pattern to 
these three. An F2:A-:B1 plasmid called pAPEC-O2-ColV (AY545598) was previously 
described in the ExPEC strains
187;205
. This implies that the infection in some of the cows from 
which the amp
R
 isolates were collected and used in study II might have been caused by the 
APEC-like strains or at least the F2:A-:B1 plasmids from these cows might have been of 
avian origin (or vice versa). In fact, Skyberg et al. demonstrated that this virulence pAPEC-
O2-ColV plasmid may contribute to the increased virulence when transmitted to the 
previously commensal E. coli strains
187
.  On another hand, this original plasmid (AY545598) 
does not encode any bla genes and was originally isolated in USA
101
. It  is therefore possible 
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that not a horizontal transmission of plasmids is in question here, but the similar plasmid 
types might be generally hallmarks of the pathogenic E. coli strains from the diverse 
geographical locations 
99
. 
In two diagnostic pig isolates and in one diagnostic cattle isolate similar IncFII blaTEM-1 
plasmids sharing the RFLP type ‘d’ were detected in the study II. Two of these plasmids 
underwent RST and they were related to ST F35 (both had three nucleotide differences 
compared to F35). There is no 100% identical match found in GenBank for this F35-related 
locus. The F35:A-:B- pattern was previously found on blaCTX-M-9 plasmids from E. coli 
isolates from pets in China (pHN0113-2; HQ706665.1)
61
 and blaCTX-M-14 (the blaCTX-M-9 
family) from en epidemic, human E. coli ST131 strain from China (pWCE35; 
GU462158.1)
219
. 
Finally, similar  IncFII, RFLP ’g’, RST type F2:A-:B-  plasmids were found in three different 
clones of human E. coli (Manuscript II). This pattern was previously described on the diverse 
plasmids from human  isolates of E. coli , S. flexneri, S. sonnei and K.pneumoniae; the latter 
plasmids harboured blaTEM-1, blaCTX-M-14 ,15 or 24 , or encoded virulence factors like 
haemmaglutinin, colicin or iron transport systems
205
.  Recently, Deng et al.
61
 also 
demonstrated an epidemic dissemiation of an F2:A-:B- plasmids with rmtB (aminoglycoside 
resistance), qepA (fluoroquinolone efflux pump) and diverse blaCTX-M variants in different 
Enterobacteiraceae from humans and animals in China. Madec et al.
124
 demonstrated 
dissemination of blaCTX-M-15 F2:A-:B- plasmids among humans and animals in France (also 
mentioned in section 1.2.3). 
3.3.5 IncN plasmids with blaTEM-1 genes  
Two IncN plasmids (p7372121-1 and p1308-CO3) detected in the study II were compared 
with each other by pMLST. IncN blaTEM-1b p7372121-1 from poultry belonged to ST 3; 
similar ST3 plasmids with blaCTX-M-1 and qnrS1 (human isolate) were previously described in 
E. coli and S. enterica from Denmark and The Netherlands
73
. The blaTEM-1b IncN p1308-CO3 
from human belonged to ST6. The later types of plasmids harbouring blaCTX-M-3, blaKPC-3 and 
blaOXA-3 were previously reported in S. enterica (United Kingdom) and K. pneumoniae 
(USA) 
73
 . 
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3.4 NHR, host specific plasmids are recipients of blaTEM genes, BHR plasmids are 
transporters for mobilized genetic traits from the environment or between more 
distantly related species 
In the 1980s Datta and Hughes examined a collection of 400 Enterobacteriaceae from human 
infections (E. coli, K. pneumoniae, Shigella, Salmonella and Proteus from diverse 
geographical locations)
57;103
. The isolates originated from so called pre-antibiotic era 
(abbreviated PAE) isolates and were collected between 1917 and 1954. They managed to 
conjugate plasmids from 84 PAE to E. coli recipients and none of these plasmids conferred 
antimicrobial resistance phenotype in the recipient. Moreover, these plasmids represented the 
same Inc groups as the ones currently found in the key infectious Enterobacteriaceae but 
harbouring sometimes multiple resistances, namely IncB (now known as IncB/O), IncN, 
IncFII, IncI1and IncX
57;103
. This implied that the resistance genes in humans must have been 
acquired from some external sources rather than being the genes endogenously found in 
bacteria from humans. In this study (Manuscripts I and  II) the blaTEM genes in E. coli and in 
other aforementioned enteric bacteria resided mainly on the similar types of plasmids, the 
IncF-plasmids (IncFII, IncFIIk, IncFIA and -B) and IncI1 complex (IncI1, IncB/O, one case 
of IncK) plasmids. The IncI1 and IncB/O plasmids were both found as epidemic types 
transmitting either the blaTEM-52 (IncI1) or blaTEM-1 (IncI1 and IncB/O).  
Considering that the similar IncF or IncI-complex plasmids with the same resistance gene are 
found both in human and animals it is difficult to point out whether the blaTEM-1 genes were 
acquired by humans from animals (or vice versa). It can only be speculated that, similarly to 
other bla genes, the blaTEM-1 genes originated form chromosomes of bacteria other than the 
well characterised Enterobacteriaceae of which genomes are available in the databases like E. 
coli, S. enterica or K. pneumoniae. It seems likely that the BHR like IncP, IncR, IncA/C or 
IncN detected in this study might have been in the past the links between the yet unrevealed 
blaTEM-1 chromosomal progenitors. Also the IncY replicons (being actually forms of 
bacteriophages) with the blaTEM genes were previously sporadically detected
33
, one case was 
detected with blaTEM-1 in this study (Manuscript II).  Probably not all bacteriophages assume 
the plasmidic forms like the IncY and hence their participation in the transmission of these 
resistance traits might have been to some extend overlooked. Nevertheless, at the current 
state of knowledge the participation of bacteriophages in the transmission of resistance is still 
considered minor in Enterobacteriaceae compared to the plasmid driven transmission
74
. 
Typically IncP plasmids are known to poses one of the broadest host ranges among the Inc 
groups of Enterobacteriaceae. They are capable of transfer even to Gram positive bacteria, 
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although they cannot replicate in the latter.
189
 Curiously, in study II a rather large fraction of 
IncFII, IncFIB, IncI1 and IncB/O was detected as co-integrates with the IncP replicons. 
Particularly in the cattle isolates the IncP plasmids were more prevalent. Actually, Bahl et al. 
previously demonstrated high prevalence of the IncP plasmids in the influents into a Danish 
wastewater treatment plant, which emphasizes the abundance of these plasmids in the outside 
environments
5
. 
The IncR family has not yet been well characterised. First description of this replicon was on 
pKp245, a plasmid originating from UTI isolate of K. pneumoniae
41
. IncR were detected on a 
blaTEM-1 plasmid from Escherichia fergusonii (human infection; CU928144), on the blaTEM-52 
plasmid pK727 from E. coli (Manuscript I) and on a plasmid pLV1403 from Pantoea 
agglomerans  (member of Enterobacteriaceae) from lake water sediment
148
 (studies I and III). 
These replicons were actually often detected in K. pneumoniae examined in the study III.  By 
analogy to the IncP plasmids from study II it seems that the BHR IncR replicons tend to form 
co-integrates with the host specific replicons like IncFIIk (Manuscript III). 
Two conclusions based on the above can be made in this subsection. Firstly, the ‘naive’ 
(resistance free) NHR plasmids in E. coli in humans and in animals must have originally 
depended either on the mutation rate to develop resistance to antimicrobials, or on the 
occurrence of the external resistance genes carried on the BHR plasmids (or other MGEs) 
that were passing by
192
. BHR plasmids like IncP, IncA/C, IncR, IncN detected in this study 
and probably other plasmids (like IncY) species function as transporters for various traits. As 
these BHR scaffolds plasmids are exposed to variety of potential hosts and conditions, they 
are likely to be recipients of a large number of genetic elements including transposons or 
even other plasmids.They may be the key factors needed for mobilization of the bla genes 
from yet undetermined environmental sources.  
3.5 Plasmid encoded resistance is an ecological problem and studying plasmids 
epidemiology calls for specialized tools 
Diverse Enterobacteriaceae found in the GI tract of humans and animals without doubt 
doubts interact with each other and with other bacterial species as well as with viruses 
(bacteriphages)
192
. The same statement applies to the bacterial species found in the natural 
environments like soils, plants, surface waters, lake sediments etc. Many bacterial species 
probably pass through the GI tracts; the transmission of bla genes (and possibly other genetic 
traits) is driven not only by the defined resistant bacterium, but also by a range of MGEs, 
some of them being self-transmissible (plasmids, ICEs) or can be mobilized from one 
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bacterium to another
143
. Currently the term plasmid epidemiology is frequently used to 
underline that not only a given clone of bacterium but a stable ‘clone’ of plasmid can traverse 
across different bacterial host organisms. For many years assessment of plasmids 
incompatibility and since 2005 typing of replicons by PBRT was combined with the RFLP 
methods and these served as standard means to study epidemiology of plasmids.  
3.5.1 PBRT vs novel mPCR 
Upon the initiation of this study (2009) the published PBRT
35
 did not encompass  as many 
replicon variants as it does now. Especially the plasmids from K .pneumoniae seemed to 
escape the detection and hence classification by this PCR-based method. Therefore, an 
attempt was made in study III to collect the available sequences of plasmids from this species 
and to design a PCR-based method for rapid detection and classification of plasmids 
specifically in K. pneumoniae (Manuscript III). A novel multiplex PCR was designed 
(mPCR) and it was targeting a range of rep sequences (e.g. encoding the Rep initiator of 
replication). By the end of 2010 Villa et al. presented an updated PBRT scheme
205
. Many of 
the plasmids from K. pneumoniae used as the references for designing of the mPCR turned 
out to be the IncFIIk variants as defined by Villa et al. However, an interesting observation 
was made combining the data from study III and from the study of Villa et al. Namely, 
multiple plasmids in the same bacterium apparently carried similar incompatibility 
determinants belonging to the IncFIIk group. The K. pneumoniae strain MGH78578 (ATCC 
700721; GenBank) harbours three large plasmids; two of these are IncFIIk both with the FAB 
formulas [K1:A-:B-]
205, where ‘K’ stands for the FIIk locus (pKPN3 and pKPN4; the third 
plasmid is an IncR plasmid called pKPN5). This challenges the assumption that plasmids 
from the same Inc group are not suppose to reside in the same bacterium
144
. The mPCR 
combined with the in silico analyses solved this issue indicating that secondary 
incompatibility factors may be encoded by these co-residing FIIk plasmids in K. pneumoniae 
MGH78578, namely the secondary replicases (which presumably are part of independent 
replicons). Indeed pKPN3 harbours the repAFIIk and a second rep gene belonging to a repIV 
group (defined in Manuscript 3), while pKPN4 harbours repAFIIk and a rep sequence of 
repVI type. Co-existence of several resistance plasmids belonging to the IncF-family in the 
same isolate is apparently not unusual; a similar phenomenon was recently described for 
resistance F-plasmids in the E. coli strain by other authors
61
.  
In conclusion, the above illustrates that the classification of plasmids to the Inc groups 
requires continuous optimizations of the PCR-based protocols (and species considerations) in 
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order to tract the plasmids relatedness as well as genetic rearrangements in their scaffolds. 
Designing of the PCR is largely depended on the available sequencing data. Moreover, the 
designation ‘Inc groups’ gradually loses its original meaning and it seems to be more proper 
to consider some of the novel Inc types rather as homology or similarity groups (Manuscript 
III). 
3.5.2 K. pneumoniae from humans and from the environment harbours few classical Inc 
types and a range of potentially novel replicons  
Study III revealed that only a limited range of replicons were present in the examined 
K. pneumoniae from humans and from the surface waters
191
. Typically IncFIIk, a novel 
replicon repIV and also IncR were detected. In many cases the plasmids remained non-
typable. Possibly inclusion of the secondary replicases collectively termed in Manuscript III 
as the ‘remaining rep’s’ as the targets of the mPCR would solve the problem of these non-
typable replicons. Furthermore, it is proposed in this thesis that repIV replicon detected often 
on plasmids in this study might be a Klebsiella specific equivalent of either IncFIA or -FIB 
replicons usually found in E. coli (Manuscript III). 
The isolates in study III were not selected based on any resistance markers, hence can be 
considered as ‘normally found’ in K. pneumoniae in humans or in the environment. Some  
K. pneumoniae can transiently colonize mucosal surfaces in humans and animals, however 
unlike for E. coli, a term commensal seem to be inappropriate in this case as some of the 
strains were in fact pathogenic causing UTI or bacteraemia (Manuscript III); K. pneumoniae 
is an opportunistic pathogen therefore the strains causing infections in general would be 
similar to those found  normally in the natural environments
159
. In the recent study of 
Mataseje et al. 
127
 RepFIIA, IncR and also a range of non-typable plasmids were found to be 
responsible for transmission of blaKPC genes in carbapenemase producing K. pneumoniae 
from clinical settings. By analogy to the II
nd
 study it seems that the plasmids typical for 
K. pneumoniae (FIIk, possibly repIV or other replicons that were untypable in study III) and 
also the broad host range IncR, IncN, IncA/C and IncL/M (mentioned in Manuscript III) 
would also be prone to acquire the diverse bla genes.  
3.6 Plasmids and transposable elements in enteric bacteria - implications in mobilization 
and spread of the blaTEM genes  
Although plasmids are the main focus of this study, the subject of transposable elements 
should not be overlooked. It was previously shown that the most frequently detected bla 
genes encoding Ambler class A ESBLs, namely blaSHV, blaCTX-M, and blaTEM, were typically 
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transmitted not only on the similar types of replicons in Enterobacteriaceae (mainly IncF-
family, IncI1, IncN, IncA/C
33;34
), but also on the specific transposable platforms. The blaSHV 
were shown to be usually located on DNA segments containing also other resistance genes 
and flanked by the IS26 elements thus constituting the composite transposons
131
.  
The blaCTX-M were shown to be typically mobilized by insertion sequences ISEcp1 (blaCTX-M-
3, blaCTX-M-14, blaCTX-M-15, blaCTX-M-10) and ISCR1 (blaCTX-M-9, blaCTX-M-2)
4
. The blaTEM genes 
were detected within the Tn3-like transposons
6
 and this was also observed in study I and II 
(actually the IncR plasmid pEFER analysed in silico in study III also harbours the blaTEM-1b 
on the Tn2 transposon; data not shown in Manuscript III).  
The linking PCR in study I was initially designed based on the sequenced element EF141186 
annotated previously as Tn3 transposon with blaTEM-52 gene 
11
. It was later realized that this 
element was in fact Tn2 type 
6
. This PCR setup from Manuscript I was re-analyzed in silico 
and the conclusion was made that the primers used in the linking PCR (Manucript I) indeed 
matched with the Tn2 type transposons but also with the Tn1 type elements; Tn3 transposons 
would actually not be detected by this set up. In the second study the linking PCR was 
redesigned, in order to distinguish between the different elements and encompass larger 
variety of the putative elements upstream of the blaTEM-1 genes (e.g. Tn1, -2,-3 and IS26 in 
two different orientations with respect to the blaTEM gene). The new linking PCR was in fact 
tested initially on the plasmids from Manuscript I, confirming that the majority of the blaTEM-
52 genes indeed resided on the Tn2 transposons, although in one case of the pK727 many 
unspecific bands were produced and it was decided to designate the element upstream of the 
blaTEM-52 gene on this plasmid as unknown in order to get more specific information of this 
sequence in the future studies (erratum to Manscript I).  
As indicated previously, PCR based methods are sensitive to the polymorphisms in the 
primer binding sequences. Moreover, the substitutions between the primers would typically 
not be detected without further sequencing or application of methods like single-nucleotide 
polymorphism-specific PCR 
134
. This was the reason why in Manuscript II it is particularly 
emphasized that any result of the linking PCR should be interpreted as ‘putative element 
linked to blaTEM gene’.  
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3.6.1 BlaTEM-1b,-1c & -52 are typically mobilized by Tn2; insertions of IS26 upstream of the 
blaTEM genes are also frequent  
Table 2. Analysis of transposable elements associated with blaTEM genes (study I and II) 
blaTEM allele                   blaTEM-1b 
                  N total=112 
blaTEM-1a 
Ntotal=15 
blaTEM-1c 
Ntotal=22 
blaTEM  diverse 
Ntotal=10 
blaTEM-52b, -c 
Ntotal=22 
Associated transposable 
element  
and size(s) of  PCR 
product a 
nwith the specified element    
 
nwith the specified 
element 
 
nwith the specified 
element   
nwith the specified 
element   
nwith the specified element 
 
Tn1  1 (FII & FIB)     1 (blaTEM-1d FII;FIB;FIA) 
 
Tn2  48 
(FII; FIB; FIA; I1; P; B/O; N; 
NT; K; FII&R) 
                            22 
(FII;FIB; B/O; NT; IncI1) 
4 (blaTEM-1g, -1j, 
30, -135 
FII; FIB; B/O) 
20 
   (X1A; I1; L/M; N-like) 
Tn3  1 (NT) 
 
15 
(B/O; I1, FIB; 
FII;P; NT; X1A) 
 2 ( blaTEM-1c/1d, -30 ;both NT) 
IS26a 0.4 kb 2 (B/O & P)      
IS26a 2 kb and 0.4 kb 7 (B/O; P; B /O & IncP; FII & FIB 
& P;  FII & FIB) 
     
IS26a 2 kb 14 (FII; FIB; I1; P; FIB & Y; NT; n-
trsf) 
     
IS26a 1.3 kb 17 (FII; FIA; FIB; P)    1 (blaTEM-30 ; FII) 
 
IS26a  
& 
IS26b  
 
2 kb (IS26a) & 
0.6 kb (IS26b) 
9 (B/O; B/O&P; I1& P)      
IS26b 0.6 kb 3 (B/O; IncFII & IncFIB)      
IS26b 1  kb      1  (blaTEM-40; 
FIB) 
 
IS26b 1.2 kb 1 (FII &FIB)      
         
ukn  9 (FII; FIB; NT; n-trsf; HI1)      1 blaTEM-1d                       2 
(FII;FIB;FIA)           (A/C blaTEM-52b; R blaTEM-52c ) 
 
 
a- refers to PCR form paper II, relevant only for the ISa and ISb linking PCRs which were expected to generate miscellaneous products; n-trsf – the blaTEM-1 was 
non transferable from the wild type and not associated with any of the plasmids detected in the wild type strain; ukn- unknown 
 
The summary of typing of the genetic environment of the blaTEM genes (study I and II) is 
presented in the Table 2. Overall, the blaTEM-1b located on Tn2 transposons were most 
frequently detected on the various plasmids in E. coli (Manuscript II); blaTEM-52b and blaTEM-
52c were also mainly located on the Tn2 transposons on various plasmids from E. coli and S. 
enterica (Manuscript I). The blaTEM-1a genes were exclusively detected on Tn3 and blaTEM-1c 
were only found on Tn2 transposons (Manuscript II). In many cases in study II the elements 
detected upstream of the blaTEM-1b were IS26 (no such case was observed upstream of the 
blaTEM-1a and the blaTEM-1c). Insertions of IS26 elements must have occurred in different 
orientations with respect to the blaTEM genes and possibly multiple times (illustrated 
examples are presented in Manuscript II, S2 supplement). That would explain the presence of 
multiple or differently sized bands produced in the ISa/b- blaTEM PCR (Table 2).  
Tn1 (suggested previously to be the typical transposon associated with blaTEM-2 in 
Pseudomonas spp.) was detected  in two cases in the II
nd
 study; a multireplicon IncFII & 
IncFIA &IncFIB plasmid from human E. coli carried Tn1 -blaTEM-1d  and  another IncFII 
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&IncFIB plasmid from poultry carried  putative Tn1 -blaTEM-1b (Manuscript II). The latter is 
an unusual combination and should preferably be verified in the future studies. 
In summary, this study confirmed that the transmission of blaTEM genes is driven by Tn3-
family elements on the plasmids in Enterobacteriaceae. The two elements, Tn2 and IS26 
seem to be particularly involved in shaping of the accessory regions of plasmids from 
Enterobacteriaceae as well as other bacterial families. Partridge et al. demonstrated that the 
Tn2 and IS26 also drive the evolution and rearrangements of the regions containing the 
ISEcp1-blaCTX-M-15 on the IncF-family plasmids from E.coli.
152
  
3.6.2 Candidates for chromosomal progenitors of plasmid encoded blaTEM-1  
There are no records in the literature or in GenBank of a fully sequenced genome of an 
enteric bacterium that would harbour chromosomally located blaTEM-1 gene (or Tn3-like- 
blaTEM-1 inserted on the chromosome). TnpR of Tn2 linked to blaTEM-1b was previously found 
on a genomic island designated ICEhinc1056 from H. influenzae (AJ627386; the allele was 
originally annotated as blaTEM-1d, however, analysis in this study showed 100% identity of 
this open reading frame with blaTEM-1b). There is no tnpA present on ICEhinc1056, however 
further upstream of the tnpR-blaTEM-1b there is an integrase gene present 
132
 (illustrated on the 
figure S2 in Manuscript II). This genomic island was shown to be typically integrated into the 
H. influenzae chromosome, but could be excised, circularize and also conjugate to other 
hosts
132
. Related elements with genes either coding for virulence factors or degradative 
enzymes, but not with blaTEM genes, were detected in other species of Haemophilus, 
Pseudomonas spp. and Salmonella spp.
132
 It is interesting that also other blaTEM variants 
(‘full’ version of Tn2-blaTEM-1b is found on the sequenced chromosome of H. influenza 
CP002277; blaTEM-15b on the small plasmid pSF2
200
 from H. parainfluenzae, AM849805) 
were described in Haemophilus spp. The latter are members of the family Pasteurellaceae and 
these bacteria, similarly to K. pneumoniae, can be free living microorganisms. Moreover, 
Haemophilus has increased permeability to penicillin G compared to enteric bacteria like E. 
coli 
199;200
, hence it seems logical that the β-lactamase driven mechanisms of resitance could 
have been somehow induced  in these (or related) bacteria in the earily history of penicillin 
usage in humans and animals; or by the presence of this compund naturally produced by 
fungi in soil (although H. influenzae can also modify its outer membrane permeability as a 
mechanism of resistance to β-lactams). Resistance to aminopenicillins had its outbreak in  
H.  influenza almost ten years after the first description of TEM-1 in Enterobacteriaceae 
132
. It 
is therefore a far- reaching hypothesis, but it seems plausible that the blaTEM-1 genes could 
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have been in the past derived from these kinds of ICEhinc1056-similar elements (possibly 
originating from other members of environmental or animal associated Pasteurellaceae). 
Recombination might have led to creation of Tn3- like-blaTEM-1 elements that were later 
transmitted on BHR plasmids (or the ICE- elements) to Enterobacteriaceae and also 
Pseudomonas
64
 (the latter produce their chromosomal AmpC β-lactamases therefore they 
seem to be rather recipients of plasmid mediated blaTEM genes
121
). It can be further speculated 
that consequently the [Tn3-like -blaTEM-1] elements transposed onto the endogenous plasmids 
in species like K. pneumoniae (IncFIIk, IncR or other scaffolds) as well as E. coli plasmids 
IncF, IncB/O and IncI1 or onto BHR platforms like IncP, IncR, IncN or other replicons.   
Naturally, it could also be opposite and the blaTEM genes were initially transmitted (likely on 
plasmids) from Enterobacteriaceae to other families of bacteria. In any case, the question of 
the blaTEM-1 origins remains to be answered in the future studies. 
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4. Conclusions  
The following conclusions were deduced from this thesis:  
 
i) Two types of replicons were mainly detected on the blaTEM-1-plasmids from E. coli of 
human and food production animal origin: the IncF-complex (IncFII, IncFIA, IncFIB, 
IncFIC) and the IncI-complex (IncI1, IncB/O, IncK); in food production animals often IncP 
plasmids were forming co-integrates of the aforementioned types; overall, in few or single 
cases IncN, IncHI1, IncR and IncY replicons were detected. 
 
ii) BlaTEM-52 plasmids were mainly associated with IncI1 and IncX1 and to lesser extend 
IncA/C, IncL/M, IncN-related, IncR in E. coli and S. enterica; IncA/C are frequently found 
on diverse other blaTEM variants encoding TEM-ESBLs. 
 
iii) Often the same plasmids that are normally prevalent in the given bacterium are also 
harbouring the resistance genes in this bacterium.  
 
iv)  Plasmids from E. coli display not only the adaptation to the given host bacterium but also 
reservoir specificity, namely IncB/O were found rather in E. coli of humans, cattle and pigs 
while IncI1 were typically found in E. coli from poultry and to lesser extend also in pigs; 
further research if required to identify the reason of this phenomenon. 
 
v) IncI1 and IncX1 plasmids with blaTEM-52 were likely acquired from food production 
animals; mainly E. coli and S. enterica from the poultry are suspected to be reservoirs of 
these resistance plasmids. It cannot be unequivocally concluded whether the blaTEM-1 
plasmids found in humans originated from animal sources or not, although the clonally 
related blaTEM-1 IncB/O and IncI1 can apparently circulate in E. coli from humans and diverse 
food production animals. This confirms that the plasmids can be horizontally exchanged 
between bacteria from animals and humans 
  
vi) IncI1 scaffolds belonging to CC5 might have been the main platforms driving the 
transmission and evolution of the blaTEM-1genes to blaTEM-52 genes. 
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vii) BHR scaffolds like IncP, IncA/C, IncR, IncN and also IncL/M probably serve as 
transporters bringing the new traits (like the blaTEM or other resistance genes) from other 
bacteria species.  
 
viii) BlaTEM usually reside on Tn3- family transposons but the different gene alleles tend to be 
associated with the specific members of the Tn3-family (blaTEM-1b,-1c, -52b, -52c typically were 
located on Tn2; blaTEM-1a  typically were located on Tn3); different plasmids in 
Enterobacteriaceae can  exchange their resistance genes owing to the association of these 
genes with the transposable elements. 
 
ix) Despite the improvements in the standard PBRT methods for typing of plasmids in  
K. pneumoniae (IncR and IncFIIk), this species seem to harbour a variety of secondary 
replicons detected by the mPCR designed in study III. This further implies that optimizations 
are still needed in the detection and classification methods for plasmids from the diverse 
bacteria species in order to tract the epidemiology of these MGEs. 
 
Overall, the studies presented here contributed to understanding that not only enteric bacteria 
but also mobile genetic elements like plasmids can be transmitted in a zoonotic mode. In 
some cases it was not possible to unequivocally state what was the direction of the plasmid 
transmission, i. e. from the animals or natural environments to humans or the other way 
round.  Nevertheless, this thesis delivered evidences that blaTEM plasmids can be horizontally 
transmitted between enteric bacteria of human and animal origin and can also be found in 
bacteria contaminating meat products. The need for further research in order to determine the 
genetic background of bacteria from various niches and mobile genetic platforms transmitting 
resistance genes like the blaTEM-1 is emphasized. This might eventually enable the prediction 
of which bacteria and from which niche/organisms constitute reservoirs of mobilizable 
resistance traits.   
5. Future perspectives 
When it comes to Gram negative bacteria, so far the best studied plasmids originated mainly 
from families like Enterobacteriaceae, in particular plasmids form the model organism (and 
also the common infectious agent) like E. coli. Detailed studies allowed for recognition that 
plasmids from other enteric species developed certain bacterial host specificities like the FIIk, 
FIIs or FIIy variants of the IncFII replicons. Study III provided data suggesting that plasmids 
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form K. pneumoniae generally may constitute distinct Inc groups than those described for E. 
coli. It is clear, however, that the occurrence of the resistance and virulence genes on 
plasmids stimulated researchers to focus mainly on these selected types of plasmids. By 
analogy, mainly resistance and degradative plasmids from Psudomonas spp. are also 
relatively well studied. Recently a replicon typing scheme was published for previously not 
that well characterized plasmids from Acinetobacter baumanii 
14
. These plasmids again drew 
attention mainly because of their association with the resistance genes in A. baumanii. Some 
of the Inc groups (comprised typically of the broad host range plasmids) overlap between the 
various bacterial families as described in section 2.3.1. It is not difficult to imagine that the 
resistance genes as well as other genetic traits may be transmitted on the mobile platforms 
between microorganisms found often in the natural environments. Supposable because of the 
aforementioned bias in the research foucusing on resistance plasmids, many other plasmids as 
well as their original hosts have not been yet well characterized and therefore it is difficult to 
get a full picture of where the hot spots for mobilization of the unwanted resistance genes are 
located 
189
. To address this problem, future studies should preferentially include also plasmids 
as well as overall genetic diversity in the various environmental niches (soils, water 
reservoirs, plants, reservoirs of commensal bacteria in humans and animals etc.). This way 
the presence of potentially novel resistance genes in the environment could be rapidly 
estimated. Having the knowledge about where the progenitors for resistance genes are born 
would allow for predicting and in the future preventing of the further spread of these 
unwanted traits.  
Moreover, studies on reservoir-specificity and plasmid- (bacterial) host interactions are 
needed to fully encompass the ecology of resistance transmission driven by these MGEs. 
Finally, tracking down the epidemiology of MGEs requires rapid, cost effective but also with 
appropriate discriminatory power. PCR methods like PBRT are sensitive to the nucleotide 
substitutions at the primer binding positions. At the present moment pMLST is probably the 
most effective way for performing sequence-based comparisons of the diverse scaffolds in 
the screening studies like this one. However, pMLST is rather a prelude for future 
methodologies involving the whole genome sequencing. The latter would likely require 
elaboration of rapid annotation pipelines (or some possibility for instant in silico analysis of 
the obtained sequences, possibly with the use of predefined primers for the specific trait). 
This would allow for fishing out the traits specific for example for plasmids (like the replicon 
or genes characteristic for transfer regions); or traits like resistance or virulence.  
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Objectives: To investigate the diversity of plasmids that carry blaTEM-52 genes among Escherichia coli and
Salmonella enterica originating from animals, meat products and humans.
Methods: A collection of 22 blaTEM-52-encoding plasmids was characterized by restriction fragment length
polymorphism (RFLP), replicon typing (by PCR or replicon sequencing), susceptibility testing, assessment of
plasmid ability to self-transfer by conjugation and typing of the genetic environment of the blaTEM-52 gene.
Detected IncI1 plasmids underwent further plasmid multilocus sequence typing.
Results: RFLP profiles demonstrated dissemination of blaTEM-52 in Denmark (imported meat from Germany),
France, Belgium and the Netherlands from 2000 to 2006 by mainly two different plasmids, one encoding
blaTEM-52b (IncX1A, 45 kb) and the other blaTEM-52c (IncI1, 80 kb). In addition, blaTEM-52b was also found to be
located on various other plasmids belonging to IncA/C and IncL/M, while blaTEM-52c was found on IncN-like
as well as on IncR plasmids. In themajority of cases (n¼21) the blaTEM-52 genewas located on a Tn3 transposon.
Seven out of 10 blaTEM-52 plasmids tested in conjugation experiments were shown to be capable of self-transfer
to a plasmid-free E. coli recipient.
Conclusions: The blaTEM-52 gene found in humans could have been transmitted on transferable plasmids orig-
inating from animal sources. Some of the blaTEM-52 plasmids carry replicons that differ from the classical ones.
Two novel replicons were detected, IncX1A and IncN-like. Unlike its predecessor blaTEM-1, the blaTEM-52 gene was
not detected on F-type replicons suggesting that this gene evolved on other types of plasmid scaffolds.
Keywords: antibiotic resistance, ESBLs, human and non-human isolates
Introduction
Plasmids are usually circular, double-stranded DNA entities that
can self-replicate.1 Theyoftenencode functionsgivingextraadvan-
tages to their hosts in the presence of selective pressure.1 The
ability of some plasmids to transfer antibiotic resistance genes
from one bacterial host to another constitutes a real threat to
human health.1,2 Extended-spectrum b-lactam antibiotics are
commonlyused for treatmentof severe infections causedbyGram-
negative bacteria, in particular those caused by Enterobacteria-
ceae. Resistance to these b-lactams is often plasmid encoded
and the frequency of resistance is alarmingly increasing.1
Plasmid-encoded BlaTEM-type enzymes capable of degrading
b-lactam antibiotics were first described in 1965 and have
since then disseminated worldwide.1 The blaTEM-52 gene, encod-
ing an extended-spectrum b-lactamase (ESBL), was first
described in 1998 in France.3 Since then it has been detected
in clinical isolates and/or production animals from Canada,
Portugal, France, Greece, the Netherlands, Germany, Belgium,
Great Britain, Croatia and Japan, and has become the most
prevalent ESBL in Korea, where it seemed to spread both clonally
and horizontally.4–17 Currently BlaTEM-52 b-lactamases constitute
one of the most common types of ESBLs along with the BlaSHV
and BlaCTX-M enzymes.
1 Many of the reports on the occurrence
of blaTEM-52 genes come from ESBL prevalence studies, which
did not focus on detailed characterization of plasmid species
associated with the blaTEM-52 genes.
4–6,8–12,15–17 Thus little is
known about the possible relationship between plasmids encod-
ing the BlaTEM-52-type b-lactamases. Knowledge about the
mechanisms of dissemination of b-lactam resistance traits by
mobile elements like plasmids can facilitate development of
methods for predicting and further controlling that
dissemination.
Currently, the largest amount of data on plasmids harbouring
ESBL genes exists for plasmids carrying blaCTX-M genes. Replicons
belonging to IncI1, IncN, IncFIB, IncFIA, IncFII, IncA/C, IncL/M
and IncHI2 families were, in the majority of cases, associated
with diverse subtypes of blaCTX-M.
1 Overall, other b-lactam
# The Author 2011. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.
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resistance genes like blaCMY, blaSHV, blaVIM and diverse blaTEM sub-
types were also most often localized on plasmids carrying the
aforementioned replicons.1 Replicons belonging to other Inc
families were detected sporadically on the ESBLs encoding
plasmids.1
Different blaTEM genes, including blaTEM-52, evolved from
blaTEM-1 and blaTEM-2.
2 BlaTEM-1 and BlaTEM-2 b-lactamases are
not considered ESBLs due to their narrow substrate spectrum.
Subsequent mutations in the blaTEM genes led to amino acid sub-
stitutions that expanded the substrate spectrum of the encoded
enzyme due to an enlargement of the active site.2 BlaTEM-52
differs from the BlaTEM-1 b-lactamase by three amino acid substi-
tutions; Glu(104)Lys, Met(182)Thr and Gly(238)Ser.18
Also the silent point mutations are useful in tracing the evol-
utionary origin of the resistance genes.18 Thus far two variants
of the blaTEM-52 gene (blaTEM-52b and blaTEM-52c) have been
described.4–7,9–11,19 Detection of similar plasmids harbouring
different alleles of the blaTEM genes would indicate that the plas-
mids might have acquired these genes possibly on transposable
elements from different sources.6
The sparse knowledge about the possible relationship between
plasmids harbouring the blaTEM-52 resistance genes prompted us
to conduct a study on these plasmids in order to obtain further
insight into their dissemination among the Enterobacteriaceae.
Plasmids from both human and animal (or meat) isolates were
analysed to investigate a potential plasmid-associated transfer
of blaTEM-52 from animal to human reservoirs.
Materials and methods
Selection of strains
Twenty-two strains including Escherichia coli (n¼13) and various sero-
vars of Salmonella enterica (n¼9) and carrying a version of the
blaTEM-52 gene were collected from different sources and further charac-
terized in this study (see Table 1). Isolates were collected during the
period from 1995 to 2006 in different countries [Denmark (German
meat), France, the Netherlands, Belgium, Spain, Korea and Canada].
They were kindly provided by different researchers and institutes and ori-
ginated from poultry, poultry meat, beef meat or clinical samples from
humans.4–7,9–11,19
Isolation of individual plasmids carrying the blaTEM-52
gene
Plasmidic DNA was purified from wild-type isolates and later from trans-
formants using a Qiagen Plasmid Mini or Midi Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions.
Plasmids were introduced to electrocompetent plasmid-free E. coli
GeneHogsw (Invitrogen) cells by means of transformation by electropora-
tion (Bio-Rad, MicropulserTM). The transformation set-up was as follows:
2.5 kV; resistance 200 V; and capacitance 25 mF. Electroporants (trans-
formants) were resuspended in 1.2 mL of brain hearth infusion (BHI)
broth (Becton, Dickinson & Co., BactoTM), incubated for a minimum of
1 h at 378C and plated onto selective BHI (Becton, Dickinson & Co.,
DifcoTM) agar plates.
Verification of transformants harbouring individual
plasmids carrying the blaTEM-52 gene
Plasmids from the 22 donor strains were used for transformation by elec-
troporation as described above. Selection of transformants (further
designated with the suffix TF) was done on agar plates containing
2 mg/L cefotaxime. If necessary, plasmids from transformants were pur-
ified as described previously and the procedure was repeated until trans-
formants with single blaTEM-52 plasmids were isolated for all 22
corresponding primary strains.
The presence of plasmids in the transformants and their sizes were
determined using S1-PFGE;20 5 U of S1 nuclease (Fermentas) was used
per plug slice. Plug slices with XbaI-digested Salmonella Branderup were
used as size ladders.21 Samples were run on a CHEF-DR III System
(Bio-Rad Laboratories, Hercules, CA, USA) and the conditions used were a
1% agarose gel (SeaKem Gold Agarose/Lonza) in 0.5× Tris/borate/EDTA, a
voltage gradient of 6 V/cm, with phase from 6.8 to 38.4 s, and a run time
of 19 h. Staining and image capture were performed as stated in Ribot
et al.21
Verification of blaTEM-52 genes
The presence of ESBL genes was confirmed for both donor strains and
transformants by PCR targeting conserved regions flanking the blaTEM
gene, as described by Hasman et al.9 Unless the blaTEM-52 gene
was already sequenced, PCR products were purified using GFX columns
(Amersham Biosciences) and fully sequenced (Macrogen Inc., Korea).
Plasmid characterization by restriction fragment
length polymorphism (RFLP)
RFLP was performed on blaTEM-52 plasmids from the 22 transformants.
Plasmids from all transformants were purified as described and digested
with EcoRI. The resulting fragments were separated and visualized on a
0.8% agarose gel (SeaKemwLA Agarose/Lonza) after 5 h at 4.0 V/cm or
21 h at 1.2 V/cm.
Replicon typing
Replicons of plasmids from the transformants were typed as described by
Carattoli and co-workers.22,23 In cases when it was impossible to deter-
mine the replicon by this method, cloning of the replicon or full
plasmid sequencing was performed using a GS FLX pyrosequencer
(Roche).
From plasmid preparations of pE001 (located in E. coli 2161TF) and
pGOC049 (located in E. coli GOC049TF), a standard FLX sequencing
library was built using 5 mg of DNA according to the manufacturer’s
guidelines (Roche). Test emulsion PCRs were performed to obtain the
best copies/bead ratio. DNA containing beads with each plasmid library
were sequenced in two regions using the GS FLX standard sequencing
kit on a 4-region 25×75 pico titre plate. A total of 11000 and 20000
reads from each of plasmids pE001 and pGOC049 were aligned and
assembled using the Newbler assembler software version 2.0.01.14
provided with the GS FLX instrument.
In the case of the plasmid from727TF, a fragment carrying the putative
replicon was generated by digestion of the plasmid with BglI and BamHI
(Fermentas) and subsequent purification on the GFX column (Amersham
Biosciences). The fragment was ligated to the chloramphenicol resistance
gene that was PCR amplified from the vector pLOW1 (Amersham Life
Science). The construct was transformed by electroporation into electro-
competent GeneHogsw. Transformant was selected on BHI agar plates
supplied with 25 mg/L chloramphenicol. Plasmid was purified from this
transformant and used as the template for sequencing. Sequencing was
performed by the standard Sanger sequencing method at Macrogen Inc.
(Korea).
Results were further processed using Vector NTI Suite 11 (Invitrogen,
Inc.) and then BLASTN and BLASTX searches against known replicon
sequences from the GenBank database were performed to identify puta-
tive replication proteins located on the plasmids.
Bielak et al.
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Multilocus sequence typing of IncI1 plasmids
All plasmids from transformants positive for the IncI1 replicon in the
multiplex PCR22 underwent further plasmid multilocus sequence typing
(pMLST) as described by Garcia-Fernandez et al.24
Incompatibility assay
Incompatibility testing was performed for blaTEM-52 plasmids located in
E. coli GOC049TF (designated as pGOC049) and E. coli 2161TF (designated
as pE001). In separate transformations, E. coli GeneHogsw carrying
plasmid R46 (IncN plasmid, kindly provided by Alessandra Carrattoli, Isti-
tuto Superiore di Sanita`, Rome, Italy; accession number AY046276) and
the IncX1 plasmid pOLA52 bla::npt (Kanr),25 respectively, were obtained.
Plasmids were purified from these by the described method. Each of the
four transformants mentioned in this section was made electrocompe-
tent using a standard protocol for preparation of electrocompetent
E. coli cells.26 The protocol employed to perform the incompatibility
assay was as described by Norman et al.25 with modification so that
the tested plasmid was introduced into the electrocompetent cells har-
bouring the second plasmid by means of transformation by electropora-
tion. pGOC049 (CTXr) was tested against IncN representative plasmid R46
(Tetr). Selection of transformants with both pGOC049 and R46 was made
on an agar plate supplied with cefotaxime together with tetracycline
(2 mg/L and 16 mg/L, respectively). pE001 (CTXr) was tested against
IncX1 representative pOLA52 bla::npt (Kanr). An agar plate supplied
with cefotaxime together with kanamycin (2 mg/L and 50 mg/L, respect-
ively) was used to select transformants harbouring both pOLA52 bla::npt
and pE001.
Each of the two tested plasmids was used in the incompatibility assay
both as the incoming and as the residual agent. To assess the plasmid
losses in the incompatibility assay for pGOC049 and R46, selective
plates with 16 mg/L tetracycline and 2 mg/L cefotaxime were used,
respectively. To assess plasmid losses in the incompatibility assay for
pE001 against pOLA52 bla::npt, selective plates supplied with 2 mg/L
cefotaxime and 50 mg/L kanamycin were used, respectively. As controls,
each of the four transformants originally harbouring only one plasmid
was inoculated into the broth without selection, and plasmid stability
was further assessed following the method described by Norman
et al.25 The presence/absence of specific replicon types in the obtained
transformants was confirmed by PCR targeting replicons of R46,
pOLA52 bla::npt, pE001 and pGOC49, respectively.
PCR conditions for detecting IncN replicon of R46 were as described by
Carattoli et al.27 Primers for detecting the remaining replicons were
designed based on the obtained sequencing data. For the sequences of
the primers and for PCR details please see Table S1 (available as
Supplementary data at JAC Online).
Examination of clonal relationship of wild-type isolates
harbouring similar plasmids
If plasmids carrying the same replicons and displaying similar RFLP pro-
files were detected in more than one of the transformants, the corre-
sponding E. coli wild-type strains harbouring similar plasmids were
tested by a PCR phylotyping method as described by Clermont et al.28
to pre-determine the potential clonality of these strains.
Genetic environment upstream of the blaTEM-52 gene
PCR linking for the presence of the tnpA gene of Tn3 upstream of the
blaTEM-52 gene was performed on the transformants (n¼22). The
primers used and PCR details are given in Table S1. The PCR product
obtained from strain 54.12TF was purified using GFX columns (Amersham
Biosciences) and sequenced. The sequence was aligned with the
sequence of Tn3-blaTEM-52 (EF141186).
Plasmid transmissibility
blaTEM-52-carrying plasmids from selected strains (representing each of
the different RFLP groups (76-33094TF, 44.02TF, ESBL 140TF, ESBL
424TF, YMC 95/4/4199TF, YMC 96/7/4035TF, 549TF, 641TF, GOC043TF
and 727TF) were tested for the ability to self-transfer to the plasmid-free
recipient E. coli MT101 (Nalr, Rifr). Conjugation was set-up as follows;
sterile paper filter (pore diameter 0.2 mm, Advantecw) was placed in
the centre of a blood agar plate, 2 mL of donor and recipient cultures
in exponential phases of growth were mixed together and 500 mL of
the mixture was placed on the paper filter, allowing the liquid to soak
into the medium. After overnight incubation, filters were washed with
4 mL of 0.9% salt water and 100 mL of the suspension was inoculated
onto BHI (Becton, Dickinson & Co., DifcoTM) agar plates with 2 mg/L cefo-
taxime, 32 mg/L nalidixic acid and 25 mg/L rifampicin. After overnight
incubation at 378C the presence of transconjugants was assessed.
Susceptibility testing
Unless stated in the references, the primary strains were tested for their
susceptibility to a range of antimicrobial agents by means of a commer-
cially available panel for Enterobacteriaceae (Sensititrew). The antimicro-
bial agents included were amoxicillin/clavulanic acid, ampicillin,
apramycin, cefotaxime, ceftiofur, chloramphenicol, ciprofloxacin, colistin,
florfenicol, gentamicin, nalidixic acid, neomycin, spectinomycin, strepto-
mycin, sulfamethoxazole, tetracycline and trimethoprim. Testing was per-
formed according to the recommendations of the CLSI (formerly the
NCCLS). CLSI breakpoints (2003) were used for interpretation of the
results except for cefotaxime. For cefotaxime, and if no CLSI breakpoints
were available for a tested compound, the criteria of the European Com-
mittee on Antimicrobial Susceptibility Testing (EUCAST) were used for
interpretation of the results.
Based on the resistance profiles obtained for donor strains, transfor-
mants were tested for susceptibility to the selected antimicrobials. Sus-
ceptibility testing of transformants was performed using the disc
diffusion method according to the guidelines of the CLSI. The recipient
strain of E. coli GeneHogsw was included as a control. CLSI zone diameter
interpretative standards (2003) were used for interpretation of the
results. Results for ceftiofur were interpreted as recommended by
Aarestrup et al.29
Results
Verification of blaTEM-52 genes
Twenty-two strains carrying a blaTEM-52 plasmid were obtained
from different sources as listed in Table 1 and transferred to a
plasmid-free E. coli recipient. The obtained transformants were
given the same names as the corresponding donor isolates,
but with a TF suffix. Both the primary strains and the obtained
transformants were positive in PCR targeting the blaTEM gene.
Among these isolates, 13 were found to carry a plasmid with
the blaTEM-52b version of the gene and 9 carried the blaTEM-52c
version.
Plasmid characterization by RFLP
Purified plasmids from all 22 transformant strains were digested
with the EcoRI enzyme. RFLP patterns indicated that strains
2161TF, 7633094-7TF, 36.52TF, 44.02TF, 46.20TF, 48.78TF,
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Table 1. List of wild-type strains harbouring the blaTEM-52 plasmids characterized in the study and the results of plasmid characterization
Wild-type strain Phylotype
Isolation source
(country of origin)
Year of
isolation
blaTEM-52
allele
Plasmid
RFLP type
Replicon
type
Self-
transmissibility
Plasmid
size (kb)
Element
upstream of
blaTEM-52
Resistances associated with the
blaTEM-52 plasmid Reference
E. coli 2161 B1 broiler meat (DEa) 2006 TEM-52b a IncX1A ND 45 Tn3 AMP, CEF, CPD, XNL 4
E. coli 7633094-7 B1 beef (DEa) 2004 TEM-52bb a IncX1A yes 45 Tn3 AMP, CEF, XNL 10
Salmonella Blockley
36.52
NA poultry meat (NL) 2001 TEM-52bb a IncX1A ND 45 Tn3 AMP, CEF, XNL 9
Salmonella Paratyphi
44.02
NA poultry (NL) 2001 TEM-52bb a IncX1A yes 45 Tn3 AMP, CEF, XNL 9
Salmonella Blockley
46.20
NA poultry meat (NL) 2001 TEM-52bb a IncX1A ND 45 Tn3 AMP, CEF, XNL 9
Salmonella
Typhimurium 48.78
NA poultry (NL) 2002 TEM-52b a IncX1A ND 45 Tn3 AMP, CEF, XNL 9
Salmonella Blockley
51.09
NA poultry (NL) 2002 TEM-52bb a IncX1A ND 45 Tn3 AMP, CEF, XNL 9
Salmonella Virchow
54.12
NA poultry (NL) 2002 TEM-52bb a IncX1A ND 45 Tn3 AMP, CEF, XNL 9
E. coli 660 A human (F) 2001 TEM-52bb a IncX1A ND 45 Tn3 AMC, AMP, XNL, CTX 6
Salmonella
Typhimurium 44.78
NA poultry (NL) 2001 TEM-52cb b IncI1 ND 80 Tn3 AMP, CEF, SPT, XNL 9
E. coli 549 A human (F) 2000 TEM-52cb b IncI1 no 80 Tn3 AMP, XNL, CTX 6
E. coli 641 B1 human (F) 2002 TEM-52cb b IncI1 yes 80 Tn3 AMC, AMP, XNL, CTX 6
E. coli 692 A human (F) 2001 TEM-52cb b IncI1 ND 80 Tn3 AMC, AMP, XNL, CTX 6
E. coli 710 D human (F) 2002 TEM-52cb b IncI1 ND 80 Tn3 AMP, XNL, [CTX] 6
E. coli Cloeckaert TKc NA human/poultry (B, F) 2001–05 TEM-52cb b IncI1 ND 80 Tn3 AMP, [CAZ], CEF, [CRO], [XNL] 7
E. coli GOC043 B2 poultry (ES) unknown TEM-52c c IncN-like yes 40 Tn3 AMP, XNL, CTX 5
E. coli GOC049 B1 poultry (ES) unknown TEM-52c c IncN-like ND 40 Tn3 AMP, XNL, CTX, SPT 5
E. coli 727 ND human (F) 2003 TEM-52cb d IncR no 40 Tn3 AMP, [XNL], [CTX], GEN, NEO 6
E. coli ESBL 140 ND human (CA) 1999–2000 TEM-52b e IncA/C no 81 unknown AMP, XNL, [CTX], GEN 17
E. coli ESBL 424 ND human (CA) 1999–2000 TEM-52b f IncI1 yes 115 Tn3 AMP, XNL, CTX, GEN, SPT, TET 17
Salmonella Saintpaul
YMC 95/4/4199
NA human (KR) 1995–97 TEM-52bb g IncL/M yes 65 Tn3 AMC, AMP, XNL, CTX, SPT, SMX, TMP 11
Salmonella Stanley
YMC 96/7/4035
NA human (KR) 1995–97 TEM-52b h IncL/M yes 80 Tn3 AMC, AMP, XNL, CTX, GEN 11
DE, Denmark; NL, the Netherlands; F, France; B, Belgium; ES, Spain; CA, Canada; KR, Korea; ND, not determined; NA, not applicable; AMP, ampicillin; AMC, amoxicillin/clavulanate (2:1);
CAZ, ceftazidime; CEF, cefalotin; CPD, cefpodoxime; CRO, ceftriaxone; CTX, cefotaxime; GEN, gentamicin; NEO, neomycin; SMX, sulfamethoxazole; TET, tetracycline; TMP, trimethoprim;
XNL, ceftiofur; SPT, spectinomycin; [], intermediate resistance.
aGene was sequenced by the researcher/institute providing the strain.
bIsolated in Denmark.
cPlasmid originally isolated from S. enterica; transconjugant provided by Cloeckaert et al.7
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51.09TF, 54.12TF and 660TF shared a very similar blaTEM-52b-type
plasmid with an approximate size of 45 kb. The RFLP profile of
these plasmids was designated type a. Strains 44.78TF, 549TF,
641TF, 692TF, 710TF and Cloeckaert TF were shown to share a
similar 80 kb blaTEM-52-type plasmid, which differed from the
already mentioned pblaTEM-52b RFLP type a. This RFLP type was
designated type b. pGOC043 and pGOC049 shared an almost
identical pattern, as they differed only by the presence of one
extra band in pGOC049, and were thus designated as type c.
RFLP profiles of plasmids from the remaining transformants
were significantly different from each other (difference of more
than six bands) and from the three described types. These plas-
mids ranged in size from 40 kb to 146 kb and were desig-
nated with RFLP profile letters d to h.
Replicon typing
All transformants carrying plasmids with RFLP profile b and ESBL
424TF (RFLP type f) were positive for the IncI1 replicon in the
multiplex PCR. YMC 95/4/4199TF (RFLP type g) and YMC 96/7/
4035TF (RFLP type h) were positive for the IncL/M replicon. In
one case for ESBL 140TF (RFLP type e) the replicon IncA/C was
detected and 727TF (type d) gave a positive signal for the IncR
replicon.
Replicons of plasmids from 2161TF (representing type a) and
GOC49TF (representing type c) did not produce positive results by
the standard multiplex PCR and were therefore detected by
partial or full plasmid sequencing. As the IncR replicon is not
so commonly detected in E. coli, the replicon of plasmid from
727TF (plasmid designated as p727) was also cloned and
sequenced to perform further analysis. The sequences were
compared with the GenBank database to identify similar
plasmids with known replicons. The sequence encoding the puta-
tive replicase of plasmid p727 showed 100% similarity with repB
sequences of two different IncR plasmids, namely pEFER
(GenBank accession number CU928144) and pK245
(DQ449578), originating from Escherichia fergusonii and Kleb-
siella pneumoniae, respectively.
The putative rep sequence of the plasmid pE001 from strain
2161TF shared 100% similarity with the pir sequence of
pMAS2027 classified as IncX1 (FJ666132). No significant simi-
larity was observed between the putative rep of pE001 and pir
of another IncX1 plasmid, pOLA52 (EU370913) (40% similarity
at the amino acid level). What is more, a fragment of 590 bp
upstream of repB of pE001 shared 96% identity at the nucleotide
level with a fragment of the same size determining the incom-
patibility properties of a classical IncX1 plasmid R485
(M11688). Also the stbE and stbD genes determining the stability
properties of R485 (AF072126) were shown to be present on
pE001. The remaining components of the replicon and the
entire transfer region of pE001 shared a large number of simi-
larities with pOLA52 (IncX1), pMAS2027 and other plasmids con-
sidered as IncX1, namely pSE34 (EU219533), pOU1115
(DQ115388) and pOU1114 (DQ115387). These included frag-
ments or full sequences of replication origins, genes encoding
diverse accessory proteins found on the replicon (among
others bis, taxD, parA) and components encoding the conju-
gation machinery (taxA, taxB, taxC, taxD, pilx1-6, pilx8-11). The
comparison of the pE001 replicon with other IncX1 replicons
mentioned is presented in Figure 1. Based on the sequence
analysis, we propose to classify the replicon of pE001 as an
IncX1 variant, namely IncX1A. All strains sharing the RFLP
profile ‘a’ in this study appeared positive in rep-pE001 PCR, thus
they were also assigned to the IncX1A subgroup.
The rep sequence of pGOC049 showed 72% identity at the
DNA level (and 78% at the amino acid level) with the repA
sequence of the IncN plasmid R46 and also repA of plasmid
pKOX105 (HM126016). Due to the similarity to the IncN replicon
of R46, pGOC049 was assigned to be a type of IncN plasmid. PCR
targeting the replicon of pGOC049 was also performed on the
plasmid from GOC043TF due to the similarity of their RFLP pat-
terns. A positive product for pGOC043 was observed in this PCR.
The sequences of pE001, the rep fragment of pGOC049 and
the rep fragment of p727 were deposited in GenBank with acces-
sion numbers JF776874, JF708955 and JF708954, respectively.
Multilocus sequence typing of IncI1 plasmids
Plasmids positive for the IncI1 replicon in the multiplex PCR,
namely from ESBL 424TF, 44.78TF, 549TF, 641TF, 692TF, 710TF
and Cloeckhaert TF, underwent further pMLST.22,24 Based on
the sequencing results, the plasmid from ESBL 424TF (RFLP
type f) was assigned to be of sequence type (ST) 2. The remain-
ing tested plasmids (sharing RFLP type b) were assigned by
pMLST to ST5. Various insertions or deletions were observed in
the sequences obtained for the six IncI1 plasmids of ST5 com-
pared with the allele variants described in the reference.
However, these mutations were not located on the sites corre-
sponding to the relevant nucleotides, e.g. those determining
the STs on the reference sequences.
Incompatibility testing
Incompatibility testing was performed for blaTEM-52 plasmids
originating from E. coli GOC049TF (pGOC049) and E. coli
2161TF (pE001) to investigate their incompatibility affiliation.
In transformants harbouring only one of the respective plasmids,
e.g. pGOC049, R46, pOLA52 bla::npt or pE001, and grown for 50
generations without selective pressure, no loss of original resist-
ance was observed. The presence of respective replicons was
additionally confirmed in selected colonies from the transfor-
mants by the PCRs targeting these replicons. This demonstrated
the stability of the plasmids in the recipient. The pE001 plasmid
turned out to be compatible with pOLA52 bla::npt (an IncX1
plasmid). Regardless of which of the plasmids was the incoming
or residing agent in the assay, in both cases 99% of transfor-
mants retained the initial resistance to both cefotaxime and
kanamycin, indicating that the two plasmids could co-exist in
the same cell. Two selected transformants with resistance to
both antibiotics underwent S1-PFGE, and they were shown to
harbour two plasmids at the same time, thus demonstrating
that no co-integration had occurred. This led to the conclusion
that the two plasmids are compatible. However, based on the
large homology of the overall pE001 sequence with pOLA52
and 100% identity of the putative rep of pE001 with pir of
pMAS2027 (classified as IncX130), we suggest assigning this
plasmid to the IncX family, and further to the IncX1A subgroup.
The rep sequence of pGOC049 showed 72% identity with the
repA sequence of the classical IncN plasmid R46. Attempts to
introduce pGOC049 into electrocompetent cells already
Investigation of diversity of plasmids carrying the blaTEM-52 gene
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harbouring R46 did not produce transformants on the plate with
selection for both plasmids at the same time. However, transfor-
mants were observed on this selective plate when R46 was used
as the incoming agent and pGOC049 as the residing one. What is
more, no loss of resistance either to cefotaxime or to tetracycline
was observed after cultivating that transformant for 50 gener-
ations without selection. At the end of the incompatibility
assay a selected transformant colony that was resistant to
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Figure 1. Schematic comparison of the pE001 replicon with the replicons of IncX1 and IncX1-related plasmids. Black arrows indicate the genes and
open reading frames (ORFs) found on pE001 and similar genes and ORFs found on other plasmids included in the scheme, grey arrows indicate genes
and ORFs that were not found on pE001 but are shared by at least two or more other plasmids described, grey arrows filled with slanting lines
represent genes and ORFs found only on the individual plasmids indicated, white rectangles with black slanting lines correspond to the fragment
of the sequence of R485 (M11688), black crosses indicate the position at which the sequence of the given plasmid differs significantly from the
described R485 fragment (M11688) and black ovals indicate origins of replication. The sequences were obtained from GenBank. ORFs were
predicted for all the plasmids examined in this study with Vector NTI Suite 11 software (Invitrogen, Inc.). orfX on pOLA52 and orfY on pOU1115
were predicted in this study, but were not found in the original annotations of the plasmids.
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both cefotaxime and tetracycline was tested using S1-PFGE and
was shown to harbour the two plasmids at the same time. The
results obtained from the incompatibility assay are difficult to
interpret since transformants harbouring two plasmids simul-
taneously were obtained only when R46 was the incoming
plasmid, but not when the pGOC049 was the incoming agent.
Due to the similarity of the two replicons we propose to term
the replicon of pGOC049 as IncN-like.
Examination of clonal relationship of wild-type
isolates harbouring similar plasmids
Three E. coli strains 2161, 7633094-7 and 660 harboured similar
IncX1A plasmids. E. coli 2161 and 7633094-7 were shown to
belong to the same phylotype B1, and thus could possibly be clon-
ally related. E. coli 660was assigned to phylotype A andwould not
be expected to be clonally related to the two phylotype B1 isolates
with similar plasmids. E. coli 549, 641, 692 and 710 strains har-
boured very similar IncI1 plasmids. Two of these isolates, E. coli
549 and 692, shared the same phylotype A and could be clonally
related. E. coli 641 and 710were shown to belong to B1 andD phy-
lotypes, respectively. E. coli GOC043 and GOC049 harboured
similar IncN-like plasmids. These two strains gave a positive
signal in the PCR to B2 and B1 phylotypes, respectively.
The Salmonella Blokley wild-type isolates 36.52, 46.20 and
51.09 harbouring similar IncX1A plasmids have been previously
examined by XbaI-digested PFGE by Hasman and Aerstrup31
and were shown to be undistinguishable.
Genetic environment upstream of the blaTEM-52 gene
In the plasmid originating from the Cloeckaert TK isolate the
blaTEM-52c gene had previously been reported to reside on a
Tn3 element.7 Thus the upstream regions of blaTEM-52 genes in
plasmids from the remaining transformants of this study were
also investigated. For the plasmid originating from ESBL 140TF
(RFLP type e), no signal was observed in the PCR linking the pres-
ence of tnpA with the blaTEM-52 gene. The remaining plasmids
were positive in the described PCR, indicating that the blaTEM-52
genes were located within the Tn3 transposon and downstream
of the transposase.
Plasmid transmissibility
blaTEM-52 plasmids belonging to different RFLP groups (indicated in
parentheses) and originating from selected transformants that
were shown not to carry any other plasmids—76-33094TF (RFLP
type a), 44.02TF (RFLP type a), ESBL 140TF (RFLP type e), ESBL
424TF (RFLP type f), YMC 95/4/4199TF (RFLP type g), YMC 96/7/
4035TF (RFLP type h), 549TF (RFLP type b), 641TF (RFLP type b),
GOC043TF (RFLP type c) and 727TF (RFLP type d)—were tested
for the ability to self-transfer to the plasmid-free recipient E. coli
MT101. Transconjugants were observed for all the above listed
strains except three; 549TF (RFLP type b/IncI1), ESBL 140TF (RFLP
type e/IncA/C) and 727TF (RFLP type d/IncR).
Susceptibility testing
Not surprisingly, all primary strains were resistant to ampicillin,
ceftiofur and cefotaxime. All 22 transformants that carried only
a variant of a blaTEM-52 plasmid were likewise resistant to the
tested b-lactam antimicrobials.
Thirteen of the primary strains were resistant to sulphona-
mides and trimethoprim. In one case these resistances were
apparently associated with the blaTEM-52b/IncL/M plasmid from
YMC 95/4/4199TF. Ten primary strains were resistant to tetra-
cycline. Tetracycline resistance associated with the blaTEM-52b
IncI1 plasmid was observed in one case in the ESBL 424TF
strain. Five of the primary strains were resistant to neomycin.
This resistance was observed in one of the corresponding trans-
formants, namely 727TF, indicating that it was residing on the
IncR blaTEM-52c plasmid. Five of the primary isolates were resist-
ant to gentamicin and in four cases this resistance was associ-
ated with blaTEM-52b and blaTEM-52b plasmids from ESBL 140TF
(IncA/C plasmid), ESBL 424TF (IncI1), 727TF (IncR) and
YMC 96/7/4035TF (IncL/M). Five of the primary strains were
resistant to one or both of the tested amphenicol compounds
(chloramphenicol and florfenicol). Resistance to the tested
amphenicols was not observed in the corresponding
transformants.
Discussion
Little is known about the possible relationship between plasmids
harbouring blaTEM-52. Therefore we characterized plasmids from
a collection of 22 blaTEM-52-positive isolates from animals,
humans and food products originating from several different
European countries as well as Canada and Korea.
Thirteen plasmids in our study carried the blaTEM-52b allele,
while nine carried the blaTEM-52c allele. Both alleles were dissemi-
nated among plasmids from human and non-human isolates
and they were generally associated with different plasmid
incompatibility groups. Clearly the IncI1 (n¼7) and IncX1A
(n¼9) replicons dominated among the blaTEM-52 plasmids
characterized in the study. Six of the seven IncI1 plasmids
carried the blaTEM-52c allele. These belonged to RFLP type b and
all represented ST5. One IncI1 plasmid carried the blaTEM-52b
allele, represented RFLP type f and was found to be ST2. Cur-
iously the six ST5 IncI1 blaTEM-52c plasmids originated from
strains isolated in European countries, while the ST2 blaTEM-52b
plasmid originated from Canada (human isolate). One of the
ST5 IncI1 plasmids found in E. coli Cloeckaert TK and described
in this study was originally isolated by Cloeckaert et al.7 from S.
enterica species. Apparently epidemic blaTEM-52c ST5 IncI1 plas-
mids circulated in European countries during the time between
diverse strains of E. coli (phylotypes A, B1 and D; this study)
and serovars of S. enterica.7 The strains were isolates from
humans and poultry, indicating possible transmission of the
ST5 IncI1 blaTEM-52c plasmid between these two reservoirs.
Nine of the 13 blaTEM-52b plasmids appeared identical in RFLP
profiles (RFLP type a) and they shared the same IncX1A replicon.
E. coli (phylotypes A and B1) and various S. enterica serovars har-
bouring the nine plasmids originated from poultry, poultry meat,
broiler meat and beef, as well as one from a human infection.
These originated from Germany, France and the Netherlands
between 2001 and 2006, which demonstrates a relatively wide
spread of the similar blaTEM-52b IncX1A plasmids among the
mentioned reservoirs.
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Both the IncI1 and the IncX1A plasmids described above ori-
ginated generally from diverse serovars of S. enterica and diverse
phylotypes of E. coli. Although in some of the cases it is possible
that the wild-type strains harbouring the similar plasmids were
clonally related, it is clear that these very similar plasmids were
capable of residing in diverse strains.
Other replicons associatedwith blaTEM-52 genes detected in this
study belonged to IncL/M (n¼2; both carried blaTEM-52b), IncA/C
(n¼1; blaTEM-52b), IncR (n¼1; blaTEM-52c) and IncN-like (n¼2;
both carried blaTEM-52c) incompatibility families. The two IncL/M
plasmids originated from different S. enterica serovars and they
did not seem to be closely related, as their RFLP patterns were
very different. The two IncN-like plasmids originated fromdifferent
E. coli strains (phylotypes B1andB2) isolated fromSpanish poultry.
Their RFLP profiles were very similar, suggesting an interspecies
transmission of these similar IncN-like plasmids.
Overall, the findings described above indicate that both the
blaTEM-52b and blaTEM-52c genes may be distributed on the
diverse plasmid replicons, most probably due to the association
with Tn3 elements. Once integrated onto the plasmid backbone,
the Tn3-blaTEM-52 element may possibly have been transferred on
that plasmid both horizontally and clonally.
Interestingly, several of the blaTEM-52 plasmids in this study
were negative in the standard multiplex PCR for replicon
typing.27 These replicons were sequenced and the corresponding
plasmids were tested in incompatibility assays with known repre-
sentatives of classical Inc families. The putative Rep protein of
pE001 from E. coli 2161 shared 100% identity at the amino
acid level with the p replicase of plasmid pMAS2027 and 40%
identity at the amino acid level with the p replicase of pOLA52.
pE001 turned out to be compatible with the latter, and this
could have been due to the differences between pE001 and
pOLA52 replicases. All of the remaining components of the repli-
con and also the transfer regions of the pE001 shared from 74%
to 100% amino acid identities with pMAS2027, pOLA52 and
several other plasmids classified as IncX1-like (Figure 1).
pMAS2027 was assigned by Ong et al.30 to the IncX1 family
based solely on its sequence analysis; therefore we can only
speculate that pMAS2027 could display similar incompatibility
properties to the IncX1A pE001. The two plasmids share high
sequence similarity with the incompatibility fragment of the clas-
sical IncX1 plasmid R485 (M11688), while the remaining IncX1
plasmids share only a partial similarity with the R485 fragment
(Figure 1). The full sequence of R485 is not yet publicly available.
It is highly possible that pE001 and pMAS2027 represent a sep-
arate branch of the IncX1 family termed in this study as IncX1A.
In the case of pGOC049, the results of the incompatibility
assay with R46 (IncN) were difficult to interpret. Due to the simi-
larity of pGOC049 replicase and RepB of the IncN plasmids and
the lack of data on the remaining part of the pGOC049 sequence,
we decided to term this plasmid as IncN-like. Another blaTEM-52c
plasmid from E. coli GOC043 was found to be very similar to
pGOC049. It is likely that this type of IncN-like replicon represents
a separate branch of the IncN family.
The rep sequence of p727 shared 100% identity with repBs of
IncR plasmids originating from K. pneumoniae (pKP245) and
E. fergusonii (pEFER). IncR replicons apparently have a broad
host range. Surprisingly, the sequences of pEFER and pKP245
do not seem to contain the functional and typical conjugative
transfer elements.32 This could explain why the blaTEM-52c IncR
plasmid p727 examined in the study was incapable of self-
transfer in conjugation. This further indicates that IncR replicons
could be mobilizable.
An important observation drawn from our study is that
blaTEM-52 seemed to be primarily associated with a limited
number of aforementioned classical replicons or replicons
closely related to the classical IncX1 and IncN, but not with
the IncF family. This is contrary to the blaTEM-52 predecessor,
namely blaTEM-1, which is most often associated with
IncFII/FIB/FIA families.1 The question is raised as to why
blaTEM-52 is not observed on the same IncF scaffolds as
blaTEM-1 if blaTEM-52 evolved from blaTEM-1. The reason could
be that the blaTEM-52 gene did not evolve on IncF plasmids,
but evolved from blaTEM-1 that transposed initially to IncI1,
IncA/C, IncL/M, IncR or other plasmid backbones. Supporting
this theory is the fact that blaTEM-1 as well as its evolutionary
followers blaTEM-3, blaTEM-21 and blaTEM-24 were detected on
other than IncF scaffolds.1 The blaTEM-52 gene residing on Tn3
was apparently not able to re-associate with IncF scaffolds
that already harboured the Tn3 elements due to transposon
immunity, thus the occurrence of this type of ESBL is limited
to other mentioned replicons.33 Occurrence of blaTEM-19 and
blaTEM-15, which are the most probable intermediates of evol-
ution from blaTEM-1 to blaTEM-52, has been reported.
34,35
However, there are no sufficient data available on replicons
of plasmids carrying these. This makes the model explaining
where and when the upgrade occurred from BlaTEM-1 to the
extended-spectrum BlaTEM-52 incomplete.
Our study underlined that primarily the conjugative and rela-
tively broad host range plasmids belonging to IncI1, IncX1A,
IncA/C, IncL/M and IncN-related types are the transporters for
blaTEM-52 genes. Also, not so commonly detected and possibly
mobilizable IncR plasmids play a role in blaTEM-52 transmission.
A conclusion drawn from our study is that IncX and IncN families
of replicons might be more diverse than previously thought. In
particular, the occurrence of the IncX plasmids could be gener-
ally underestimated due to the lack of suitable detection
methods currently available, as the classical multiplex PCR
targets only the IncX2 replicons.22
Moreover, the blaTEM-52 plasmids were found in enteric bac-
teria from food-production animals, meat products and
humans and in many cases they were capable of self-transfer
in conjugation. Some of them conferred other than ESBL resist-
ances to the host bacteria, namely to aminoglycosides, tetra-
cycline and sulphonamides. This underscores the potential
risk of selection for co-resistances when blaTEM-52 plasmids
are present in enteric bacteria. The discovery of new plasmid
types like IncX1A and the N-related replicons that were not
detectable by means of currently available screening methods
underscores the importance of further research within the
area of plasmid biology, with a focus on plasmid-associated
antibiotic resistance.
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Erratum
Investigation of diversity of plasmids carrying the blaTEM-52 gene
Eliza Bielak, Rikke D. Bergenholtz, Mikael Skaanning Jørgensen, Søren J. Sørensen, Lars H. Hansen
and Henrik Hasman
J Antimicrob Chemother 2011; 66: 2465–74
There were errors in Table 1. Except for plasmid p727, in all cases
where the element upstream of blaTEM-52 is currently indicated to
be Tn3, this should be changed to Tn2. In the case of p727, the
element upstream of blaTEM-52 should be labelled ‘unknown’. The
cause of the errors was the design of the Tn-blaTEM linking PCR (Mate-
rials and methods section, Genetic environment upstream of the
blaTEM-52 gene) based on the sequence EF141186, which was previ-
ously classified as Tn3-blaTEM-52. This element should be correctly
classified as Tn2-blaTEM-52.
1 The authors apologize for the errors.
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Supplementary data 
Table S1.  Primers and PCR conditions used in the study to detect the selected targets  
 
Standard PCR conditions were applied in all cases. 
aSequence obtained in collaboration with L. Hansen, Copenhagen University (lh@10-12.dk). 
bThis study. 
Primer sequence Target sequence 
Amplicon size 
(bp) 
Annealing 
temperature 
used in PCR 
(°C) 
Reference or 
accession number 
Pfw 5’-GCAGATTGATTCACGTGAAG-3’ 
 
pir gene of pOLA52 bla::npt 720 58 25 
Prv 5’-CCTCTGAAACCGTATGGTATTC-3’ 
 
    
Pfw 5'-AGGCTTCAGGTGAAAACTGT-3' 
 
repB of pE001 838 58 JF776874
a,b 
Prv 5'-TATCAAACTCTTCCAAGAATTTAGCT-3’ 
 
    
Pfw 5'-GAATAAAAAGGTTAATGTAAAACAGG-3' 
 
rep of  pGOC049 703 58 JF708955
b 
Prv 5'-CAGCTAATGGCTTGTTGATG-3'. 
 
    
Pfw 5’-TGAAGCTCATCCGGTTCAC-3’ 
 
Tn3-blaTEM-52 1268 60 EF141186 
Prv 5'-CTGAGAATAGTGTATGCGGCGAC-3' 
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Abstract 
 
Objectives: To examine the relationship between blaTEM-1 plasmids from E. coli from 
humans and food-production animals.  
 
Methods: Ampicillin resistant E. coli strains were collected from diseased and healthy 
humans, cattle, poultry and pigs in Denmark. Plasmids with blaTEM-1 genes were isolated 
from these strains and characterized by replicon typing PCR, restriction fragment length 
polymorphism (RFLP), susceptibility testing and typing of the genetic environment of the 
blaTEM-1 gene by PCR. 
 
Results: Respectively 68.4 %, 86.2 %, 50.0 % and 30.4% of blaTEM-1 plasmids from 
humans, cattle, pigs and poultry harboured IncF-family and/or IncB/O replicons; IncFII 
and IncFIB replicons were detected on blaTEM-1 plasmids from all reservoirs, IncB/O were 
not detected in poultry, IncI1 were not detected in cattle; 56.5 % and 20.0 % of blaTEM-1 
plasmids from poultry and pigs, respectively, carried IncI1 replicons. IncF-family, IncB/O 
and IncI1 were often present on the same scaffolds with IncP replicons. Single cases of 
IncX1, IncK, IncHI1, IncN, IncY and IncR were detected. Typically, blaTEM-1b &-1c alleles 
resided on Tn2 while blaTEM-1a on Tn3 transposons. The majority of the examined  
blaTEM-1 plasmids conferred co-resistances to sulfamethoxazole, trimethoprim and 
tetracycline. 
 
Conclusions: Similar distribution of replicons was observed among E. coli from healthy 
and diseased individuals. IncI1 replicons were specific for poultry and pigs; IncB/Os were 
specific for humans, cattle and pigs. Related IncB/O, IncI1 and IncFII blaTEM-1 plasmids 
were found across human and animal reservoirs. Broad host range IncP, IncR and IncN 
plasmids probably transmit blaTEM-1 genes between E. coli and more distantly related 
species. 
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Introduction 
In 1960s and -70s respectively ampicillin and amoxicillin were introduced to 
chemotherapy and these aminopenicillins were able to efficiently penetrate the outer 
membranes of the gram-negative bacteria.(
1;2
) Aminopenicillins cause relatively few side 
effects to humans and animals and have broad spectrum of activity, among others against 
Escherichia coli, Salmonella enterica, Haemophilus influenzae and Neisseria 
gonorrhoeae.(
3
) However, bacteria soon developed resistance to these drugs. Today the 
TEM-1 β-lactamase encoded by the blaTEM-1 gene is the most common cause of resistance 
to aminopenicillins and to some of the first generation cephalosporins (cephalotin and 
cephaloridine) in Enterobacteriaceae.(
3
)  TEM-1s are currently found also in 
Pseudomonas aeruginosa, H. influenzae and N. gonorrhoeae.(
3;4
) High frequency of 
occurrence of TEM-1 β-lactamases not only hampers the treatment of infections caused 
by the resistant isolates; it is also most likely that the selective pressure induced by usage 
of other classes of β-lactam antimicrobials might induce mutations in the blaTEM-1 genes 
leading to production of diverse TEM enzyme variants with a broader substrate 
spectrum.(
3;4
) The majority of such variants detected so far in clinical and in experimental 
laboratory settings are either Extended Spectrum β-Lactamases (ESBLs) or they confer 
resistance to β-lactam inhibitors (IRTs).(3;4) An alarming fact is that mutations in the 
blaTEM-1 gene leading to substitution of only one of the key amino acids in the active 
centre of the TEM-1 enzyme can be enough to encode variants with ESBLs properties. 
This is exemplified by TEM-17, TEM-19 or TEM-135 that differ by single amino acid 
substitutions compared to their TEM-1 predecessor 
(www.lahey.org/Studies/temtable.asp).(
3
) 
The blaTEM genes in Enterobacteriaceae are almost exclusively located on plasmids.(
5;6
) 
Plasmids are usually double stranded, circular and often self-transmissible DNA 
molecules that replicate autonomously from the bacterial chromosomes.(
7
) The minimal 
region required for a plasmid to replicate and maintain itself is termed replicon. Based on 
the replicon similarities plasmids can be classified to incompatibility groups (Inc 
groups).(
8
) Previous studies reported the occurrence of blaTEM-1 genes primarily on the 
IncF-related scaffolds.(
5;6
)  Diverse blaTEM variants encoding ESBLs (TEM-3, -10, 21, -
24 and -52) has been typically reported on broad host range IncA/C replicons, therefore it 
was suggested that these TEM-ESBLs evolved outside of the human reservoir of  
4 
 
E. coli.(
6
) Recent studies indicated that the blaTEM-52 genes were generally located on 
IncX1, IncI1, IncA/C, IncL/M and IncN-related plasmid scaffolds found in E. coli and S. 
enterica mainly from poultry and from humans. (
9
) Contrary to blaTEM-1, there is no report 
in the literature on blaTEM-52 alleles associated with IncF-family replicons.  
Previously it has been shown that various blaTEM genes usually resided on Tn3- related 
transposons found on variety of plasmid scaffolds.(
9;10
) Tn3- like family of transposons 
has been subdivided into Tn1, 2 and -3 groups.(
10
) Question should be therefore raised not 
only about the diversity of blaTEM-1 associated replicons, but also whether there are 
possible differences in distribution of these distinct Tn- types transmitting blaTEM-1 genes 
in humans and in animals. 
The aim of this study is to examine the diversity of blaTEM-1 plasmids from E. coli isolated 
from humans and food production animals like cattle, poultry and pigs. Both the 
diagnostic (from diseased humans or animals; the diagnostic human isolates were termed 
as clinical) and the faecal indicatory (from healthy individuals) isolates were analyzed in 
this study. The focus was stated on the plasmids originating from E. coli as this bacterium 
is a common inhabitant of human and animal gastro-intestinal tracts that may also cause 
infections in the aforementioned hosts. (
11
) Here we present data on the possible 
differences in distribution of plasmid replicons in the healthy and diseased individuals 
and we investigate whether the blaTEM-1 genes found in humans could have arrived to this 
reservoir on the plasmids originating from food-production animals (poultry, cattle, and 
pigs).  An attempt is made to point out on which mobile platforms (plasmids or specific 
variants of transposons) the transmission and evolution of the blaTEM-1 genes occurred in 
humans and animals. This knowledge is essential to generate models illustrating 
mobilization, transmission and evolution routes of blaTEM resistance genes. Such models 
could be applied in the future as tools to prevent further spread of the resistance in 
bacteria. 
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Materials and Methods 
Selection of wild type E. coli strains harbouring blaTEM-1 genes 
Ampicillin resistant E. coli wild type (WT) isolates from cattle, poultry and pigs have 
been selected from the previously published collection of Olesen et al.(
12
) The selected 
WTs included diagnostic samples  as well as indicatory isolates collected from healthy 
animals routinely sampled at slaughtering .(
12
) Ampicillin resistant indicator E. coli WTs 
from humans originated from a collection published previously as part of the NorMat/ 
Danmap studies. (
13
) Ampicillin resistant clinical E. coli WTs have been collected from 
bacteraemia patients with different initial sites of infection and originated from Aaborg 
Hospital, Denmark.(
14
) All of the WT isolates were collected in Denmark in the period 
2000-2004.   
 
Verification of the presence of the blaTEM by PCR 
PCR targeting the blaTEM genes was initially performed on all of the ampicillin resistant 
WTs. PCR set-up was as described by Hasman et al.(
15
) Unless the blaTEM genes found in 
the selected WTs were sequenced by the corresponding reference studies, the PCR 
products have been sequenced in this study by standard capillary sequencing method 
(Macrogen Inc., Korea). Obtained sequences were blasted against the blaTEM reference 
database available at Lahey Clinic (http://www.lahey.org/Studies/temtable.asp). WT 
isolates harbouring the blaTEM-1 genes were selected for further analysis. In individual 
cases WTs harbouring other blaTEM variants were also included in further analysis to 
obtain broader overview of the plasmids associated with blaTEM genes in the examined E. 
coli collections. 
Phylotyping and Pulse Field Gel Electrophoresis (PFGE) 
The E. coli WT isolates harbouring blaTEM-1 genes or other included blaTEM variants 
underwent phylotyping by a triplex PCR method  described by Clermont et al. (
16
)Then 
Xba I- PFGE (
17
) was performed on the WT strains; Plugs were run on a CHEF-DR III 
System (Bio-Rad Laboratories, Hercules, CA, USA). PFGE running conditions, staining 
and image capture procedures applied were as described by Cao et al.(
18
) Salmonella 
Branderup was used as a size ladder.(
17
)  The analysis of the obtained images was 
performed with BioNumerics version 4.6.1 software (Applied Maths, Belgium). Program 
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parameters were set up on Dice and unweighted -pair group method using average 
linkages (UPGMA) with 1% band tolerance. Cut off value assumed for designation of the 
strains as possibly related was 80%.(
19
)  
 
Isolation of plasmids 
WT strains with blaTEM-1 genes from cattle and poultry were initially used in conjugation 
to verify the transmissibility of the ampicillin resistance; conjugation assay was 
performed as described previously by Bielak et al.(
9
) Plasmid free recipients used  in 
conjugation were either E. coli MT102 (naldixic acid (NAL) and rifampicin (RIF) 
resistant)(
9
) or E. coli K-12 HEHA4 (kanamycin (KAN) resistant).(
12
) Transconjugants 
(TCs) were isolated on the plates with the selection adjusted to the recipient type 
(described below). TCs in which no other than the individual blaTEM-1 plasmids were 
detected (see below) were selected for further analysis. 
For WT isolates, where conjugation did not work as well as all WTs from pigs and 
humans, total plasmid content was purified  Plasmids were introduced to 
electrocompetent E. coli GeneHogs ® or E. coli DH10B
TM
 (Invitrogen, Inc.) by 
electroporation method; conditions were as described by Bielak et al.(
9
) Transformants 
(TFs) in which no other than the individual blaTEM-1 plasmids were detected were selected 
for further analysis. 
Plasmid purifications from the WTs and later from TFs and TCs were done using Qiagen 
Plasmid Mini or Midi Kit (Qiagen, Hilden, Germany) according to manufacturer’s 
instructions.  
 
Media, antibiotics and growth conditions 
Brain-Heart Infusion (BHI; Becton, Dickinson & Co., Bacto™) agar plates were used for 
cultivation of the strains. Ampicillin (100 mg/L) was used as selection for the WTs, 
isolation of TFs in GeneHogs ® and DH10B
TM
 recipients (Invitrogen, Inc), and later for 
sub-cultivation of the obtained TFs and TCs with individual blaTEM plasmids. Ampicillin 
(100 mg/L) together with nalidixic acid (32 mg/L) and rifampicin (25 mg/L) were used to 
select for TCs when E. coli MT102 (NAL
R
, RIF
R
 ) was used as the recipient strain; 
ampicillin (100 mg/L) together with kanamycin (50 mg/L) were used to select for TCs 
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when E. coli K-12 HEHA4(
12
) was used as the recipient. All strains were typically 
incubated overnight at 37°C. 
Verification of plasmid transfer to TFs and TCs 
The TFs and TCs obtained underwent the PCR targeting the blaTEM genes.(
15
) TFs and 
TCs in which the presence of blaTEM genes was confirmed were then subjected to S1-
PFGE (S1, supplementary material).(
20
) Plugs were run on a CHEF-DR III System (Bio-
Rad Laboratories, Hercules, CA, USA). Concentration of S1 nuclease (Fermentas) per 
plug slice, running conditions for the S1-PFGE, conditions of staining and image capture 
applied were as described by Bielak et al.(
9
) This procedure allowed for verification of 
presence of plasmids and estimation of their sizes in the obtained TFs and TCs. In the 
further text plasmids isolated from the verified TFs or TCs are designated as p[with 
specified strain number]. 
Verification of WTs harbouring non-transferable blaTEM genes  
Selected WTs from which neither TFs nor TCs with blaTEM genes could be generated 
underwent S1-PFGE as described above. Individual plasmids, if detected, were extracted 
from the agarose gels and purified at GFX columns (Amersham Life Sciences) according 
to manufacturer instructions. These extractions underwent blaTEM PCR as described 
above; samples yielding positive signals were further used as templates for replicon 
typing PCRs (described below). This allowed for estimation of which replicons might be 
possibly present on these plasmids. Additionally, a standard electrophoresis of the 
plasmid purifications from the selected WTs was performed (18 h at 50% in 0.8% 
agarose, Lonza) to visualise plasmid content in these WTs. 
 
Replicon typing of blaTEM plasmids  
PCR-based replicon typing (PBRT) was performed on the obtained and verified TFs and 
TCs. Primers and the PCR conditions used were as described by Carattoli et al. (
8
). If no 
positive PCR signal was observed in the latter, other replicon typing PCRs targeting 
variants of the following replicons: IncFII, IncX1 and IncN-like  have been applied as 
described by Villa et al. (
21
) and Bielak et al. (
9
)  
 
Analysis of blaTEM-1 plasmids by restriction fragment length polymorphism (RFLP) 
Selected plasmids with blaTEM genes originating from poultry, cattle, pigs and humans 
were purified from the corresponding TFs and TCs as described above and underwent 
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RFLP profiling. Plasmids harbouring IncB/O replicons were digested with BamHI. The 
remaining plasmids were digested either HincII or with EcoRV to access best possible 
resolution of bands on the produced fingerprints. The fragments were separated by 4 h 
electrophoresis in 0.8 % agarose gel (Lonza) at 120 V and visualised by standard staining 
in ethidium bromide. Whenever possible the fingerprints were analysed in BioNumerics 
software (version 4.6.1, Applied Maths, Belgium) with parameters set up as described 
above for PFGE analysis. 
 
 
Examination of the genetic environment upstream of the blaTEM-1 genes 
Five simplex PCRs were designed for the purpose of this study linking the presence of 
either Tn1 (PCR I), Tn2 (PCR II), Tn3 (PCRIII) or IS26 in two different configurations 
(
10
) (PCR IV and V) with the blaTEM genes. Three newly designed forward primers were 
used in PCR I, -II and –III targeting respectively tnpA sequences common for all three Tn 
-types,  tnpR fragment specific for Tn2 and tnpA fragment specific for Tn3 (Figures S1-3 
in Table S2).  The forward primers used in PCR  IV and V were as described by Bailey et 
al. (
10
) The same reverse primer targeting the blaTEM gene was used in each of the five 
aforementioned simplexes.(
9
) PCR conditions, the primers used and interpretation of the 
results are specified in the Table S2.  
 
Susceptibility testing 
Unless resistance phenotypes were specified in the reference studies for corresponding 
WT strains, the susceptibility tests were performed on WT isolates by means of the 
commercial microtitre panels for Enterobacteriaceae (Sensititre®). Antimicrobials 
included on the panels were amoxicillin/ clavulanic acid, ampicillin, apramycin, 
cefotaxime, ceftiofur, chloramphenicol, ciprofloxacin, colistin, florfenicol, gentamycin, 
nalidixic acid, neomycin, spectinomycin, streptomycin, sulfamethoxazole, tetracycline 
and trimethoprim. Testing and interpretation of the results were performed according to 
the CLSI standards. For cefotaxime and other antimicrobials for which no CLSI 
breakpoints were available, the results were interpreted using criteria of the European 
Committee on Antimicrobial Susceptibility Testing (EUCAST). 
Based on the resistance profiles observed for the WT strains the corresponding 
transformants and transconjugants were further tested to the selected antimicrobials by 
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means of the disc diffusion method. Testing was performed according to the CLSI 
standards (2003). Each of the recipient strains used for production of transformants and 
transconjugants, namely GeneHogs ® , DH10B
TM
,  MT102 and HEHA4 were included as 
controls. The results were interpreted using CLSI zone diameter interpretation standards 
(2003). 
Plasmid Multilocus SequenceTyping (pMLST) 
Selected plasmids with IncF –family, IncI1 and IncN replicons underwent the 
corresponding pMLST with conditions as described respectively by Villa et al. (
21
)(here 
the term replicon sequence typing-RST will be further used), Garcia- Fernandez et al. 
2008 (
22
) and Garcia-Fernandez et al. 2010 (
23
). 
 
 
Results  
The list of selected E. coli WT strains and the detailed results of plasmids 
characterizations described in the following sections are specified in the Tables S3a-e.  
Selection of wild type E. coli strains harbouring blaTEM-1 genes 
A collection of ampicillin resistant E. coli strains from diverse reservoirs (poultry, cattle, 
pigs and humans) underwent PCR targeting blaTEM genes. The positive PCR products 
were sequenced and annotated. 24 strains from poultry (12 indicator strains and 12 from 
diagnostic samples), 33 strains from cattle (2 indicator strains and 31 from diagnostic 
samples), 40 strains from pigs (14 indicator and 26 from diagnostic strains) and 62 from 
humans (31 indicator and 31 clinical isolates) were selected for further studies. 2 of the 
selected WT diagnostic strains from cattle harboured blaTEM-30 genes (E. coli 74123511 
and 74129511) and 3 WT indicator strains from humans harboured respectively blaTEM-40 
(E. coli 257-CO2), blaTEM-30 (E. coli 875-CO3) and blaTEM-135 (E. coli 1112-CO3). The 
remaining selected WTs harboured the blaTEM-1 genes. 
Isolation of TFs and TCs with individual blaTEM  plasmids  
Conjugation of WT strains harbouring blaTEM-1 and blaTEM-30 genes from cattle and 
poultry reservoirs was initially performed to isolate the individual blaTEM plasmids. In the 
remaining cases an attempt was made to transfer the plasmids with blaTEM-1 or other 
included blaTEM variants into the plasmid free recipients by means of electroporation. The 
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presence of the blaTEM genes was confirmed in the obtained TFs and TCs by PCR. 
Transfer of single plasmids from WTs to the recipients was verified by S1-PFGE. 
From the 33 WT cattle E. coli isolates 7 TCs and 22 TFs with individual blaTEM-1 
plasmids were obtained. For 2 of the cattle WT isolates neither TC nor TF were produced 
(WT 74-13295-1 and WT 74-11793-1). In both cases plasmids of variable sizes were 
detected in WTs; these plasmids were negative in blaTEM PCR after gel extraction 
suggesting that the blaTEM-1 genes were most likely integrated into the chromosomes in 
these two strains.1 TC and 1TF with individual blaTEM-30 plasmids were obtained (74-
12351-1TF and 74-12951-1 TC), however in the 74-12351-1TF it was suspected that two 
plasmids might have transferred to the recipient.   
From the 24 poultry WT isolates 7 TCs and 14 TFs with individual blaTEM-1 plasmids 
were obtained; in 3 cases (strains 7430605-1, 7277386-1 and 7278662-1) neither TFs nor 
TCs were produced from the corresponding WT isolates. The WT isolates 7430605-1 and 
7277386-1 were shown in S1-PFGE to harbour two plasmids each. In the strain 7430605-
1 plasmids sized to 85 kb produced the positive signal to the blaTEM gene; in WT 
7277386-1 plasmids sized to 138 kb produced the positive signal in the blaTEM PCR. No 
plasmid was detected by S1-PFGE in WT 7278662-1. 
TFs with individual blaTEM-1 plasmids were obtained from all except one (WT 74-04083-
1) of the 40 WT isolates from pigs. Here it was suspected that two plasmids with 
estimated sizes of 180 kb and 30 kb had transferred to 74-04083-1 TF based on the S1 
PFGE.  
From the 31 human faecal indicator isolates 27 TFs with individual blaTEM-1 plasmids 
were obtained and 3 TFs were obtained with the blaTEM-135, blaTEM-40 and blaTEM-30 
plasmids, respectively. In one case (WT 1437-CO3) TF was not produced. No signal 
corresponding to a plasmid was observed in S1-PFGE for this WT E. coli indicating that 
the blaTEM-1 gene could be located on the chromosome. From the 31 clinical human 
isolates 24 TFs with individual blaTEM-1 plasmids were obtained. In one case of WT 2002-
27242 no TF with blaTEM-1 plasmid was obtained. In 6 cases the TFs obtained from 
human WTs were suspected to harbour more than one plasmid (2000-14183TF, 2000-
27668TF, 2000-49043TF, 2000-78651 TF, 2001-13567TF and 2001-71294TF). These 
TFs shared a common pattern, namely they all contained one larger plasmid of 
approximately 20kb/30 kb and one or two smaller plasmids (<10 kb). Co-transmission of 
cryptic plasmids during transformation has previously been reported in the literature.(
24
) 
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Therefore, 74-12351-1TF from cattle, 74-04083-1TF from pig and the six TFs from 
humans suspected to harbour two plasmids underwent further characterization with a 
remark that these results should be interpreted as features potentially associated with the 
blaTEM plasmids in these TFs.  
 
Replicon typing of blaTEM -1 plasmids   
The results of the replicon typing are summarized in Table 1 and Table 2. Symbol ‘&’ is 
used for indication of multiple replicons on the same plasmid. Overall, 57 TFs with 
blaTEM-1 plasmids from humans and 92 TFs and TCs with blaTEM-1 plasmids from animals 
underwent PCR-based replicon typing (PBRT). Both in human and animal reservoirs the 
most commonly detected were IncFII replicons and also multireplicons composed of 
diverse combinations of IncFII, IncFIB, IncFIA and/or IncP groups; 46 % and 48 % of 
the blaTEM-1 plasmids from humans and from animals, respectively, carried one or more of 
the IncF- type replicons listed above. Individual cases of multireplicons IncFII & IncR 
(73-30615-7TF; pig faecal indicator isolate) and IncFIB & IncY (2002-48269 TF; human, 
clinical isolate) were also detected. In addition, 23 % and 14 % of blaTEM-1 plasmids from 
human and animal sources, respectively, belonged to IncB/O family or carried double 
replicons IncB/O & IncP; 7 % of blaTEM-1 plasmids from humans harboured IncI1 or IncI1 
in combination with other replicons. IncI1 replicons were almost three times more 
frequently detected on blaTEM-1 plasmids from animals (23 %) than humans. Rather large 
fraction of blaTEM-1 plasmids turned out to be non-typable by the applied PBRT methods 
(19 % from human and 10 % from animal isolates). This group of non-typable plasmids 
contained among others all of the 8 TFs suspected to harbour more than one plasmid (74-
12351-1TF from cattle, 74-04083-1TF from pig and 2000-14183TF, 2001-71294TF, 
2001-13567 TF,  2000-27668TF, 2000-49043TF and 2000-78651 TF from humans).  
Other replicon types were detected sporadically. Single cases of IncX1 (1413-CO3 TF) 
and IncK (1084-CO3 TF) replicons were detected on blaTEM-1 plasmids from human 
faecal indicator E. coli. An IncHI1 replicon was detected on the blaTEM-1 plasmid from 74-
12901-2 TF (from diagnostic pig isolate); 2 blaTEM-1 plasmids with no other than  IncP 
replicons were detected in cattle diagnostic E. coli isolates 74-12891-1and 74-30138-2; in 
3 cases IncN replicons were present on the examined plasmids; one of these plasmids 
originated from human faecal indicator sample (1308-CO3TF) and two from poultry 
diagnostic samples (7372121-1 TF and 7373304-1 TF; here,  the corresponding WT 
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strains were later shown to be clonally related by PFGE); 3 blaTEM-30 plasmids examined 
in the study harboured the following replicons: IncB/O (p875-CO3 from human faecal 
indicator strain), IncFII (p74-12951-1 from cattle diagnostic strain) and a non typable 
replicon was present on p74-12351-1T (from cattle diagnostic isolate). The blaTEM-40 and 
blaTEM-135 plasmids from human faecal indicator isolates harboured respectively IncFIB 
(p257-CO2 ) and IncI1 (p1112-CO3) replicons.  
 
Restriction fragment length polymorphism (RFLP) 
Plasmids with the same or similar combinations of replicons were grouped together and 
underwent RFLP. The characterizations of IncFII, IncB/O and IncI1 plasmids across the 
diverse reservoirs are summarized in Tables 3-5, respectively. The remaining results for 
the tested plasmids are listed in the Table S3. RFLP fingerprints are available in 
supplementary materials (S4). Plasmids differing by up to 3 bands (corresponding to 
approximately 85 % identity) were designated with the same symbols. 
EcoRV digestion of the IncFII plasmids  
IncFII plasmids from humans, cattle and pigs were initially digested with HincII and 
subsequently with EcoRV to access which enzyme generates sufficient number of bands 
for analysis. The EcoRV digestions generated fingerprints most suitable to compare the 
IncFII plasmids across the reservoirs. 3 blaTEM-1b plasmids from diagnostic isolates of 
cattle (p73-14678-1) and pigs (p74-13348-1 and p74-13297-1) shared similar RFLP 
fingerprints differing from each other by 1 to 2 bands; they were designated as RFLP type 
d; 3 blaTEM-1b plasmids from human clinical isolates produced similar RFLP fingerprints 
designated as type g (plasmids p2001-49440 and p2002-37995 had undistinguishable 
band patterns;   plasmid p2002-134976 differed by 2 bands). Otherwise, the plasmids 
with no other than IncFII replicons and originating from human and animal isolates 
produced diverse RFLP types (Table 3). 
 
HincII digestions of selected plasmids with multiple IncF-type replicons 
Selected plasmids from cattle and poultry, which were positive in PBRT to two or more 
of the F- type replicons (IncFII, IncFIB and/or IncFIA) were digested with HincII (12 
plasmids from cattle and 7 from poultry);4 IncFII & IncFIB plasmids detected in cattle 
shared similar RFLP profiles designated hinc2 (Table S3a); 3 of these plasmids harboured 
blaTEM-1c (p 74-12867-1; p 74-12969-1 and p 74-13379-1; these RFLP profiles were 
13 
 
undistinguishable) and one plasmid harboured blaTEM-1b (p 74-12866-1; this fingerprint 
differed by 3 bands from hinc2 profile). The remaining F-family plasmids originating 
from the different cattle isolates produced diverse RFLP profiles (Table S3a).  The IncFII 
& IncFIB as well as IncFII & IncFIB & IncP plasmids from the different isolates from 
poultry yielded diverse RFLP profiles (Table S3c). Due to the common presence of the 
IncF-family multireplicon blaTEM-1 plasmids, the latter were not further compared by 
RFLP across the reservoirs. Selected plasmids underwent RST as described below to 
complement the RFLP analysis. 
 
BamHI digestion of the IncB/O, IncP and IncK plasmids 
27 plasmids with individual IncB/O replicons as well as with double IncB/O & IncP (14 
plasmids from humans, 9 from pigs and 4 from cattle) underwent RFLP profiling. 
Fingerprints clustered into two groups of similarities. In the first group 3 blaTEM-1b 
plasmids from humans (p457-CO2, p2001-131351 and p2001-37255 ), 3 blaTEM-1b 
plasmids from pigs (p74-12934-1, p74-12933-1, p74-30367-2 ) and 2 blaTEM-1b plasmids 
from cattle (p74-12865-1 and p74-12894-1) produced undistinguishable RFLP profiles 
designated as p (Table 4);  3 other plasmids produced similar profiles to p with 
differences ranging from 1 to 3 bands (blaTEM-1a p433-CO2 from human, blaTEM-1b p74-
13266-1 from pig and blaTEM-1b p74-30014-3 from cattle).  
The second similarity cluster was comprised of 9 plasmids from humans which shared 
RFLP profiles designated as m; 5 of these plasmids produced undistinguishable RFLP 
fingerprints (blaTEM-1c plasmids: p438-CO2, p2002-50 and p1082-CO3;  blaTEM-1g  plasmid 
p1297-CO3 and blaTEM-30 p875-CO3). In 4 cases 1 to 3 three bands differences were 
observed compared to the RFLP m patterns (blaTEM-1c  plasmids:  p2002- 14946, p2001-
25022 and p2002-110474, and blaTEM-1b p 97-CO2).  
 2 blaTEM-1a plasmids from  pigs, p74-12927-1 and p74-11919-1, produced identical RFLP 
patterns o; 2 blaTEM-1b plasmids from pigs, p73-30819-1 and p74-30165-7,  produced 
similar (3 bands difference) RFLP patterns q and q_1, respectively. The remaining 
plasmids with incB/O replicons yielded distinct RFLP types (Table 4). Also, 2 IncP 
plasmids from cattle and the IncK plasmid from human underwent the RFLP and 
generated distinct RFLP types (Table S3a and S3d).  
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EcoRV digestions of the IncI1 plasmids  
Digestion with EcoRV generated most suitable fingerprint for analysis of IncI1 
plasmids.7 blaTEM-1 IncI1 plasmids from poultry isolates (p7430186-1, p7430287-1, 
p7430521-1, p7370817-2, p7430125-1, p7430557-1, and p7430237-1) and 1 IncI1 
blaTEM-1 plasmid from human (p1341-CO3) produced similar RFLP fingerprints 
designated with t (Table 5). In two of these plasmids the same difference of 2 bands 
compared to the ‘t’ profile was observed (p7430521-1 and p7370817-2); 4 IncI1 plasmids 
originating from different reservoirs and carrying different blaTEM alleles produced 
similar RFLP profiles designated with ’u’ (blaTEM-1b p1033-CO3 and blaTEM-135  p1112-
CO3 from  human;  blaTEM-1b p7430284-1 from poultry and blaTEM-1a p74-30164-4 from 
pig). These plasmids shared overall from 80% to 100% similarities hence they were 
designated as ’u’ variants. 
2 plasmid from humans, IncI1& IncP blaTEM-1b p2002-70903 and  IncI1 blaTEM-1c p545-
CO2 shared over 80% similarity and were designated as RFLP ’w’ and ’w_1’ types. 
Otherwise the RFLP profiles of the detected IncI1 plasmids differed from each other 
(Table 5). 
 
Relatedness of the WTs harbouring similar plasmids 
E. coli WTs that were shown to harbour plasmids with similar replicons and RFLP 
profiles were initially examined by phylotyping and also by Xba-I PFGE (if they 
belonged to the same phylotypes); 6 of the InFII blaTEM-1 plasmids from cattle shared an 
identical RFLP profile ‘a’ and their corresponding WTs were shown to be the same or 
closely related clones (WT 7413236-1, WT 7313865-1, WT 7412972-1 and WT 
7413296-1, WT 7412973-1 and WT 7413208 shared from 85 % to 100% identity in XbaI 
PFGE); 2 WT strains from pigs, WT 74-12934-1 and WT 74-12933-1, harbouring similar 
RFLP types p IncB/O plasmids also produced indistinguishable band patterns in the 
PFGE. 2 WT 74-13361-2 and WT 74-12892-1 shared 93% band identity with each other; 
these two strains harboured similar IncFII&IncFIA &InFIB plasmids. 2 poultry WT 
isolates 7276769-1 and 7277386 harbouring the similar IncFII &IncFIB plasmids 
produced indistinguishable band patterns ; also two poultry isolates, WT 7372121-1 and 
WT 7373304-1 harbouring the IncN plasmids turned out to be clonally related (Table S3). 
In the remaining cases the WTs harbouring the similar plasmids were not 
epidemiologically related with each other. Notably, no clonal relatedness was seen among 
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isolates originating from different animal species or humans. Since clonally related WTs 
originated from different individuals [sampled at different dates over a four-year period], 
their resident blaTEM plasmids were characterised and included in the analyses as 
independent units (Tables1-7). This enabled estimation if these similar plasmids from the 
related clones possibly acquired diverse features.  
 
Examination of the genetic environment upstream of the blaTEM-1 genes 
It has been previously suggested that blaTEM-52 genes often resided on the Tn3- family 
transposons.(
9;10
) The linking PCR in the previous study of Bielak et al. targeted primarily 
Tn2 elements.(
9
) A set of  new linking PCR protocols was designed in this study to detect 
the three subtypes of the Tn3 –like transposons and IS26 elements possibly present 
upstream of the blaTEM genes (Table S2). Plasmids with the blaTEM-1 genes and the 
selected variants were tested with the use of these new PCR schemes. Overall, similar 
pattern was observed in humans and in animals (Table 6). Namely, on the majority of 
plasmids blaTEM-1b  and blaTEM-1c genes were located on Tn2 transposons. However,  
insertions of IS26 elements were also frequently detected upstream of the blaTEM-1b  
alleles. BlaTEM-1a genes resided exclusively on Tn3 elements (Table 6).  
A range of other blaTEM-1 alleles was detected mainly in human faecal indicator isolates, 
namely blaTEM -1d, blaTEM -1g and a novel allele blaTEM -1j (JQ423955) . The blaTEM -1g 
(IncB/O p1297-CO3) and blaTEM  -1j (IncFII & FIB; p904-CO3) resided on Tn2 elements; 
blaTEM-1d was found on p862-CO3 (IncFII & IncFIB) and on p2000-103495 (this plasmid 
had a non-typable replicon and harboured apparently two copies of the blaTEM  gene, each 
being a different allele, namely blaTEM -1c and blaTEM -1d); in p862-CO3 blaTEM -1d gene 
resided on Tn1; 2000-103495 TF was positive to Tn3, however it cannot be concluded 
which of the alleles was linked to this transposon. Unusual combinations were also 
detected, namely Tn1 -blaTEM-1b was found on p7370940-1 (IncFII & IncFIB replicon 
from poultry, diagnostic isolate), Tn3 -blaTEM-1b on p 74-30181-3 (non-typable replicon 
from pig) and blaTEM-30 was detected either on Tn3 in cattle (p74-12351-1; non-typable 
replicon) or on Tn2 in a human isolate (p 875-CO3; IncB/O; RFLP type ‘m’).  
Tn2-blaTEM-135 was found on p 1112-CO3 (IncI1, human) and IS26 was found upstream of 
blaTEM-40 on p 257-CO2 (IncFIB, human). 
In 2 WTs from cattle, 1 WT from poultry and 2 WTs from humans either no plasmid was 
detected or the detected plasmids were negative to the blaTEM PCR. These WTs were also 
16 
 
subjected to the linking PCR. WT 7278662-1 from poultry produced positive signal to 
Tn2-blaTEM; in WT 2002-27242 and WT 1437-CO3 from humans and in WT 74-11793-1 
from cattle, IS26 were detected upstream of the blaTEM-1 genes; in WT 74-13295-1 the 
element upstream of the blaTEM-1 gene was non-typable.  
 
Susceptibility testing  
In general, no significant differences were observed in the distributions of resistances 
associated with blaTEM-1 plasmids between the faecal indicator and diagnostic/clinical 
isolates from animals and humans (Table 7). Overall, many of the blaTEM-1 plasmids from 
all reservoirs conferred accessory resistances to sulphonamides, tetracycline and 
trimethoprim. Co-transfer of  sulphonamide resistance  was seen among 42% to 56% of 
the blaTEM-1 plasmids from humans and animals, respectively. Overall, 35% and 25 % of 
blaTEM-1 plasmids from humans and 49 % and 32% of blaTEM-1 plasmids from animals co-
transmitted resistances to tetracycline and to trimethoprim, respectively (Table 7). To a 
lesser extend the resistances to aminoglycosides (neomycin, spectinomycin or 
gentamycin) and surprisingly to amoxicillin/clavulanate were found to be associated with 
the blaTEM-1 plasmids. In total, resistance to at least one of the aforementioned 
aminoglycosides was associated with approximately 12 % of plasmids from human 
reservoirs and with 24 % of plasmids from animals. In particular higher occurrence of 
blaTEM-1 plasmids associated with neomycin resistance was found in animals (19 % of 
examined plasmids) than in humans (3.5 %). Conversely, a larger fraction of the blaTEM-1 
plasmids from humans than from animals conferred the reduced susceptibility to the 
amoxy-clavulanate (respectively 25 % and 5 % of blaTEM-1 plasmids from humans and 
animals).  
 
pMLST of selected IncF-family, IncN and IncI1 blaTEM-1 plasmids 
7 IncI1 plasmids underwent IncI1 pMLST(
22
). 3 of these, namely p74-13303-1 (pig, IncI1 
& IncFIB & IncFIC, RFLP s), p7430125-1 and p1341-CO3 (RFLP types t from poultry 
and human, respectively) shared the same ST36 pattern (clonal complex CC5); the FIB 
and FIC loci on  p74-13303-1 were B16-related:C2 according to RST (1 nucleotide 
difference was seen in the FIB locus compared  to the C16- reference allele);   
3 IncI1 & IncP plasmids were compared and they produced different patterns, namely 
p7365811-1 (poultry, RFLP θ) was pMLST ST3/CC3, p74-12848-1 (pig, IncP& IncI1, 
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not readable in RFLP) was ST97-related (at least 3 nucleotide differences)  and p2002-
70903 (human, IncI1 & IncP, RFLP w) was typed as a new ST, whereas p74-30166-3 
(pig RFLP α) belonged to ST27/CC26 type. 
Two blaTEM-1b IncN plasmids detected in the study (not compared with each other by 
RFLP) were compared by pMLST and they turned out not to be related; p7372121-1 from 
poultry belonged to ST 3 and p1308-CO3 from human belonged to ST6.  
2 IncFII, RFLP types d plasmids were compared by RST  (p73-14678-1 from cattle and 
p74-13297-1 from pig); they produced F-35 related:A-:B- patterns. In both cases the F-35 
allele was the closest match and the same mutation with respect to this reference allele 
was detected on both plasmids (3 nucleotide difference).  2 of the IncFII, RFLP types g 
plasmids from humans were compared and they represented F2: A-:B- pattern (Table 3). 
Multireplicon p73-14130-2 plasmid from cattle was verified by RST (RFLP hinc3, IncFII 
& IncFIA & IncFIB) and it produced RST pattern F 35-related: A2:B24; the same 
mutations as in the two RFLP d IncFII plasmids described above were observed in the FII 
loci of this multireplicon plasmid compared to the reference allele F35. 3 plasmids from 
cattle with IncFII & IncFIB double replicons were examined (p74-12867-1, p74-12969-1 
and p74-13379-1; RFLP hinc2); they belonged to RST types F2:A-:B1 (Table S3a). 
 
Discussion and conclusions 
This study provides evidences that similar, possibly epidemic blaTEM-1 plasmids circulated 
in commensal and pathogenic E. coli from humans and food-production animals (cattle, 
pigs and poultry) in Denmark. Related IncFII RFLP types d (closely related to RST types 
F35:A-:B-) plasmids with blaTEM-1b genes were found in diagnostic E. coli isolates from 
pigs and cattle. Similar IncI1 blaTEM-1b RFLP types t (pMLST ST36/CC5) plasmids were 
found in indicator E. coli from human and diverse poultry isolates. Possibly related IncI1 
plasmids (RFLP type u and u_variants) harbouring blaTEM-1a, blaTEM-1b blaTEM-135 were 
detected in indicator E. coli strains of pig, poultry and human origin. Similar IncB/O 
plasmids with different blaTEM-1 alleles belonging to two major RFLP types m were 
detected both in humans and in animals in this study.  IncI1, IncB/O  and IncK plasmids 
are members of the same, I-complex family.(
25
) It should also be considered whether the 
high degree of similarity observed in RFLPs on the blaTEM-1 IncB/O plasmids could be 
due to the general conservation of these I-complex backbones in the different host.(
26
) 
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Previously, similar backbones to the blaTEM-1 IncI1 ST3/CC3 (poultry, RFLP θ) and 
ST36/CC5 plasmids( RFLP t, poultry and human) were described on plasmids encoding  
CTX-M-1  (ST3/CC3) and TEM-52 (ST36/CC5) from humans and poultry isolates in the 
Netherlands.(
27
) Based on the RST profiles of the IncFII &IncFIB RFLP hinc2 plasmids 
from cattle (F2:A-:B1) they may be related to the previously described virulence plasmid 
from avian pathogenic E. coli pAPEC-02-ColV.(
28
) The ST3 and ST6 backbones of the 
two blaTEM-1 IncN plasmids detected in E. coli from poultry and human, respectively, 
were previously detected on blaCTX-M-1, qnrS1 (ST3)and blaCTX-M-3, blaKPC-3 and blaOXA-3 
(ST6) plasmids from E. coli, K. pneumoniae and S. enterica of various origins.(
23
)  
Overall, based on the results it can be concluded that IncF-family and IncB/O replicons 
were predominant in blaTEM-1 plasmids on E. coli from humans, cattle and pigs.  IncI1 
were also found in pigs and sporadically in humans. IncI1 replicons dominated on  
blaTEM-1 plasmids from E. coli in poultry. A similar distribution of replicons to the one 
described above was previously observed in commensal and pathogenic E. coli from 
poultry and human reservoirs by Johnson et al. (
11;26
) In these studies the plasmids were 
not selected based on the resistance, hence they represented the replicons normally found 
in these reservoirs. In summary, the collected data suggest that blaTEM-1 genes might have 
been acquired by endogenous, host or reservoir (human, pigs, poultry and cattle) specific 
IncI1, IncB/O and IncF-family plasmids.  
Other replicon types like IncX1, IncK, IncHI1, IncN, IncY and IncR were detected on 
blaTEM-1 plasmids in single isolates from the different reservoirs. Several of the plasmids 
turned out to be non-typable by the PBRT method. This could suggest a presence of either 
novel plasmid types or variants with polymorphisms within the primer binding areas for 
the PBRT primers. Further investigation will be needed to verify this. 
Interestingly, in the study relatively large fraction of blaTEM-1 plasmids from humans and 
in rare cases the blaTEM-1 plasmids from food-production animals conferred reduced 
susceptibility to amoxy-clavulanate in the previously susceptible recipients (25 % and 5% 
of plasmids form humans and animals, respectively).  This was surprising as the TEM-1 
does not confer the resistance to clavulanate.(
3
)Although, a similar phenomenon was 
previously observed.(
29;30
)Two hypotheses were suggested, one that the reduced 
susceptibility to the inhibitor was due to the hyper -production of TEM-1 β-lactamases in 
bacteria; or due to decreased permeabillity especially in the clinical isolates of E. coli.(
29
) 
The overproduction of the TEM-1 may be related to the strength of the promoters of the 
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blaTEM-1 genes.(
31
) Lartigue et al. showed previously that one nucleotide difference in the 
proposed -35 signal in the promoter P3 of blaTEM-1b gene resulted in the production of 
promoter P5 leading to increase in the MIC for AMC from 32 µg/mL to 1024µg/mL.(
31
) 
In our study the primer used for sequencing of the blaTEM genes was located to close to 
the putative -35 signal upstream of the blaTEM-1 genes to determine the promoter types in 
the isolated with the reduced susceptibility to clavulanate. Finally, another possibility 
could be that other than blaTEM –type genes are present on the same plasmid scaffolds 
contributing to the decreased susceptibility to the β-lactamase inhibitor in these isolates.  
Further examination of this phenomenon will be persuaded. 
Conversely to the above, a larger fraction of blaTEM-1 of plasmids from animals conferred 
co-resistance to aminoglycosides (neomycin, spectinomycin or gentamycin) compared to 
plasmids from humans. This discrepancy seems to be a natural consequence of increased 
usage of these aminoglycosides in veterinary (in particular neomycin and spectinomycin) 
rather than in human chemotherapy, which probably led to higher occurrence of 
aminoglycoside resistance genes in animal reservoirs.(
32
) In fact, the data obtained in this 
study illustrate that the occurrence of resistance in the given reservoir corresponded to the 
increased usage of the specific antimicrobials in this reservoir. According to DANMAP 
report in the period 2001-2004 the annual consumption of active compounds 
aminoglycosides in animals was over 10
3
 kg and approximately 30 kg in humans.(
33
) 
Particularly in pigs aminoglycosides were used more frequently.(
33
) Accordingly, we 
noticed that 33 % of blaTEM-1 plasmids from pigs conferred co-resistance to neomycin 
which is at minimum 3 times more compared to other reservoirs (cattle 11%, poultry 5% 
and humans 4%; Table 7).  
The study supported previous observations that Tn2 were the most common transposons 
linked to blaTEM genes in E. coli.(
9;10
) Further correlation was deduced based on the 
results of the linking PCR, namely blaTEM -1b and blaTEM -1c gene alleles typically resided 
on Tn2 transposons, while blaTEM -1a alleles was found exclusively on Tn3. Other blaTEM 
variants were generally located on or linked to different elements (Tn1, -2, -3, IS26 or 
untypable elements). Interestingly, on one of the IncFII &IncFIB plasmid from human  a 
Tn1 -blaTEM-1d  was detected and similar combination to this one, namely Tn1 -blaTEM-2 
was previously found on IncP-1plasmids originating from P. aeruginosa (these are IncP 
plasmids in E. coli) (
10
;
 33
); blaTEM-1d and blaTEM-2 differ by one nucleotide substitution at 
position 109 from the first nucleotide of the blaTEM start codon (GenBank AF188200 and 
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BN000925, respectively). Moreover, the following unusual combinations were detected: 
Tn1 -blaTEM-1b on IncFII & IncFIB plasmid from poultry, Tn3 -blaTEM-1b located on non-
typable replicon from pig; blaTEM-30 was detected in cattle on Tn3 (non-typable replicon) 
and on Tn2 in human isolate (IncB/O plasmid; RFLP type m).These examples implied 
that possible recombination between the transposons and similar blaTEM alleles probably 
occurred on the examined plasmids and generated new Tn-blaTEM variants. (
34
) 
Curiously, in some of the examined WTs it was not possible to transfer the blaTEM-1 genes 
to plasmid free recipient. In some of these WTs the blaTEM -1 genes were shown be linked 
to the Tn2 or IS26 elements. It was suspected that the blaTEM genes might be residing on 
the chromosomes in these strains. In the view of the above findings the question should 
be raised about the very origins of the plasmid encoded blaTEM-1 in Enterobacteriaceae in 
humans and animals. It is likely that the Tn2 transposons first mobilized the blaTEM-1 
genes from their original chromosomal locations and then these transposable elements 
were further spread on plasmids in different bacteria species. 
In conclusion, both indicator and pathogenic E. coli from humans, cattle, pigs and poultry 
apparently shared similar plasmids with blaTEM-1 genes; these blaTEM-1 plasmids might 
have been acquired by humans via direct contact or food chain from food-production 
animals.(
27
) The progenitors of blaTEM-1 genes might have been mobilized in the past by 
Tn3- like elements from yet undetermined chromosomal locations. Further research is 
required to investigate that hypothesis. IS26 were often found inserted upstream of the 
blaTEM-1 genes probably contributing to further acquisitions of diverse resistance genes by 
these plasmids.(
10
) Co-resistance to sulfamethoxazole, trimethoprim and/or tetracycline 
was conferred by the relatively large number of examined blaTEM-1 scaffolds. This 
constitutes a threat for selection for such multi-resistant bacteria in the infected 
individuals treated with these classes of antimicrobials. Moreover, more discriminative, 
preferably sequencing based tools like pMLST or full genome sequencing needs to be 
designed to obtain better perspective of the apparently conserved backbones of IncB/O 
plasmids. 
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List and description of Tables and Figures 
Table 1. Summary of replicon typing results of blaTEM-1 and blaTEM  variants plasmids 
from human and animal reservoirs 
x
- TFs harbouring possibly two plasmids were also included in the general analyses as in 
all cases the replicons turned out to be non- typable in these TFs, these cases are indicated 
with the ’x’ superscript throughout the Table 1; RFLP  [type] – subgroups of plasmids sharing 
similar RFLP profiles were indicated with this superscript, for example six of the nine 
IncFII plasmids from cattle harboured similar RFLP  ‘a’ profiles etc.; detailed results of 
RFLP analyses of plasmids across the reservoirs are listed Tables 3-5 and the same letters 
were used here to designate the RFLP types of the specified plasmids; NT- non -typable 
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Table 2. Distrubution of replicons among the blaTEM-1 plasmids from humans, cattle, 
poultry and pigs 
a
The  TFs from pigs and humans that possibly harboured two plasmids were negative in 
PBRT, therefore these were counted as single cases of NT plasmids with blaTEM-1 genes 
 
Table 3. Characterization of selected IncFII blaTEM-1 and blaTEM-30 plasmids from humans, 
pigs and cattle 
 
IND- faecal indicator; CL- clinical; DG-diagnostic; NR- results not readible; NT- non 
typable ; NAP- not applicable, plasmid DNA was isolated from agarose gel; 
a
- numbers 
next to the same  RFLP submbols indicate that there were  some differences observed  
between these marked fingerprints, otherwise the profiles were closely related (max. 3 
bands difference was the criterium to designate plasmids with the same symbol); 
b
- 
should be interpreted as a putative element upstream of the blaTEM gene; 
Xba_[number] 
WT
 
strains marked with the same Xba_[numbers] were shown to be clonally related in Xba I -
PFGE; 
c 
-phylotype A from the original study of  Clermont et al. is sub-divided here into 
yjaA positive A1 type and  yjaA negative A2 type; AMP- amplicillin; AMC- amoxy-
clavulanate 2:1; APR- apramycin; CHL- chloramphenicol; GEN- gentamycin; NEO- 
neomycin, SMX- sulfamethoxazole; SPT- spectinomycin; SXT- co-trimoxazole 
(trimethoprim/ sulfamethoxazole 1:5); TET- tetracyclin; TMP- trimethoprim; []-
intermediate resistance; the different RFLP profiles are indicated with letters from a to z 
,if necessary additional symbols of  Greek alphabet were used; RST- Replicon Sequence 
Typing; pMLST- plasmid Multilocus Sequence Typing;  Highlighted background is 
applied to  cases when similar plasmids were found across the different reservoirs (e.g. 
humans, pigs, cattle or poultry) 
 
Table 4. Characterization of  IncB/O blaTEM-1 and blaTEM-30 plasmids from humans, pigs 
and cattle. 
The legend is as described for Table 3.  
Table 5. Characterization of  IncI1 blaTEM-1 and blaTEM-135 plasmids from humans, pigs 
and poultry 
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The legend is as described for Table 3. 
 
 
Table 6. Diversity of elements detected upstream of the blaTEM genes in AMP
R
 E. coli  
from humans and from  food-production animals 
 
a
- Wild type strains with non- transferable blaTEM genes were transferred  to the 
corresponding were also tested in the PCR I-V in order to obtain a general overview of 
the diversity of the elements linked to the blaTEM genes in the examined strains collection; 
b
- two copies of the blaTEM-.1 gene were detected on the same plasmid in 2000-103495 TF, 
the two copies were -1c and  -1d alleles , respectively; ukn- unknown 
 
Table 7. Summary of resistances typically co-transferred to the recipients on the blaTEM-1 
plasmids from humans and food-production animals 
a
- some of the plasmids co-transferred  simultaneously resistances to a combinations of 
the listed antimicrobials; however, in the Table 7 each plasmid was counted 
independently each time for the analysed antimicrobial; aabbreviations for antimicrobials 
are explained in the legend to Tables 3; 
b
TFs suspected to harbour more than one plasmid 
were not included in this analysis 
 
 
Table S1. Explanatory material 1  
 
Table S2. Primers used in five simplex PCRs for typing of the regions upstream of the 
blaTEM genes. 
 
 
Table S3a. Summary of results for E. coli from cattle 
Table S3b. Summary of results for E. coli from pigs 
Table S3c. Summary of results for E. coli from poultry 
Table S3d. Summary of results for E. coli from humans- faecal indicator isolates 
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Table S3e. Summary of results for E. coli from humans- clinical isolates 
 
S4. Supplementary RFLP data  
 
 
Figure S1. Targets of the PCR I, II and III on the typical TnpA-blaTEM elements 
 
Figure S2. Fragment of ICEhin1056 from Haemophilus influenzae (AJ627386); in silico 
analysis indicated primers for PCR I would not match to this sequence as tnpA gene of 
Tn2 is not present on this element; however the sequence matches with PCR II primers 
targeting the tnpR of Tn2 and blaTEM gene 
 
Figure S3. The blaTEM-1 region on IncB/O plasmid p3521 (GU256641). Based on the in 
silico analysis, in PCR IV two products of lengths 551 kb and 2122 kb would be 
produced for this sequence (indicated with lines below the open reading frames)  
 
Figure S4. The structure of transposon Tn6039B previously described for pHCM1 
(AL513383) plasmid by Bailey et al. PCR IV and V would be expected to generate 
products of 1393 bp and 1888 bp lengths, respectively, for this sequence.  
 
Figure S5. Putative arrangement of IS26 inserted upstream of blaTEM-1 genes on plasmids 
producing in this study an approximately 2 kb signal in IS26a-blaTEM PCR and 
approximately 0.6 kb signal in IS26b-blaTEM PCR. 
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Table 1 Summary of replicon typing results of blaTEM-1 and blaTEM  variants plasmids from human and animal reservoirs 
 
Reservoir CATTLE POULTRY PIGS HUMANS 
Total of WT amp
r
 isolates examined 33 24 40 62 
Isolate type indicator diagnostic indicator diagnostic  indicator diagnostic indicator clinical 
Number of WTs from the specifed type   2 29 12 12 14 26 31 31 
Cases when blaTEM-1 possibly located on the chromosome  - 2 - 1 - - 1 1 
TFs/ TCs with plasmids harbouring other than blaTEM-1 variants 
a
 - 1 blaTEM-30, IncFII 
1
x
  blaTEM-30, NT 
- - - - 1 blaTEM-30, IncB/O 
1 blaTEM-135, IncI1
RFLP K
 
1 blaTEM-40, IncFIB 
- 
 
TFs/ TCs with blaTEM-1 plasmids from specified reservoir
 a
 2 27 11 12 14 26 27 30 
Replicon \ Total of  examined TFs/ TCs with blaTEM-1 plasmids 
a
  29 23 40 57 
IncB/O 1  9 (2
RFLP o;  4RFLP p; 2RFLP q) 10 (9RFLP m; 1RFLP p) 
IncB/O & IncP 3
RFLP p   3 
RFLP p 
IncFIB 1  1  
IncFII 8 (6
RFLP a
)  5 7 (3RFLP g) 
IncFII & IncFIB 4
RFLP hinc2
 4 7 14 
IncFII & IncFIB & IncFIA/ FIB & FIA  7 (2
RFLP hinc5)   1 
IncFII & IncFIB & IncP 1 3 (2
RFLP poul4
) 1 2 
IncFII & IncP     1  
IncFII & IncR     1  
IncFIB & IncY       1 
IncI1   12 (7
RFLP t) 6 4 (1
RFLP t
) 
IncI1 & IncP   1 1 1 
IncI1 & IncFIC & IncP     1   
IncHI1     1   
IncK       1 
IncN   2
RFLP poul5 
   1 
IncP 2       
IncX1       1 
NT 2 1 6
 
(1
x
) 11 (6
x
) 
 
x- TFs harbouring possibly two plasmids were also included in the general analyses as in all cases the replicons turned out to be non- typable in these TFs, these cases are indicated with the ’x’ 
superscript throughout the Table 1; RFLP  [type] – subgroups of plasmids sharing similar RFLP profiles were indicated with this superscript, for example six of the nine IncFII plasmids from cattle 
harboured similar RFLP  ‘a’ profiles etc.; detailed results of RFLP analyses of plasmids across the reservoirs are listed Tables 3-5 and the same letters were used here to designate the RFLP 
types of the specified plasmids; NT- non -typable 
Table 2. Distrubution of replicons among the blaTEM-1 plasmids from E. coli isolates from humans, 
cattle, poultry and pigs 
aThe  TFs from pigs and humans that possibly harboured two plasmids were negative in PBRT, therefore these were counted 
as single cases of NT plasmids with blaTEM-1 genes 
 
 
Reservoir Human
a
 Animals
a
 Cattle Poultry
a
 Pigs
a
 
Total of blaTEM-1 plasmids typed 
from different WT 
57 
(100 %) 
92 
(100 %) 
29 
(100 %) 
23 
(100 %) 
40 
(100 %) 
Replicons distrubution 
IncFI; IncFII and IncF –family 
combined with other replicons 
 
26  (45.6 %) 44 (47.8 %) 21  (72.4 %) 7  (30.4 %) 16  (40.0 %) 
IncB/O and IncB/O  combined with 
IncP 
 
13  ( 22.8 %) 13  (14.1 %) 4  (13.8 %) - 9 (22.5 %) 
IncI1 and IncI1 combined with other 
replicons 
4  (7.0 %) 21  (22.8 %) - 13 (56.5 %) 8  (20.0 %) 
      
Non typable 11  (19.3 %) 9  (9.8.0 %) 2  (6.2 %) 1  ( 4.3 %) 6  (15.0 %) 
IncK, IncN, IncX, IncP, IncHI1 3 
IncK, IncN, IncX1 
(5.3 %)   5 (5.4 %) 2
IncP
  (6.2 %) 2
IncN
 (4.3 %) 1 
IncHI1
 (2.5 %) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Characterization of selected  IncFII blaTEM-1 and blaTEM-30 plasmids from humans, pigs and cattle 
E. coli WT 
number 
Isolation source WT 
phylotype c 
blaTEM 
allele 
Replicon(s) (RST if 
performed) 
Plasmid 
RFLPa 
Plasmid size 
[kb] 
Element upstream 
of blaTEM-1
b 
Plasmid associated resistances 
74-12973-1 Cattle DG A2 Xba_1 blaTEM-1b IncFII a 51 IS26 AMP, SMX, TMP  
74-13208-1 Cattle DG A2 Xba_1 blaTEM-1b IncFII a 51 unknown AMP, SMX, TMP  
74-13236-1 Cattle DG A2 Xba_1 blaTEM-1b IncFII a 51 unknown AMP, SMX, SXT, TMP  
73-13865-1 Cattle DG A2 Xba_1 blaTEM-1b IncFII a 51 IS26 AMP, SMX, SXT, TMP  
74-12972-1 Cattle DG A2 Xba_1 blaTEM-1b IncFII a 51 IS26 AMP, SMX, SXT, TMP  
74-13296-1 Cattle DG A2 Xba_1 blaTEM-1b IncFII a 51 IS26 AMP, SMX, TMP  
74-12951-1 Cattle DG A2 Xba_1 blaTEM-30 IncFII b 151 IS26 AMP, AMC, AMX, SMX, TMP 
74-13287-1 Cattle DG B1 blaTEM-1b IncFII c 148 unknown AMP, NEO, SMX, TMP  
73-14678-1 Cattle DG A2 blaTEM-1b IncFII  (F35-rel.:A-:B-) d_1  77,2 unknown AMP, SMX, SXT, TMP  
74-13348-1 Pig DG A1 blaTEM-1b IncFII d 70 IS26 AMP, GEN, TMP 
74-13297-1 Pig DG A1 blaTEM-1b IncFII  (F35-rel.:A-:B-) d_2  70 IS26 AMP, SMX 
74-13205-1 Pig DG B1 blaTEM-1b IncFII e 105
c Tn2 AMP, SMX, TET 
73-30620-6 Pig IND D2 blaTEM-1b IncFII f 70 IS26 AMP, SMX, TET, TMP 
2001-49440 Human CL D blaTEM-1b IncFII  (F2:A-:B-) g 64 IS26 AMP, SMX, TMP  
2002-37995 Human CL D blaTEM-1b IncFII g 65 IS26 AMP,SMX, TMP 
2002-134976 Human CL B2 blaTEM-1b IncFII  (F2:A-:B-) g_1 60 IS26 AMP, SMX 
1307-CO3 Human IND B2 blaTEM-1b IncFII h 70 IS26 AMP, SMX, TMP 
2001-59632 Human CL B2 blaTEM-1b IncFII i 70 IS26 AMP, SMX, [GEN] 
2001-106784 Human CL B2 blaTEM-1a IncFII j 70 Tn3 AMP 
855-CO3 Human IND B2 blaTEM-1b IncFII k 60 Tn2 AMP, AMC 
74-13224-1 Pig DG A2 blaTEM-1b IncFII l 80 Tn2 AMP 
IND- faecal indicator; CL- clinical; DG-diagnostic; NR- results not readible; NT- non typable ; NAP- not applicable, plasmid DNA was isolated from agarose gel; a- 
numbers next to the same  RFLP types indicate that there were  some differences observed  between these marked fingerprints, otherwise the profiles were closely 
related (max. 3 bands difference was the criterium to designate plasmids with the same symbol); b- should be interpreted as a putative element upstream of the 
blaTEM gene; 
Xba_[number] WT strains marked with the same Xba_[numbers] were shown to be clonally related in Xba I -PFGE; c -phylotype A from the original study 
of  Clermont et al. is sub-divided here into yjaA positive A1 type and  yjaA negative A2 type; AMP- amplicillin; AMC- amoxy-clavulanate 2:1; APR- apramycin; 
CHL- chloramphenicol; GEN- gentamycin; NEO- neomycin, SMX- sulfamethoxazole; SPT- spectinomycin; SXT- co-trimoxazole (trimethoprim/ sulfamethoxazole 
1:5); TET- tetracyclin; TMP- trimethoprim; []-intermediate resistance; the different RFLP profiles are indicated with letters from a to z ,if necessary additional 
symbols of  Greek alphabet were used; RST- Replicon Sequence Typing; pMLST- plasmid Multilocus Sequence Typing;  Highlighted background is applied to  
cases when similar plasmids were found across the different reservoirs (e.g. humans, pigs, cattle or poultry) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4. Characterization of  IncB/O blaTEM-1 and blaTEM-30 plasmids from humans, pigs and cattle. 
E. coli WT 
number 
Isolation source WT 
phylotype 
blaTEM allele Replicon(s) Plasmid 
RFLPa 
Plasmid size 
[kb] 
Element upstream of 
blaTEM-1
b 
Plasmid associated resistances 
1297-CO3 Human IND NT blaTEM-1g IncB/O m 70 Tn2 AMP, SMX 
875-CO3 Human IND D blaTEM-30   IncB/O 
m 80 Tn2 AMP, AMC, SMX 
438-CO2 Human IND B2 blaTEM-1c IncB/O 
m 88 Tn2 AMP, SMX 
2002-110474 Human CL B2 blaTEM-1c IncB/O m_1 70 Tn2 AMP, SMX 
2002-50 Human CL D blaTEM-1c IncB/O m 80 Tn2 AMP, SMX, SPE 
1082-CO3 Human IND B2 blaTEM-1c IncB/O m 92 Tn2 AMP, SMX 
97-CO2 Human IND B2 blaTEM-1b IncB/O m_2 95 Tn2 AMP, SMX 
2002-14946 Human CL B2 blaTEM-1c IncB/O m_3  80 Tn2 AMP, SMX 
2001-25022 Human CL D blaTEM-1c IncB/O m_4  90 Tn2 AMP, SMX 
1231-CO3 Human IND B2 blaTEM-1b IncB/O n 85 Tn2 AMP 
74-11919-1 Pig DG A1 blaTEM-1a IncB/O o 105 Tn3 AMP, SMX, TET, TMP 
74-12927-1 Pig DG A2 blaTEM-1a IncB/O o 100 Tn3 AMP, SPT, SMX, TET, TMP 
74-13266-1 Pig DG A2 blaTEM-1b IncB/O p_1 105 IS26 AMP, NEO,SMX, TET 
433-CO2 Human IND A1 blaTEM-1a IncB/O p_2 95 Tn3 AMP 
457-CO2 Human IND B2 blaTEM-1b IncB/O &  IncP p 110 IS26 AMP, NEO, SMX, TET 
2001-131351 Human CL A1 blaTEM-1b IncB/O &  IncP p 110 IS26 AMP, SMX, TET 
2001-37255 Human CL A1 blaTEM-1b IncB/O &  IncP p 125 IS26 AMP, SMX, TET, TMP 
74-12934-1 Pig DGXbaI_2 A1 blaTEM-1b IncB/O p 105 IS26 AMP, NEO,SMX, TET 
74-12933-1 Pig DGXbaI_2 A1 blaTEM-1b IncB/O p 105 IS26 AMP, NEO,SMX, TET 
74-30367-2 Pig DG A1 blaTEM-1b IncB/O p 105 IS26 AMP, NEO,SMX, TET 
74-12894-1 Cattle DG B1 blaTEM-1b IncB/O &  IncP p 115 IS26 AMP, SMX, TET 
74-12865-1 Cattle DG A2 blaTEM-1b IncB/O &  IncP p 115 IS26 AMP, SMX, TET 
74-30014-3 Cattle IND B1 blaTEM-1b IncB/O &  IncP p_3 115 IS26 AMP, NEO,SMX, TET 
73-30819-1 Pig IND A2 blaTEM-1b IncB/O q 105 IS26 AMP, SMX, TMP 
74-30165-7 Pig IND D2 blaTEM-1b IncB/O q_1  140 IS26 AMP, NEO,SMX, TET 
74-13196-1 Cattle DG D2 blaTEM-1b IncB/O r 106 IS26 AMP, SMX 
73-30622-3 Pig IND B1 blaTEM-1b IncB/O NR 105 IS26 AMP, NEO,SMX, TET 
The legend is as described for Table 3. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5. Characterization of  IncI1 blaTEM-1 and blaTEM-135 plasmids from humans, pigs and poultry  
E. coli WT 
number 
Isolation source WT 
phylotype 
blaTEM 
allele 
Replicon(s) 
( pMLST type, if tested) 
Plasmid 
RFLPa 
Plasmid 
size [kb] 
Element upstream of 
blaTEM-1
b 
Plasmid associated resistances 
74-13303-1 Pig DG A1 blaTEM-1b 
IncI1, IncFIB, IncFIC 
(ST36/CC5:FIB16:FIC2) 
 
s 80 Tn2 AMP 
1341-CO3 Human IND NT blaTEM-1b IncI1  (ST36/CC5) t 85 Tn2 AMP 
7430186-1 Poultry IND A1 blaTEM-1b IncI1 t 82 Tn2 AMP 
7430287-1 Poultry IND A2 blaTEM-1b IncI1 t 90 Tn2 AMP 
7430521-1 Poultry IND B1 blaTEM-1b IncI1 t_1 85 Tn2 AMP 
7370817-2 Poultry DG B1 blaTEM-1b IncI1 t_1 85 Tn2 AMP 
7430125-1 Poultry IND A1 blaTEM-1b IncI1  (ST36/CC5) t 82 Tn2 AMP 
7430557-1 Poultry IND A1 blaTEM-1b IncI1 t 85 Tn2 AMP 
7430237-1 Poultry IND A2 blaTEM-1b IncI1 t 85 Tn2 AMP 
1033-CO3 Human IND NT blaTEM-1b IncI1 u 100 Tn2 AMP, SMX 
7430284-1 Poultry IND A2 blaTEM-1b IncI1 u_1 104 Tn2 AMP, SMX 
1112-CO3 Human IND A1 blaTEM-135   IncI1 u_2 104 Tn2 AMP, SMX, TMP 
74-30164-4 Pig IND A2 blaTEM-1a IncI1 u_3 80 Tn3 AMP 
73-30816-2 Pig IND A1 blaTEM-1b IncI1 v 80 Tn2 AMP 
2002-70903 Human CL NT blaTEM-1b IncI1 ( ST-new) & IncP w 120 IS26 AMP, SMX, TET, TMP 
545-CO2 Human IND D blaTEM-1c IncI1 w_1 105 Tn2 AMP, SMX, TET, TMP 
74-13304-2 Pig DG D blaTEM-1b IncI1 x 150 IS26 AMP, SMX, TET, TMP 
74-13309-1 Pig DG A1 blaTEM-1b IncI1 y 80 IS26 AMP 
74-30167-1 Pig IND B1 blaTEM-1b IncI1 z 105 IS26 AMP, NEO, SMX, TMP 
74-30166-3 Pig IND A1 blaTEM-1b IncI1 α 105 IS26 AMP 
7430621-1 Poultry IND D blaTEM-1b IncI1 β 82 Tn2 AMP 
7365811-1 Poultry DG A2 blaTEM-1b IncI1 (ST3/CC3) &  IncP θ 125 Tn2 AMP, SMX, SXT, TET, TMP 
7430605-1 Poultry IND A1 blaTEM-1b IncI1 NAP 85 Tn2 NAP 
7430641-1 Poultry IND B1 blaTEM-1b IncI1 NR 85 Tn2 AMP 
7275882-1  Poultry DG A2 blaTEM-1b IncI1 NR 85 Tn2 AMP, AMC 
74-12848-1 Pig DG A1 blaTEM-1b IncI1 (ST97-rel.) & IncP NR 100 IS26 AMP, TET 
 
The  legend is as described  for Table 3. 
 Table 6. Diveristy of elements detected upstream of the blaTEM genes in amp
r E. coli  from humans and from  
food-production animals 
 
Total of ampr isolates examined                             159 (100 %)a 
Allele occurence among the total number of ampr isolates examined 
blaTEM-1a blaTEM-1b blaTEM-1c Other blaTEM-1 alleles 
(blaTEM-1c/d, -1d, -1g, -1j) 
Other examined variants (blaTEM-30, -40,- 135) 
14 (8.8 %) 113 (71.1 %) 22 (13.8 %) 5 (3.1 %) 5 (3.1 %) 
Distribution of blaTEM alleles 
Element 
detected  
upstream 
Human isolates (n= 62)a 
 
Animal isolates (n=97)a 
blaTEM  alleles blaTEM  alleles 
-1a 
n=6 
-1b 
n=33 
-1c 
n=15 
-1c/d, -1d, -1g, -1j -30, -40,- 135 -1a 
n=8 
-1b 
n=80 
-1c 
n=7 
-30 
n=2 
Tn1    
 
1 blaTEM-1d 
 
  1   
Tn2  15 15 
1 blaTEM-1g 
1 blaTEM-1j 
 
1 blaTEM-30, 
1 blaTEM-135 
  
33 7 1 
Tn3    6     1 b blaTEM-1c/d  8 1  1 
IS26   18     1 blaTEM-40   35   
Ukn       1 blaTEM-1d     10   
a- Wild type strains with non- transferable blaTEM genes were transferred  to the corresponding were also tested 
in the PCR I-V in order to obtain a general overview of the diversity of the elements linked to the blaTEM genes 
in the examined strains collection; b- two copies of the blaTEM-.1 gene were detected on the same plasmid in 
2000-103495 TF, the two copies were -1c and  -1d alleles , respectively; ukn- unknown 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table 7. Summary of resistances typically co-transferred to the recipients on the blaTEM-1 plasmids from humans and food-production animals 
Reservoir Humans Animals Cattle Pigs Poultry 
TFs/ TCs with blaTEM-1 
plasmids b 
total (% of the total) 
 
total (% of the total) total (% of the total) total (% of the total) total (% of the total) 
57 (100 %) 88 (100 %) 27 (100 %) 40 (100 %) 21 (100 %) 
Plasmid co-transferred resistance to: a   
 SMX 34 (42.1 %) 49 (55.7 %) 19 (70.4 % ) 22 (55.0 %) 8 (38.1 %) 
TET 20 (35.1 %) 43 (48.9 %) 17 (63.0 %) 17 (42.5 %) 9 (42.9 %) 
TMP 14 (24.6 %) 28 (31.8 %) 11 (40.7 %) 11 (27.5 %) 6 (28.6 %) 
NEO 2 (3.5 %) 17 (19.3 %) 3 (11.1 %) 13 (32.5 %) 1 (4.8 %) 
SPT 3 (5.3 %) 3 (3.4 %) 1 (3.7 %) 2 (5.0 %) -  
AMC 14 (24.6 %) 4 (4.5 %) 1 (3.7 %) 2 (5.0 %) 1 (4.8 %) 
 CHL 2 (3.5 %) 3 (3.4 %)  - 1 (2.5 %) 2 (1.5 %) 
 GEN 2 (3.5 %) 1 (1.1 %)  - 1 (2.5 %) -  
             a- some of the plasmids co-transferred simultaneously resistances to a combinations of the listed antimicrobials; however, in the Table 7 each plasmid was counted independently each               
         time for the analysed antimicrobial; abbreviations for antimicrobials are explained in the legend to Tables 3; bTFs suspected to harbour more than one plasmid were not included in this  
         analysis 
 
 
Table S1. Explanatory material 1. 
In two of the obtained TFs (74-13205-1TF and 74-13344-1 TF; pigs) the sizes of the 
individual blaTEM-1 plasmids observed in S1-PFGE did not correspond to sizes of any of the 
plasmids detected in the respective WTs. Size of the plasmid in the 74-13205 TF was 
estimated to105 kb; in the corresponding WT the only plasmid detected in S1-PFGE was 
approximately 140 kb. The blaTEM-1 plasmid in the 74-13344-1TF was sized to 75 kb while 
two larger plasmids (sized to 85 kb and 145 kb) were observed in the respective WT isolate.  
Possibly in WT 74-13344-1the largest plasmid was a co-integrate of two blaTEM-1 plasmids 
that was resolved in the TF. The 140 kb plasmid from the WT 74-13205 could also be a co-
integrate of two plasmids; in this case one would expect to see a second plasmid in the 
corresponding TF sized to approximately 30-35 kb. Plasmids of these sizes might be hardly 
visible in S1-PFGE. In 2001-37255TF (human reservoir) the size of the individual blaTEM-1 
plasmid (125 kb) observed in the S1-PFGE did not correspond to the size of the single 
plasmid detected in the WT (60 kb).  The plasmid from this TF could be a co-integrate of 
two plasmids of approximate 60 kb sizes.  
Co-integrate formation between plasmids in conjugation and upon transformation have been 
previously reported. 
1,2
 Since only individual plasmids were observed in the above TFs, 
these  TFs were treated as harbouring individual blaTEM-1 plasmids and were included in 
further characterizations.  
References  
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Table S2. Primers used in five simplex, linking PCRs for typing of the regions upstream of the blaTEM genes. 
 
 
* In Bailey et al. the R6K was designated as harbouring Tn1; however  in silico  analysis of the sequnce of R6K available at Wellcome Trust Sanger Institute, 
www.sanger.ac.uk predicted the presence of Tn3; the latter was confirmed by obtaining a positive signal in PCR III and I, but no signal in PCR II for the R6K; therefore the 
plasmids was used as positive control for PCR III.
PCR type Primer sequence  Target Control  
 
Amplicon 
size [bp] 
T annealing 
°C 
Time annealing 
[ min.] 
Reference 
(accession number) 
PCR I Pfw  5'-CGTATCAGCGCTGCATGCTCA-3'     tnpA of Tn1, -2, -3 JQ423956 1521 60°C 1.5 Bailey et al. 
PCR II Pfw 5'-GGTGTGAAAGCAAACCGTATA-3'     tnpR  of Tn2 JF776874.1 953 55°C 1 Bielak et al. 
PCR III Pfw 5'-CGGCTTTTTTAACACAACTG-3'           tnpA  of Tn3 R6K* 1174 55°C 1 R6K * 
PCR IV Pfw 5'-ACCTTTGATGGTGGCGTAAG-3' IS26a For details 
see 
explanation 
below this 
table 
variable 60°C 1.5 RH1270 in  
Bailey et al. 
 
PCR V Pfw 5'-GATGCGTGCACTACGCAAAG-3'         IS26b variable 60°C 2 RH882 in  
Bailey et al. 
 
PCR I, II, III,  
IV and V 
Prv  5'-CTGAGAATAGTGTATGCGGCGAC-3' blaTEM      
 
PCR conditions 
 
Reaction volume 25 µL, primers and dNTPs concentrations: 0.25 µM per reaction, 0.5 U of VWR (Promega®) polymerase was used per reaction. 
PCR set-up:  initiation step at 94°C; 5 min. followed by 30 cycles of  i) 94°C; 1 min, ii) T annealing;  Time annealing 
 iii) 72°C; 90 sec. ; and final elongation step at 72°C; 5 min.        
 
 
Interpretation of the results of the linking PCRs I-V 
 PCR I PCR II PCR III PCR IV PCR V 
Putative  Tn1-blaTEM + - - PCR IV and V  were performed only if no signal was 
produced in PCR I, II and III Tn2-blaTEM + + - 
Tn3-blaTEM + - + 
IS26a - blaTEM - - - + +/- 
IS26b - blaTEM - - - +/- + 
IS26 ’a’ and ’b’ refer to the orientation of the inverted repeats (IRs) of the  IS26  as described by Bailey et al. 
Description to Table S2 
Plasmid purifications or boiled lysates from TFs or TCs harbouring individual plasmids of 
interests were used as templates. Controls used were as follows: plasmid R6K harbouring 
Tn3-blaTEM-1 sequence (sequence available at Wellcome Trust Sanger Institute, 
www.sanger.ac.uk ) was positive control in PCR III,  plasmid pE001 carrying Tn2-blaTEM-52 
(JF776874.1) was positive control for PCR II. The Tn1-blaTEM-1 was initially found on p862-
CO3 (blaTEM-1d plasmid from human, this study). The PCR I product from this plasmid was 
sequenced, and deposited in GenBank (JQ423956). The p862-CO3 served later as the control 
in PCR I. Caution should be taken in interpretation of the results of the PCR I. Only if a given 
plasmid produced positive signal in PCR I, while no signal was produced in PCR II (Tn2 
specific) and III (Tn3 specific), the element linked to blaTEM was interpreted in this study as 
putative Tn1. PCRs IV and V were performed only when no signal was observed in PCRI-III. 
No control was prepared for these two simplexes as the obtained products were expected to 
be of different sizes as observed in Bailey et al. 2011. Any positive product observed in PCR 
IV or V was interpreted as putative IS26a or IS26b linked to the corresponding blaTEM gene, 
respectively.  
It needs to be underlined that the study aimed at giving only an overview of the diversity of 
Tn1-3 and IS26 types associated with the blaTEM genes in the examined collection of strains. 
Therefore no sequencing was performed for further confirmation of the observed PCR 
results. Tn1-3 and the IS26 elements detected upstream the blaTEM-genes  should be 
considered as putative in order to leave the labelling opened for discussion in the future when  
sequencing would be performed and more details obtained. 
Predicted outputs of the linking PCR for the different sequences available in GenBank are 
indicated on the figures below. The schemes were generated in Vector NTI suit 11 software 
(Invitrogen, Inc.) 
xyzr
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Figure S1. Targets of the PCR I, II and III on the typical TnpA-blaTEM elements. 
 
 fragment of ICEhin1056 with tnpR-blaTEM-1b AJ627386
7323 bp
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Figure S2. Fragment of ICEhin1056 from Haemophilus influenzae (AJ627386); in silico 
analysis indicated primers for PCR I would not match to this sequence as tnpA gene of Tn2 is 
not present on this element; however the sequence matches with PCR II primers targeting the 
tnpR of Tn2 and blaTEM gene. 
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Figure S3. The blaTEM-1 region on IncB/O plasmid p3521 (GU256641). Based on the in silico 
analysis in PCR IV two products of lenghts 551 kb and 2122 kb would be produced for this 
sequence (indicated with lines below the open reading frames)  
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9692 bp
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Figure S4. The structure of transposon Tn6039B previously described for pHCM1 
(AL513383) plasmid by Bailey et al. PCR IV and V would be expected to generate products 
of 1393 bp and 1888 bp lengths, respectively, for this sequence.  
 putative arrangement of IS26 inserted upstream of the blATEM-1
2941 bp
IS26
IS26
blaTEM 1
(orientation b)(orientation a)
  
Figure S5. Putative arrangement of IS26 inserted upstream of blaTEM-1 genes on plasmids 
producing in this study an approximately 2 kb signal in IS26a-blaTEM PCR and approximately 
0.6 kb signal in IS26b-blaTEM PCR. 
 
 
Table S3 a. Summary of results for E. coli from cattle (Manuscript II). 
 
Reservoir CATTLE
Species E. coli RFLP  (pMLST types if available) Plasmid Putative element  
WT PFGE WT Type of recipient bla TEM allele Resistances associated with Replicon (s) detected 
Designations  should correspond to the 
symbols size [kb] upstrem the
Selftrasmis
sibility *
wild type (WT) Strain number phylotype
relatedness of selected WT 
strains Resistances
in which the plasmid 
was characterized blaTEM   plasmid used in  Tables 3-5 in the manuscript.  blaTEM  gene
diagnostic 74-13196-1 D2 AMP, SMX, STR, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX IncB/O r 106 IS26a  (2 kb and 0.4 kb)
 faecal/ indicator 74-30014-3 B1 AMP, NEO, SMX, STR, TET TF (GeneHogs ) bla TEM-1b AMP, NEO, SMX, TET IncB/O + IncP p_3 115 IS26a  (2 kb and 0.4 kb)
diagnostic 74-12894-1 B1 AMP, SMX, STR, TET TF (GeneHogs ) bla TEM-1b AMP, SMX, TET IncB/O + IncP p 115 IS26 a  (0.4 kb)
diagnostic 74-12865-1 A2 AMP, SMX, STR, TET TF (GeneHogs ) bla TEM-1b AMP, SMX, TET IncB/O + IncP p 115 IS26a  (2 kb and 0.4 kb)
diagnostic 74-12891-1 D1 AMP,CHL, SMX, STR, TET TF (GeneHogs ) bla TEM-1b AMP,CHL, SMX, TET IncP  Ω  (omega) 100 IS26a  (2 kb and 0.4 kb)
 faecal/ indicator 74-30138-2 D1 AMP, AMC, CEF, SPT, SPR, SMX, TET TC (MT101 ) bla TEM-1b AMP, AMC, SMX, TET IncP  Δ   (delta) 100 IS26a  (2 kb and 0.4 kb) yes
diagnostic 74-13300-1 A1 AMP, SMX, STR, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, TET, TMP IIncFII, IncFIB, IncP hinc1 153 IS26a  (2 kb and 0.4 kb)
diagnostic 74-12867-1 A1 AMP, SMX, STR, TET, TMP TC (MT101 ) bla TEM-1c AMP, TET IIncFII, IncFIB hinc2  (FII2 :FIB1) 130 Tn2
diagnostic 74-12969-1 A1 Xba_4 AMP, SMX, STR, TET, TMP TF (GeneHogs ) bla TEM-1c AMP, TET IIncFII, IncFIB hinc2, (FII2: FIB1 ) 130 Tn2
diagnostic 74-13379-1 A2 AMP, SMX, STR, TET, TMP TC (MT101 ) bla TEM-1c AMP, TET IIncFII, IncFIB hinc2, (FII2) 139 Tn2
diagnostic 74-12866-1 B1 AMP, SMX, STR, TET, TMP TC (MT101 ) bla TEM-1b AMP, SMX, TET, TMP IIncFII, IncFIB hinc2_1 (3 bands diff.  compared to hinc2) 139 IS26a  (2 kb and 0.4 kb)
diagnostic 73-14130-2 B1 Xba_5 AMP, SMX, SXT, STR, TET, TMP TC (MT101 ) bla TEM-1b AMP, SMX, SXT, TMP IIncFII, IncFIB, IncFIA hinc3 (FII35-related:FIA 3* :  FIB24) 135 Tn2 yes
diagnostic 74-13361-2 A2 Xba_3 AMP, SMX, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, TET IIncFII, IncFIB, IncFIA hinc5 90 Tn2
diagnostic 74-12892-1 A2 Xba_3 AMP, NAL, SPT, SMX, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, TET IIncFII, IncFIB, IncFIA hinc5  (FII closest match to FII 33) 90 Tn2 no
diagnostic 74-13289-1 A1  (80 %  Xba_3) AMP, SMX, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, TET IIncFII, IncFIB, IncFIA hinc6 90 IS26 a (1.3 kb)
diagnostic 73-13939-1 A2 AMP, SMX, SXT, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, TET IIncFII, IncFIB, IncFIA hinc7 93 Tn2
diagnostic 74-13274-1 A2 AMP, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, TET IncFIB, IncFIA hinc8 81 Tn2
diagnostic 74-12084-1 A2 AMP, CEF, NAL, SPT, STR, SMX, TET TF (GeneHogs ) bla TEM-1b AMP, SMX, SPT, TET IIncFII, IncFIB, IncFIA not readible 160 Tn2
diagnostic 73-14678-1 A2 AMP, GEN, NEO, STR, SMX, SXT, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, SXT, TMP FII    
d_1   FII35-related, the same mutation as 
in the pig isolate 77,2 unknown
diagnostic 74-12973-1 A2 Xba 1   1_1 (85%) AMP, NAL, STR, SMX, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, TMP; ( SXT- not tested) FII a 51 IS26 a (1.3 kb)
diagnostic 74-13208-1 A2 Xba 1   1_1 (86%) AMP, NAL, STR, SMX, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, TMP; ( SXT- not tested) FII a 51 unknown
diagnostic 74-13236-1 A2 Xba 1   1 (100%) AMP, NAL, STR, SMX, SXT, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, SXT, TMP FII a 51 unknown
diagnostic 73-13865-1 A2 Xba 1   1 (100%) AMP, NAL, STR, SMX, SXT, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, SXT, TMP FII a 51 IS26 a (1.3 kb)
diagnostic 74-12972-1 A2 Xba 1   1 (100%) AMP, NAL, STR, SMX, SXT, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, SXT, TMP FII a 51 IS26 a (1.3 kb)
diagnostic 74-13296-1 A2 Xba 1   1_2 (98%) AMP, NAL, STR, SMX, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, TMP; ( SXT- not tested) FII a 51 IS26 a (1.3 kb)
diagnostic 74-12951-1 A2 Xba 1   1_2 (93%) AMP, NAL, STR, SMX, TET, TMP TC (MT101 ) bla TEM-30
AMP, AMC, SMX, TMP; ( SXT- not 
tested) FII b 151 IS26 a (1.3 kb) yes
diagnostic 74-13287-1 B1 Xba_5 AMP, NAL, STR, SMX, TET, TMP TC (MT101 ) bla TEM-1b AMP, NEO, SMX, TMP FII c 148 unknown yes
diagnostic 74-13209-1 A1 AMP, NEO, STR, SMX, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, TET IncFIB hinc9 112 unknown
diagnostic 74-13318-1 B1 AMP, CEF, GEN, NEO, STR, SMX, TET TC (MT101 ) bla TEM-1b AMP, TET NT not readible 240 unknown yes
diagnostic 74-12351-1 A2 AMP, AMC, NAL, NEO, SPT, STR, SMX, TET, TMP TF (GeneHogs ) bla TEM-30 AMP, AMC NT hinc10 138 & 30 kb Tn3 no
diagnostic 74-13301-1 A2 AMP, CIP, NAL, NEO, SPT, STR, SMX, TET, TMP TF (GeneHogs ) bla TEM-1a
transformant not preserved/ purified 
DNA available NT not tested <10 kb Tn3
diagnostic 74-13295-1 B2 AMP, CHL, STR, SMX,TET bla TEM non transferable bla TEM-1b bla TEM non transferable
{2 bla TEM  -negative 
plasmids in WT } not applicable not applicable unknown
diagnostic 74-11793-1 A2 AMP, SMX, TET, TMP bla TEM non transferable bla TEM-1b bla TEM non transferable
{1 bla TEM  -negative 
plasmid in WT } not applicable not applicable
{WT positive to IS26a 
(0.9 kb kb)}  
* selfrasmissibility - only applicable to TCs  obtained from corresponding WTs  which harboured  no more than one plasmid 
 
Recipient resistances
Recipeint strains Based on disc diffusion method
E. coli  K12HEHA4 STR, CEF,NEO, [CHL]
E. coli GeneHogs ® STR, CEF
E. coli  MT101 (rif, nal) variant STR, RIF, NAL (this variant was used in the majority of cases)
E. coli  MT101 STR, CEF
[] intermediate resistance
* recipient intrinsically resistant  
 
 
  
Table S3 b. Summary of results for E. coli from pigs (Manuscript II). 
 
Reservoir PIGS
Species E. coli 
WT PFGE WT 
Type of recipientin which 
the plasmid bla TEM allele Resistances associated with Replicon (s) RFLP  (pMLST types if available) Plasmid Putative element upstrem 
Strain phylotype
relatedness of 
selected WT strains Resistances  was  characterized bla TEM plasmid (NT- non typable) Profiles designations correspond  to  the symbols size [kb] the bla TEM  gene
wild type (WT) number  used in  Tables 3-5 in the manuscript
faecal/ indicator 74-30165-7 D2 AMP, NEO, STR, SMX, TET TF (DH10B) bla TEM-1b AMP, NEO,SMX, TET IncB/O q_1 140 IS26a (2 kb)
faecal/ indicator 73-30819-1 A2 AMP, STR, SMX, TMP, SXT TF (DH10B) bla TEM-1b AMP, SMX, TMP IncB/O q 105 IS26a (2 kb) & IS26b (0.6 kb)
faecal/ indicator 73-30622-3 B1 AMP, NEO, STR, SMX, TET TF (DH10B) bla TEM-1b AMP, NEO,SMX, TET IncB/O not readible 105 IS26a (2 kb) & IS26b (0.6 kb)
diagnostic 74-30367-2 A1 AMP, NEO, STR, SMX, TET TF (DH10B) bla TEM-1b AMP, NEO,SMX, TET IncB/O p 105 IS26b (0.6 kb)
diagnostic 74-13266-1 A2 AMP, NEO, STR, SMX, TET, [CEF] TF (DH10B) bla TEM-1b AMP, NEO,SMX, TET IncB/O p_1 105 IS26a (2 kb) & IS26b (0.6 kb)
diagnostic 74-12934-1 A1 Xba_2 AMP, NEO, STR, SMX, TET, [CEF] TF (DH10B) bla TEM-1b AMP, NEO,SMX, TET IncB/O p 105 IS26a (2 kb) & IS26b (0.6 kb)
diagnostic 74-12933-1 A1 Xba_2 AMP, NEO, STR, SMX, TET, [CEF] TF (DH10B) bla TEM-1b AMP, NEO,SMX, TET IncB/O p 105 IS26a (2 kb) & IS26b (0.6 kb)
diagnostic 74-12927-1 A2 AMP, CHL, SPT,, STR, SMX, TET, TMP, [CEF] TF (DH10B) bla TEM-1a AMP, SPT, SMX, TET, TMP IncB/O o 100 Tn3
diagnostic 74-11919-1 A1 AMP, SPT, STR, SMX, TET, TMP, [CEF] TF (DH10B) bla TEM-1a AMP, SMX, TET, TMP IncB/O o 105 Tn3
faecal/ indicator 74-30164-4 A2 AMP, SPT, STR, SMX, [CEF] TF (DH10B) bla TEM-1a AMP IncI1 u_3 80 Tn3
faecal/ indicator 74-30167-1 B1 AMP,[APR], NEO, STR, SMX, TMP TF (DH10B) bla TEM-1b AMP, NEO, SMX, TMP IncI1 z 105 IS26a (2 kb) 
faecal/ indicator 74-30166-3 A1 AMP, CHL, STR, SMX, TET TF (DH10B) bla TEM-1b AMP IncI1 α 105 IS26a (2 kb) 
faecal/ indicator 73-30816-2 A1 AMP TF (DH10B) bla TEM-1b AMP IncI1 v 80 Tn2
diagnostic 74-13309-1 A1 AMP, NEO, STR, SMX TF (DH10B) bla TEM-1b AMP IncI1 y 80 IS26a (2 kb) 
diagnostic 74-13304-2 D1 AMP, SPT, SMX, TET, TMP, CEF TF (DH10B) bla TEM-1b AMP, SMX, TET, TMP IncI1 x 150 IS26a (2 kb) 
diagnostic 74-12848-1 A1 AMP, CIP, NAL, TET TF (DH10B) bla TEM-1b AMP, TET IncI1, IncP not readible 100 IS26a (2 kb) 
diagnostic 74-13303-1 A1 Xba_6 AMP,CIP, NAL, SPT, SMX, TET, TMP, [CEF] TF (DH10B) bla TEM-1b AMP IncI1, IncFIB, IncFIC s 80 Tn2
diagnostic 74-13348-1 A1 AMP, GEN, SPT, STR, TMP TF (DH10B) bla TEM-1b AMP, GEN, TMP IncFII d    ST FII35-closest match 70 IS26a (2 kb) 
diagnostic 74-13224-1 A2 AMP, SPT, STR, SMX, TET, CEF TF (DH10B) bla TEM-1b AMP IncFII l 80 Tn2
diagnostic 74-13205-1 B1 AMP, CHL, CIP, NAL ,STR, SMX, TET, TMP, [CEF] TF (DH10B) bla TEM-1b AMP, SMX, TET IncFII e 105 (possible co-int.) Tn2
faecal/ indicator 73-30620-6 D2 AMP, STR, SMX, TET, TMP, SXT TF (DH10B) bla TEM-1b AMP, SMX, TET, TMP IncFII f 70 IS26a (1.3 kb) 
diagnostic 74-13297-1 A1 Xba_6 AMP, STR, SMX TF (DH10B) bla TEM-1b AMP, SMX IncFII d_2 70 IS26a (1.3 kb) 
diagnostic 74-11272-1 A1 AMP, APR, GEN, SPT, STR, SMX, TET, TMP, [CEF] TF (DH10B) bla TEM-1a AMP IncFIB  not tested 80 Tn3
diagnostic 74-12902-3 A2 AMP, SPT, STR, SMX, TET, TMP TF (DH10B) bla TEM-1a AMP IncFII, IncFIB  not tested 105 Tn3
faecal/ indicator 74-30162-3 D2 AMP, SPT, STR, SMX, TET TF (DH10B) bla TEM-1a AMP, SMX IncFII, IncFIB  not tested 220 Tn3
faecal/ indicator 73-30813-7 B1 AMP TF (DH10B) bla TEM-1b AMP IncFII, IncFIB  not tested 160 Tn2
diagnostic 74-13344-1 A2 AMP, CIP, NAL, NEO, STR, SMX, TMP, [CEF] TF (DH10B) bla TEM-1b AMP, TMP IncFII, IncFIB  not tested 150 (possible co-int.) IS26a (1.3 kb) 
diagnostic 74-12904-1 A2 AMP, NEO, STR, SMX, TET, TMP, [CEF] TF (DH10B) bla TEM-1b AMP, NEO, SMX, TMP IncFII, IncFIB  not tested 140 IS26a (2 kb) 
diagnostic 74-11186-2 B2 AMP, NEO, SPE, SMX, TET, TMP, CEF TF (DH10B) bla TEM-1c AMP, AMC, TET IncFII, IncFIB  not tested 180 Tn2
diagnostic 74-12935-1 A1 AMP, NEO, STR, SMX, TET TF (DH10B) bla TEM-1b AMP, NEO,SMX, TET IncFII, IncFIB  not tested 105 IS26a (1.3 kb) 
diagnostic 74-11566-3 A1 AMP, APR, GEN, NEO, STR, SMX, TET, TMP, CEF TF (DH10B) bla TEM-1b AMP, NEO, SMX, TET, TMP IncFII, IncP  not tested 180 Tn2
faecal/ indicator 73-30883-3 A1 AMP, SPT, STR, SMX, TET TF (DH10B) bla TEM-1b AMP, SPT, SMX, TET IncFII, IncFIB, IncP  not tested 200 Tn2
faecal/ indicator 73-30615-7 A2 AMP, TET TF (DH10B) bla TEM-1b AMP IncFII, IncR  not tested 130 Tn2
diagnostic 74-12901-2 A1 AMP, CHL, CIP, NAL,NEO, SPT, STR, SMX, TET, TMP TF (DH10B) bla TEM-1b AMP, CHL, NEO, SMX HI1  not tested 105 unknown
diagnostic 74-04083-1 A1 AMP, NEO, STR, SMX, TET, CEF TF (DH10B) bla TEM-1b AMP, AMC, NEO NT  not tested 2 plasmids (180 &  30) Tn2
diagnostic 74-11738-1 D1 AMP, APR, CIP, GEN, NAL, NEO, STR, SMX, TET, [CEF] TF (DH10B) bla TEM-1b AMP, NEO,SMX, TET NT  not tested 105 IS26a (2 kb) 
diagnostic 74-11649-1 A1 AMP, APR, CHL, CIP, GEN, NAL,SPT, STR, SMX, TET TF (DH10B) bla TEM-1b AMP NT  not tested 50 Tn2
diagnostic 74-11493-1 A1 AMP, STR, SMX, TMP, [CEF] TF (DH10B) bla TEM-1b AMP, SMX, TMP NT  not tested 50 unknown
faecal/ indicator 74-30181-3 D2 AMP, NEO, SPE, STR, SMX, TET, TMP TF (DH10B) bla TEM-1b AMP NT  not tested 10 Tn3
faecal/ indicator 74-30182-1 D2 AMP, CHL, SPT, STR, SMX, [CEF] TF (DH10B) bla TEM-1a AMP NT  not tested 10 Tn3  
 
 
 
 
 
 
 
 
Table S3 c. Summary of results for E. coli from poultry (Manuscript II).  
 
Reservoir POULTRY
Species E. coli 
WT WT RFLP  (pMLST types if available) Plasmid Putative element upstrem 
phylotype PFGE Resistances Type of recipient bla TEM allele Resistances associated with Replicon (s) detected Profiles designations correspond  to  size [kb] the bla TEM  gene
wild type (WT)
Strain 
number
relatedness of 
selected WT 
strains
in which the plasmid was 
characterized blaTEM   plasmid
the symbols  used in  Tables 3-5 in the 
manuscript
Selftrasmi
ssibility
faecal/ indicator 7430125-1 A1 AMP TF (GeneHogs ) bla TEM-1b AMP IncI1 t   82 Tn2
faecal/ indicator 7430287-1 A2 AMP TC (K12HEHA4) bla TEM-1b AMP IncI1 t 90 Tn2
faecal/ indicator 7430237-1 A2 AMP TF (GeneHogs ) bla TEM-1b AMP IncI1 t 85 Tn2
faecal/ indicator 7430521-1 B1 AMP, [CEF] TC (MT101) bla TEM-1b AMP IncI1 t_1  (1-2 bands difference) 85 Tn2
faecal/ indicator 7430557-1 A1 AMP TF (GeneHogs ) bla TEM-1b AMP IncI1 t 85 Tn2
faecal/ indicator 7430186-1 A1 AMP TF (GeneHogs ) bla TEM-1b AMP IncI1 t 82 Tn2
faecal/ indicator 7430284-1 A2 AMP, SMX TC (K12HEHA4) bla TEM-1b AMP, SMX IncI1 u_1 104 Tn2
faecal/ indicator 7430605-1 A1 AMP plasmid DNA from  S1-PFGE gel of WT bla TEM-1b Not applicable IncI1 Not applicable 85 Tn2
faecal/ indicator 7430621-1 D AMP, CEF TF (GeneHogs ) bla TEM-1b AMP IncI1 β 82 Tn2
faecal/ indicator 7430641-1 B1 AMP, [CEF] TF (GeneHogs ) bla TEM-1b AMP IncI1 Not readible, possibly similar to  α 85 Tn2
diagnostic 7365811-1 A2 AMP, SMX, STR, SXT, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, SXT, TET, TMP IncI1+ IncP θ 125 Tn2
diagnostic 7275882-1 A2 AMP, AMC, SMX, TET TC (K12HEHA4) bla TEM-1b AMP, AMC IncI1 Not readible 85 Tn2
diagnostic 7370817-2 B1 AMP, SMX, TET TF (GeneHogs ) bla TEM-1b AMP IncI1 t_1  (1-2 bands difference) 85 Tn2
faecal/ indicator 7430256-1 D AMP, TET TF (GeneHogs ) bla TEM-1c AMP, TET IncFII, IncFIB poul1 138 Tn2
diagnostic 7276769-1 D  Xba_7 AMP, TET TF (GeneHogs ) bla TEM-1c AMP, TET IncFII, IncFIB poul2 135 Tn2
diagnostic 7277386-1 D  Xba_7 AMP, [STR], TET plasmid DNA from  S1-PFGE gel of WT bla TEM-1c not applicable IncFII, IncFIB not applicable;  likely poul2] 138 Tn2
diagnostic 7370940-1 A2 AMP, CHL, SMX, STR, SXT, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, CHL, SMX, SXT, TET, TMP IncFII, IncFIB poull3 138 Tn1 
diagnostic 7285398-1 D Xba_8 AMP, SMX, STR, SXT, TET, TMP TC (K12HEHA4) bla TEM-1b AMP, SMX, SXT, TET, TMP IncFII,IncFIB, IncP poul4 138 IS26a (1.3 kb) yes
diagnostic 7279663-1 D Xba_8 AMP, SMX, STR, SXT, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, SXT, TET, TMP IncFII,IncFIB, IncP poul4 130 IS26a (1.3 kb) 
diagnostic 7370888-1 B2 AMP, CHL, SMX, STR, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, CHL, SMX, TET, TMP IncFII,IncFIB, IncP Not readible 138 IS26a (1.3 kb) 
diagnostic 7372121-1 B2 Xba_9 AMP, NEO, SMX, SPT, STR, TET TC (K12HEHA4) bla TEM-1b AMP, NEO, SMX, TET IncN poul5     ST3 45 Tn2 yes
diagnostic 7373304-1 B2 Xba_9 AMP, SMX, [STR], SXT, TET, TMP TC (K12HEHA4) bla TEM-1b AMP, SMX,  SXT, TET, TMP IncN poul5     ST3 45 Tn2 yes
faecal/ indicator 7430280-1 A2 AMP TF (GeneHogs ) bla TEM-1b AMP NT poul6 130 Tn2
diagnostic 7278662-1 not tested AMP, CIP, NAL, SUL, TET No plasmid detected in WT bla TEM-1b not applicable not applicable Not applicable not detected Tn2  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table S3 d. Summary of results for E. coli from humans- faecal (indicator) isolates (Manuscript II). 
 
Reservoir HUMAN FAECAL (INDICATOR)
Species E. coli 
WT PFGE WT Type of recipient bla TEM allele Resistances associated with Replicon (s) RFLP  (pMLST types if available) Plasmid Putative element upstrem 
phylotype relatedness of Resistances bla TEM   plasmid size [kb] the bla TEM  gene  
wild type (WT)
Strain 
number  
selected WT 
strains
in which the plasmid 
was characterized
faecal/ indicator 433-CO2 A AMP TF (GeneHogs ) bla TEM-1a AMP IncB/O p_2 95 Tn3
faecal/ indicator 1231-CO3 B2 AMP TF (GeneHogs ) bla TEM-1b AMP IncB/O n 85 Tn2
faecal/ indicator 97-CO2 B2 AMP, SMX, STR TF (GeneHogs ) bla TEM-1b AMP, SMX IncB/O m_2 95 Tn2
faecal/ indicator 457-CO2 B2 AMP, NEO, SMX, STR, TET TF (GeneHogs ) bla TEM-1b IncB/O, IncP p 110 IS26a (2 kb) & IS26b (0.6 kb)
faecal/ indicator 1084-CO3 B1 AMP, STR, TET TF (GeneHogs ) bla TEM-1b AMP, TET IncK RFLP _inck 66 Tn2
faecal/ indicator 438-CO2 B2 AMP, SMX, STR TF (GeneHogs ) bla TEM-1c AMP, SMX IncB/O m 88 Tn2
faecal/ indicator 1082-CO3 B2 AMP, SMX, STR TF (GeneHogs ) bla TEM-1c AMP, SMX IncB/O m 92 Tn2
faecal/ indicator 1297-CO3 NT AMP, CHL, SMX, STR, TET, TMP TF (GeneHogs ) bla TEM-1g AMP, SMX IncB/O m 70 Tn2
faecal/ indicator 875-CO3 D AMP, AMC, SMX, STR, TMP TF (GeneHogs ) bla TEM-30  AMP, AMC, SMX  IncB/O m 80 Tn2
faecal/ indicator 1307-CO3 B2 AMP, SMX, STR, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, TMP IncFII h 70 IS26a (1.3 kb) 
faecal/ indicator 855-CO3 B2 AMP, AMC, CIP, NAL TF (GeneHogs ) bla TEM-1b AMP, AMC IncFII k 60 Tn2
faecal/ indicator 550-CO2 B2 AMP, AMC, SMX, TMP TF (GeneHogs ) bla TEM-1b AMP, (AMC), (SMX) IncFII, IncFIA, IncFIB not tested 130 Tn2
faecal/ indicator 604-CO2 A AMP, SMX, STR, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, TET, TMP IncFII, IncFIB, IncP not tested 90 IS26a (2  kb) 
faecal/ indicator 955-CO3 D AMP, TET TF (GeneHogs ) bla TEM-1b AMP, TET IncFII, IncFIB not tested 155 IS26b (1.2 kb) 
faecal/ indicator 785-CO3 D AMP, CHL, SMX, STR, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, TET, TMP, CHL IncFII, IncFIB not tested 175 Tn2
faecal/ indicator 190-CO2 B2 AMP, TET TF (GeneHogs ) bla TEM-1c AMP, TET IncFII, IncFIB not tested 130 Tn2
faecal/ indicator 982-CO3 B2 AMP, TET TF (GeneHogs ) bla TEM-1c AMP, TET IncFII, IncFIB not tested 135 Tn2
faecal/ indicator 904-CO3 B1 AMP, AMC, SMX, STR, TET, TMP TF (GeneHogs ) bla TEM-1 j AMP, AMC, SMX, TET, TMP IncFII, IncFIB not tested 150 Tn2
faecal/ indicator 862-CO3 D AMP, AMC TF (GeneHogs ) bla TEM-1d AMP, AMC IncFII, IncFIB not tested 85 Tn1
faecal/ indicator 257-CO2 D AMP, AMC, SMX, STR, TMP TF (GeneHogs ) bla TEM-40 AMP, AMC, SMX, TMP IncFIB not tested 75 IS26b (1 kb) 
faecal/ indicator 545-CO2 D AMP, SMX, TET, TMP TF (GeneHogs ) bla TEM-1c AMP, SMX, TET, TMP IncI1 w_1 105 Tn2
faecal/ indicator 1341-CO3 NT AMP TF (GeneHogs ) bla TEM-1b AMP IncI1 t 85 Tn2
faecal/ indicator 1033-CO3 NT AMP, SMX TF (GeneHogs ) bla TEM-1b AMP, SMX IncI1 u 100 Tn2
faecal/ indicator 1112-CO3 A AMP, SMX, TET, TMP TF (GeneHogs ) bla TEM-135  AMP, SMX, TMP IncI1 u_2 104 Tn2
faecal/ indicator 1336-CO3 A AMP, AMC, SMX, STR TF (GeneHogs ) bla TEM-1b AMP, AMC NT not tested 180 Tn2
faecal/ indicator 1308-CO3 B2 AMP, AMC, SMX, STR, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, AMC, SMX, TET, TMP IncN not tested/   ST6 58 Tn2
faecal/ indicator 1413-CO3 NT AMP, NEO, SMX, STR, TET TF (GeneHogs ) bla TEM-1a AMP IncX1A not tested 45 Tn3
faecal/ indicator 1437-CO3 NT AMP, CHL, SMX, STR, TET
Not applicable; no pl. 
detected in WT bla TEM-1b not applicable not applicable not applicable not applicable IS26a (2  kb) 
faecal/ indicator 924-CO3 B1 AMP, SMX, STR TF (GeneHogs ) bla TEM-1b AMP NT not tested 35 Tn2
faecal/ indicator 399-CO2 B2 AMP TF (GeneHogs ) bla TEM-1c AMP NT not tested 40 Tn2
faecal/ indicator 564-CO2 B2 AMP, SMX, SPE, STR, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX NT not tested 50 Tn2  
 
 
 
 
 
 
 
 
 
Table S3 e. Summary of results for E. coli from humans- clinical isolates (Manuscript II). 
 
Reservoir HUMAN CLINICAL
Species E. coli 
WT WT Type of recipient bla TEM allele Resistances associated with Replicon (s) RFLP  (pMLST types if available) Plasmid Putative element upstrem 
phylotype PFGE Resistances in which the blaTEM   plasmid Profiles designations correspond  to  size [kb] the bla TEM  gene
wild type (WT)
Strain 
number  
relatedness of WT 
strains
plasmid was 
characterized
the symbols used in  Tables 3-5 in the 
manuscript product size is specified in kb)
clinical 2001-37255 A AMP, STR, SMX, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, TET, TMP IncB/O, IncP p 125 IS26a (2 kb) & IS26b (0.6 kb)
clinical 2001-131351 A AMP, STR, SMX, TET TF (GeneHogs ) bla TEM-1b AMP, SMX, TET IncB/O, IncP p 110 IS26a (2 kb) & IS26b (0.6 kb)
clinical 2001-25022 D AMP, STR, SMX TF (GeneHogs ) bla TEM-1c AMP, SMX IncB/O m_4 90 Tn2
clinical 2002-50 D AMP, SPT, STR, SMX, TET, TMP TF (GeneHogs ) bla TEM-1c AMP, SMX, SPT IncB/O m 80 Tn2
clinical 2002-14946 B2 Xba_ possibly rel.10 AMP, CIP, NAL, STR, SMX TF (GeneHogs ) bla TEM-1c AMP, SMX IncB/O m_2 80 Tn2
clinical 2002-110474 B2 AMP, STR, SMX TF (GeneHogs ) bla TEM-1c AMP, SMX IncB/O m_1 70 Tn2
clinical 2000-37030 A AMC, AMP, NEO, STR, SMX, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, TMP, NEO IncFII, IncFIB not tested 142 IS26a (2 kb) 
clinical 2000-128256 B2 Xba_possibly rel.11 AMP, STR, SMX, TET TF (GeneHogs ) bla TEM-1b AMP, SMX IncFII, IncFIB not tested 145 IS26b (0.6 kb)
clinical 2002-61144 B2 Xba_possibly rel.11 AMC, AMP, CIP, STR, SMX, TET TF (GeneHogs ) bla TEM-1b AMP, SMX IncFII, IncFIB not tested 153 IS26b (0.6 kb)
clinical 2002-121167 D AMC, AMP, STR, SMX TF (GeneHogs ) bla TEM-1b AMP, AMC(I), SMX IncFII, IncFIB not tested 155 IS26a (2 kb) 
clinical 2000-2592 A AMP, AMC, STR, SMX, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, AMC, SMX, TET, TMP IncFII, IncFIB not tested 110 Tn2
clinical 2000-90435 B2 AMP, TET TF (GeneHogs ) bla TEM-1b AMP, TET IncFII, IncFIB not tested 112 Tn2
clinical 2002-94787 B2 AMC, AMP, TET TF (GeneHogs ) bla TEM-1c AMP, TET IncFII, IncFIB not tested 125 Tn2
clinical 2001-93504 A AMP, TET TF (GeneHogs ) bla TEM-1c AMP, TET IncFII, IncFIB not tested 130 Tn2
clinical 2001-118896 B2 AMP, SPT, SMX, TET, TMP TF (GeneHogs ) bla TEM-1a AMP, SMX, TET, TMP, SPT IncFII, IncFIB, IncP not tested 145 Tn3
clinical 2001-1662 B2 AMC, AMP, CHL, TET, TMP TF (GeneHogs ) bla TEM-1d AMP, TMP, CHL, TET IncFII, IncFIB, IncFIA not tested 92 unknown
clinical 2002-48269 D AMC, AMP, STR, SMX, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, AMC, SMX, TET, TMP IncFIB, IncY not tested 225 IS26a (2 kb) 
clinical 2001-49440 D AMP, CIP, NAL, STR, SMX, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, TMP IncFII g              ST   FII2 64 IS26a (1.3 kb) 
clinical 2001-59632 B2 AMP, CIP, GEN, STR, SMX TF (GeneHogs ) bla TEM-1b AMP, SMX, (GEN) IncFII i 70 IS26a (1.3 kb) 
clinical 2001-106784 B2 AMP TF (GeneHogs ) bla TEM-1a AMP IncFII j 70 Tn3
clinical 2002-37995 D AMC, AMP, STR, SMX, TMP TF (GeneHogs ) bla TEM-1b AMP,SMX, TMP IncFII g 65 IS26a (1.3 kb) 
clinical 2002-134976 B2 AMP, STR, SMX TF (GeneHogs ) bla TEM-1b AMP, SMX IncFII g _ 1       ST FII2 60 IS26a (1.3 kb) 
clinical 2002-70903 non-typeable AMP, STR, SMX, TET, TMP TF (GeneHogs ) bla TEM-1b AMP, SMX, TET, TMP IncI1, IncP w 120 IS26a (2 kb) & IS26b (0.6 kb)
clinical 2000-14183 D AMC, AMP, APR, GEN, SPE, STR, SMX TF (GeneHogs ) bla TEM-1a AMP, AMC, APR(I), SPT(I) [ColE1*  -possibly the small pl.] not tested  possibly 2 pl. (20 kb; 4 kb) Tn3
clinical 2001-71294 D AMC, AMP, CHL, SPE, STR, SMX TF (GeneHogs ) bla TEM-1b AMP, (AMC), (SMX) [ColE1* -possibly the small pl.] not tested  possibly 2 pl. (30 kb; 4 kb) Tn2
clinical 2000-103495 D AMC, AMP, GEN, STR TF (GeneHogs ) bla TEM-1c/1d AMP, AMC, GEN NT not tested 82 Tn3
clinical 2001-13567 B2 AMC, AMP TF (GeneHogs ) bla TEM-1a AMP NT not tested  possibly 2 pl. (30 kb; 9 kb ) Tn3
clinical 2000-27668 B2 Xba_ possibly rel.10 AMC, AMP, SMX, TMP TF (GeneHogs ) bla TEM-1c AMP, (AMC), SMX NT not tested  possibly 2 pl. (30 kb; 8  kb) Tn2
clinical 2000-49043 B2 AMC, AMP, SMX, TET, TMP TF (GeneHogs ) bla TEM-1c AMP, AMC NT not tested  possibly 2 pl. (30 kb; 8 kb) Tn2
clinical 2000-78651 B2 AMP, STR, SMX TF (GeneHogs ) bla TEM-1c AMP NT not tested  possibly 2 pl. (30 kb; 9 kb) Tn2
clinical 2002-27242 B2 AMP, CHL, STR, SMX, TET TF (GeneHogs ) bla TEM-1b bla TEM-1  non transferable not applicable not applicable not applicable [WT tested - IS26a (0.4 kb) ]  
* ColE1 PCR (Garcia –Fernandez et al. 2009) was performed additionally on some of the transformants after the preparation of Manuscript II; the TFs that produced positive signals were suspected to harbour more than one plasmids and 
therefore further verification is needed to determine which of the plasmid harbours the blaTEM-1 gene and which of the plasmids in the ColE1 type; the plasmids with blaTEM-1 genes in Manuscript II from these TFs were designated as 
non-typable. 
 
 
 
 
S4. Supplementary data  
RFLP analysis of IncFII plasmids from humans, cattle and pigs.  
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Figures 1 a and b. The HincII digestions of plasmids harbouring no other than IncFII 
replicons from human isolates (a) and analysis with BioNumerics software (b). M stands for 
1 kb extended DNA ladder (Invitrogen). 
 
 
 
 
  
 
Figure 2. HincII digestions of selected IncF-family plasmids from cattle isolates. M, 1 kb 
extended DNA ladder (Invitrogen). 
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Figure 2 a . Analyses of HincII digestions of selected IncF-family plasmids from cattle 
isolates with the use of BioNumerics. 
 
 
 
 
 
   
 
Figure 3. EcoRV digestions od IncFII plasmids from pigs and representative IncFII plasmids 
from humans and cattle. IncFIB plasmid from 74-13209-1TF (cattle) was included to test the 
DNA extraction; M, 1 kb extended DNA ladder (Invitrogen). 
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Figure 3a . Analysis of the RFLP profiles from Figure 6 with the use of BioNumerics.  
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HincII digestions of selected plasmids with multiple IncF-type replicons 
 
 
 
 
  
Figure 4. HincII digestions of IncFII& IncFIB plasmids from cattle; plasmid p74-13300-1 
harboured also IncP replicon; x- lane not analysed; M, 1kb extended ladder (Invitrogen) 
 
RFLP analysis of plasmids with IncB/O replicons, IncB/O & IncP and IncK from humans, 
pigs and cattle.  
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Figures 5 a and b. BamHI digestions of the IncB/O and IncB/O & IncP blaTEM-1 plasmids 
from selected pig isolates and cattle isolates; M stands for 1 kb extended DNA ladder 
(Invitrogen). 
 
The fingerprints of the IncB/O plasmid p74-13196-1, IncB/O & IncP plasmids p74-30014-3, 
p74-12865-1  and p74-12894-1 have been additionaly digested with HincII enzyme (Figure 
5c below). 
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Figure 5 c. HincII digestion of IncB/O and IncP plasmids isolated from cattle. 
 
 
 
 
 
 
 
Figure 6.BamHI digestion of selected IncB/O, IncB/O & IncP and IncK plasmids from 
humans and from cattle; M stands for 1 kb extended DNA ladder (Invitrogen). Plasmid 
p2002-70903 (IncI1 & IncP) was also included in the analysis due to the presence of IncP  
replicon. 
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Figure 6a. Analysis of the RFLP fingerprints from Figure 2 with the use of BioNumerics 
software.  
 
 
 
 
 
 
 
 
Figure 7. BamHI digestion of selected IncB/O, IncB/O & IncP and IncK plasmids from 
cattle, pigs and humans. Two different volumes of DNA purifications  from the same 
plasmids from cattle were digested (indicated with ’a’ and ’b’ next to the strains names), X 
referes to the mistake at this position and this band was not included in the analysis; M stands 
for 1 kb extended DNA ladder (Invitrogen). 
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Figure 7a. Analysis of the RFLP fingerprints from the figure 3 with the use of BioNumerics.  
 
 
HincII and EcoRV digestions of IncI1 plasmids. 
 
 
 
                               
 
Figure 8. HincII digestion of selected IncI1 plasmids from poultry. Plasmids p7370817-2, 
p7430521 produced undistinguishable RFLP profiles and p7430125-1 seemed to be closely 
related to these two (2 bands difference). 
 
  
 
Figure 9. EcoRV digestions of selected IncI1 and IncI1 toghether with IncP plasmids. 
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Figure 9a. Analysis of EcoRV digestions of selected IncI1 and IncI1 toghether with IncP 
plasmids from Figure 7a in BioNumerics. 
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Abstract 
Klebsiella pneumoniae is a common opportunistic pathogen of humans. Plasmids found in 
this species can be platforms harbouring genes encoding resistance to antimicrobials and 
virulence factors.  The objective was to compare the diversity of plasmids found in 
K. pneumoniae from human infections and from the environment. Novel multiplex PCR 
(mPCR) was designed in order to detect broader spectrum of plasmids that are currently non- 
typable (NT) by the available PCR-based replicon typing methods (PBRT). Sequenced 
replicons of plasmids from K. pneumoniae available in public databases were first collected 
and aligned with each other. Based on these alignments the rep genes (encoding replicases) 
were grouped according to the similarities; eight homology groups (designated with numbers 
from repI to repVIII) were defined for these genes. The mPCR was designed to target seven 
of these groups (repI to repVII). Group repVIII comprised of the IncN replicases targeted by 
the PBRT. 
Plasmids from a collection of K. pneumoniae bacteraemia (n=20), urinary tract infections 
(n=20) and surface waters (n=10) isolates were then typed by means of the novel mPCR and 
by the PBRT methods. N=67 individual plasmids (≥30 kb) were retrieved and typed. 
Replicases from repI, -III and -IV groups were most often observed on the plasmids from  the 
tested collection. Often the classical IncFII, IncFIIk, IncR replicons and also NT - replicons 
were found on the plasmids with the diverse replicases belonging to repI-VII groups. 
Differences in distribution of replicases were observed between plasmids originating from the 
human and environmental reservoirs. A higher ratio of repIII, repIV and NT plasmids was 
found in the blood-stream isolates; repIV and repV appeared to be characteristic for plasmids 
from the environmental isolates. Moreover, the repIV-type replicase may constitute a novel 
replicon related to the classical IncFIB and IncFIA.  
The novel mPCR method proved to be an efficient tool for replicase typing and also to 
deliver accessory information about the replicons when applied together with the standard 
PBRT methods.  
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1. Introduction 
Klebsiella pneumoniae is a member of the family Enterobacteriaceae. It is commonly found 
in natural environments but may also cause infections typically in the immune-compromised 
individuals (Stahlhut et al., 2009). Among others urinary and respiratory tract infections and 
also life threatening infections like liver abscess, meningitis and sepsis are reported in 
humans (Chen et al., 2004; Chen et al., 2006; Chen et al., 2007b; Gootz et al., 2009; Jiang et 
al., 2010; Leavitt et al., 2010; Soler Bistue et al., 2008; Wu et al., 2009; Zhao et al., 2010). 
Plasmids often contribute to virulence of K. pneumoniae by encoding a range of virulence 
factors, most common examples being iron sequestering systems, adhesins and 
phospholipases (Chen et al., 2004; Gootz et al., 2009; Wu et al., 2009). Moreover, many of 
the plasmids found in K. pneumoniae harbours genes encoding resistances to antimicrobials 
and also to heavy metals which increases the capabilities of this bacterium to survive in the 
diverse niches (Chen et al., 2004; Chen et al., 2006; Gootz et al., 2009; Jiang et al., 2010; 
Zhao et al., 2010).  Studying the epidemiological relationships of the K. pneumoniae 
plasmids is therefore of high importance in order to obtain more detailed overview of the 
mobile genetic elements driving the transmission of the resistance and virulence genes in this 
species. 
Plasmids tend to have modular structures and the modules encoding the replication and the 
control of replication functions are together termed replicons (Carattoli et al., 2005). Replicon 
is an indispensable part of plasmid backbone therefore it constitutes a good target for 
epidemiological studies (Carattoli et al., 2005). It has been shown that two plasmids sharing 
similar replicons often could not be stably maintained in the same cells without the external 
selection against them. Such replicons were designated as incompatible and classified to the 
same incompatibility (Inc) groups (Carattoli et al., 2005). Currently there are more than 27 
Inc groups recognized in Enterobacteriaceae. PCR-based replicon typing (PBRT) methods 
are available for rapid detection and classification of plasmids representing the most 
commonly encountered Inc groups (Carattoli et al., 2005; Garcia-Fernandez et al., 2009; Villa 
et al., 2010). The PBRT targets the key incompatibility determinants found on plasmids. 
These targets are i) the replication control elements encoding antisense RNAs found on 
IncFII, IncFII variants (FIIk, -s -y), IncI1, IncB/O and IncK replicons ii) iterons (IncFIA, IncP, 
IncHI2) iii) genes encoding partition functions (IncHI1) iv) origins of replication (IncX2) and 
v) the rep genes encoding replicases (IncL/M, IncN, IncFIB, IncFIC, IncA/C, IncT, IncW, 
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IncY, IncR) (Carattoli et al., 2005; Garcia-Fernandez et al., 2009; Praszkier et al., 1991; Villa 
et al., 2010). 
In previous studies mainly the IncFII related replicons (RepFIIA) and also IncA/C, IncN, 
IncL/M and IncR replions were detected on the diverse resistance plasmids from 
K. pneumoniae (Andrade et al., 2011; Athanasopoulos et al., 1995; Carattoli et al., 2010; 
Ktari et al., 2011; Mataseje et al., 2011; Zhu et al., 2009). We noticed that the previously 
sequenced strain of K. pneumoniae MGH78578  harboured multiple IncFIIk plasmids (Villa 
et al., 2010). However, these plasmids encoded different secondary replication initiator 
proteins (replicases). These additional replicons possibly enabled the plasmids to overcome 
the incompatibility phenomenon. We further noticed that many of the sequenced plasmids 
from K. pneumoniae deposited in GenBank share a similar rep sequence coding for a 
replicase that could not be assigned to any of the known incompatibility groups. This 
replicase is also found as a part of independent replicons on plasmids pCK41 from 
Edwardsiella tarda (HQ332785) and pSC138 from Salmonella enterica (AY509004; Chiu et 
al., 2005). Moreover, the latter replicons share similarities with the classical IncFIB and 
IncFIA replicons found on plasmids form E. coli (according to analysis performed in this 
study). Plasmid pKP187 from K. pneumoniae Kp342 harbours this IncFIA/FIB –like 
replicase as well as another replicon encoding the RepB2 initiator protein. None of these two 
replicons of pKP187 would be detected by the currently available PCR based methods for 
plasmid replicon typing (PBRT) (Carattoli et al., 2005; Villa et al., 2010). 
As the PBRT targets diverse elements of the plasmid replicons we decided to design a 
multiplex PCR method (mPCR) targeting the diverse rep sequences of the plasmids from 
K. pneumoniea. Among others the secondary replicases of the aforementioned IncFIIk 
plasmids from K. pneumoniae MGH78578 and the two replicases of pKP187 were included 
as targets in the mPCR. We observed that the majority of the fully sequenced plasmids 
smaller than 30 kb and originating from K. pneumoniae belonged to the promiscuous ColE1 
family (Cao et al., 2002; Gootz et al., 2009; Riley et al., 2001; Sarno et al., 2002; Zhu et al., 
2009; Zioga et al., 2009). Therefore the mPCR was designed mainly to detect replicases of 
the large plasmids.  
The aim of this study was to access the diversity of plasmids in K. pneumoniae from human 
infections and from the environment not selected based on the resistance markers. This was 
done by typing of plasmids from a collection of previously published K. pneumoniae isolates 
from both human infections and from surface waters (Stahlhut et al., 2009) by the standard 
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PBRT and by the above described novel mPCR. The mPCR allowed for detection of diverse 
replicases found on plasmids that may simultaneously carry classical incompatibility 
determinants other than the replicase. 
The in silico analysis in combination with the results of plasmid typing performed in vitro 
enabled us to draw conclusions whether the K. pneumoniae causing infections in humans 
harbour similar range of plasmids as the isolates from the natural environments. Additionally, 
we deliver the new mPCR method developed to detect and characterize plasmids which 
replicons would not be detected by means of the other so far available PBRT schemes. 
 
2. Materials and methods 
2.1 Designing of the mPCR 
All work involving DNA sequence editing and analysis was performed using Vector NTI Suit 
11 (Invitrogen, Inc.). Sequences of all known plasmid replicons (except the ColE1 replicons) 
from K. pneumoniae available in public databases (ACLAME, GenBank
®
) were collected. 
These sequences were aligned with each other. Based on these alignments eight homology 
groups were defined for the genes encoding a version of the replication initiation protein 
(repA, -A2 -B, -B2 and –E etc.). These homology groups were designated as repI, -II, -III, -
IV, -V, -VI, -VII, -VIII (Table 1). Additionally, primers available for replicon typing of 
plasmids belonging to currently recognized incompatibility groups in Enterobacteriaceae 
(Carattoli et al., 2005; Garcia-Fernandez et al., 2009; Villa et al., 2010) were blasted against 
the sequenced replicons retrieved from the public databases. This allowed us to determine in 
silico the presence of other classical incompatibility determinants on these sequenced plasmid 
replicons.  
Replicases belonging to the six of the aforementioned groups (repI, -II, -III, -IV, -V, -VI) 
turned out not to be included as targets in any of the previously published PBRT PCRs. 
Although, a pattern was observed that the repI on the majority of sequenced plasmids 
corresponded the repFIIk (on these replicons the copB gene, not the replicase repAFIIk gene, 
is targeted by the PBRT), while repIII typically corresponded to the repFIA (the iterons of 
IncFIA replicons are targeted by the PBRT).  
As expected, some of the previously sequenced replicons or full plasmids with the diverse 
combinations of the replicases from repI-repVII groups also harboured the classical 
incompatibility determinants (Table 1). Namely two groups, repVII and repVIII corresponded 
to replicases of IncR and IncN type replicons, respectively. These two rep sequences, repR 
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and the repN are targeted by the standard PBRT(Carattoli et al., 2005; Garcia-Fernandez et 
al., 2009). The IncN family is reviewed elsewhere therefore these IncN plasmids were not 
included in the mPCR design (Table 1; Chen et al., 2007b; Garcia-Fernandez et al., 2011; 
Gootz et al., 2009). None of the previously published studies focused on the IncR plasmids. 
In order to learn more about the distribution of this group of replicons the repVII replicases 
have been also incorporated as targets into the mPCR. The position of the target for repVII 
PCR compared to the segment of the IncR replicon targeted by PBRT is indicated on the 
Figure 1 (generated with the use of sequences previously described by Osborn et al., 2000; 
Petty et al., 2010; Zhao and Dang, 2011).  
The sequences of the replicases of repI –repVII (repVIII excluded) were BLASTed against 
GenBank database in order to identify similar sequences originating from hosts other than 
K. pneumoniae and which would be likely detected by the primers used in the mPCR. The 
following plasmids with repIII type sequences were retrieved: pHCM1/ IncHI1 from 
S. enterica (Parkhill et al., 2001), pEK499/ IncFII, -FIA from E. coli  (Woodford et al., 
2009), pRSB10/ IncFII, -FIB from an unspecified environmental species (Szczepanowski et 
al., 2005), pEC_L8/IncFII, -FIB and  pEC_L46/ IncFII, -FIA, -N from E. coli (Smet et al., 
2010) and pU302L/ IncFIA, -FIB from S. enterica  (Chen et al., 2007a). The following 
plasmids from species other than K. pneumoniae and with repIV type replicases were 
retrieved: pSA1 from S. enterica (Mulec et al., 2002) and pECL_A EC from Enterobacter 
cloacae  (Ren et al., 2010); and with repVII (IncR): pEFER from Escherichia fergusonii 
(CU928144), pLV1403 from Pantoea agglomerans (Osborn et al., 2000) and pK727 from 
E. coli (Bielak et al., 2011). These plasmids are also indicated in the Table 1. 
For seven of the rep groups specific primer pairs were designed to be used in the 
corresponding seven simplex PCR reactions targeting respectively the repI, - II, -III, -IV, V, -
VI and -VII of plasmids listed in the Table 1. Primer sequences, the rep targets on the 
reference plasmids and the expected PCR product sizes are listed in Table 2. Primers from the 
simplex PCRs were further combined and used in the mPCR.  
Some of the replicases found on plasmids from K. pneumoniae could not be allocated to any 
of the eight groups Our in silico analysis indicated that other targets on plasmids with these 
remaining replicases can still be detected either by the standard PBRT or by PCR targeting 
the repIV-type sequences (Table 1).   
 
2.3 Bacterial strains and positive controls 
7 
 
Three strains with previously sequenced plasmids were used as positive controls for the 
simplex and then for the mPCRs described in the preceding subsection. E. coli HB101 
transconjugant with plasmid pMET1 kindly provided by Marcelo Tomalsky (California State 
University) was used as control for repII;  pMET1 was originally isolated from 
K. pneumoniae strain from human infection (Soler Bistue et al., 2008). K. pneumoniae Kp342 
with plasmids pKP91 and pKP187 was used as a control for repI, repIII, repIV and repV 
(Fouts et al., 2008). K. pneumoniae MGH78578 harbouring pKPN3, pKPN4 and pKPN5 was 
used as control for repI, repIV, repVI and repVII (Stahlhut et al., 2009). These two strains 
originated from a plant (Kp342) and from human infection (MGH78578), respectively. 
Associations of the repI-VII groups with the each of the individual reference plasmids are 
indicated in Table 1. 
Plasmids from previously published collection of fifty K. pneumoniae strains (Stahlhut et al., 
2009) were further typed by the novel mPCR and by the classical PBRT methods (Carattoli et 
al., 2005; Garcia-Fernandez et al., 2009; Villa et al., 2010). The strains were isolates from 
diverse reservoirs, namely natural surface waters (Germany, n=10), urinary tract infections 
(Denmark, n=19 and USA, n=1) and blood infections (Denmark, n=20). Strains were isolated 
in the period from 1992 to 2006 as described  in (Stahlhut et al., 2009). 
2.4 Verification of plasmids’ sizes and number per strain 
Presence and sizes of the large plasmids were verified for all strains by means of S1-PFGE 
(suitable primarily for detection of plasmids larger than 30 kb; (Barton et al., 1995); the 
running conditions were as described previously by (Bielak et al., 2011).Presence of plasmids 
smaller than 30 kb was verified by extracting plasmidic DNA using QIAprep Spin Miniprep 
Kit (Qiagen) according to manufacturer’s instructions. These plasmid purifications were 
subjected to electrophoresis at the following conditions: 0.8% agarose gel (SeaKem 
Agarose/Lonza) at 45V for 19 h. DNA was visualised by the standard ethydium bromide 
staining method.  
2.5 Running conditions for the novel mPCR 
The following conditions were applied both in the simplex PCR reactions targeting the repI-
VII groups and for the mPCR: initialization step for 5 min. at 94°C followed by 25 cycles of 
i) denaturation for 15 s at 94 °C ii) annealing for 15 s at 55 °C iii) extension step for 60 s at 
72 °C and final elongation step for 5 min. at 72 °C. DreamTaqTEM Green Polymerase 
Master Mix (Fermentas) was used according to manufacturer’s instructions. Concentration of 
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each primer used per reaction was 0.5 µM in all of the seven simplex PCR reactions and then 
in the multiplex PCR set-up. 
Results of the multiplex PCR were visualized on 1.8 % agarose gel (LA Agarose/ Lonza) 
after electrophoresis for minimum 1h at 130V and subsequent standard staining in ethydium 
bromide. 
2.6 DNA templates 
Boiled lysates from the wild type strains were used as DNA templates for initial testing of the 
control strains and then for typing of the K. pneumoniae collection containing the unknown 
plasmids. Whenever possible, the individual bands representing the plasmids were extracted 
from the agarose gels produced  either in S1-PFGE or in electrophoresis performed to 
visualised the smaller plasmids (<30 kb). The extracted plasmidic DNA was purified on GFX 
columns (Amersham) according to manufacturer’s instructions. This procedure was 
performed for all wild type strains in which at least one plasmid was detected. These GFX 
purifications were used as templates for both the mPCR and then the classical PBRT in order 
to assign specific rep types and the classical incompatibility determinants to individual 
plasmids.  
 
2.7 Typing of a collection of K. pneumoniae isolates from diverse reservoirs 
Initially the simplex and later the multiplex PCR were performed on the three control strains 
listed above containing the reference plasmids (Fouts et al., 2008; Soler Bistue et al., 2008). 
To verify the utility of the DNA templates extracted from the agarose gels as described in the 
previous subsection the individual reference plasmids were extracted using the same method. 
The mPCR was performed on these plasmids in order to verify the specificity of this novel 
method.  
Subsequently, a collection of fifty K. pneumoniae isolates underwent the typing using the 
described method. After initial typing of the wild type strains from the collection, typing with 
the novel method was further performed on the individual plasmids extracted to assign 
specific rep groups to each of the plasmids. 
Further, all the wild type strains in which at least one large plasmid (≥30 kb) was detected 
underwent the classical PBRT as described by (Carattoli et al., 2005; Garcia-Fernandez et al., 
2009; Villa et al., 2010). If necessary, the individual plasmids were also subjected to the 
screening with the use of the classical PBRT methods. 
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2.8 Sequencing of the selected targets 
Only few sequences of plasmids with no other than the repIV type replicon (pCK41, pSC138) 
or harbouring the repV replicon (pKP187; harbours repIV & repV) are currently deposited in 
GenBank. Therefore the repIV and repV PCR products from the selected plasmids that 
produced positive signals to these repIV and repV replicases were sequenced by the standard 
capillary sequencing method (Macrogen Inc., Korea). 
 
 
 
3. Results  
3.1 Development of the novel mPCR method for replicase typing 
In order to detect replicases of group repI to repVII in vitro rather than in silico, a multiplex 
PCR was developed and tested on a set comprising of three control strains (K. pneumoniae 
Kp342 and MGH78578 and E. coli HB101 transconjugant) containing plasmids covering all 
seven replicon groups. Initially, the control strains underwent the S1-PFGE. In K. 
pneumoniae Kp342 two plasmids of approximate sizes 190 kb and 90 kb were detected, 
corresponding to the reported sizes of pKP187 (187 kb) and pKP91 (91 kb), respectively; in 
K. pneumoniae MGH78578 three large plasmids were detected of the following approximate 
sizes: 175kb, 110 kb, 90 kb corresponding respectively to pKPN3 (175 kb), pKPN4 (107 kb), 
pKPN5 (87 kb). E. coli HB101 transconjugant was confirmed to harbour a plasmid sized to 
40 kb corresponding to the pMET1 (42 kb).  
Positive and correctly sized PCR products were observed in the seven simplex PCRs and in 
the mPCR performed initially on the boiled lysates from K. pneumoniae Kp342, K. 
pneumoniae MGH78578 and E. coli HB101/pMET1. For each of the individual plasmids 
extracted from the aforementioned control strains the products observed in the mPCR 
corresponded well with the results predicted by in silico analysis of the plasmid sequences 
(Table 1). The pKP187 produced positive signals to repIV and repV; pKP91 was positive to 
repI & repIII, pKPN3 was positive to repI & repIV replicases; pKPN4 produced signals to 
repI & repVI and pKPN5 was positive to repVII. The 40 kb plasmid from E. coli HB101 
(pMET1) produced positive signal to the repII replicase. No other replicase types than the 
aforementioned ones were detected in the mPCR on these reference plasmids. 
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3.2 Typing of plasmids from K. pneumoniae clinical and environmental isolates by the 
novel mPCR approach and by the classical PBRT methods  
Fifty isolates of K. pneumoniae underwent the described mPCR as well as the standard PBRT 
methods available for replicon typing. Furthermore, individual plasmids, if detected, were 
isolated from the agarose gels and replicon typing was performed on these using the same 
PCR schemes as for testing of the wild type isolates. The summary of the results is presented 
in the Table 3. Detailed results of S1 PFGE, PBRT and the mPCR performed on the wild type 
strains are listed in the Table S1 (supplementary material). 
In nine isolates no plasmid was detected by any of the applied methods, while in one isolate 
the only plasmid detected was 3.8 kb in size (Sp33, blood-stream isolate). The plasmid free 
isolates originated from blood (n=5), surface waters (n= 3) and urinary tract infection (n=1). 
These ten isolates did not produce a positive signal in the any of the tested PCR schemes. 
In the remaining strains a total of n=118 individual plasmids of various sizes were detected 
by S1 PFGE. Among these n=67 were large plasmids ≥30 kb in size. Four of the detected 
plasmids were of an intermediate range of size, from 23≤ to < 30 kb. The remaining n=47 
plasmids detected were smaller than 18 kb. The intermediate size and the small plasmids did 
not produce a PCR signal neither in the mPCR nor in the classical PBRT tested in this study 
(for details see Table S1).  
 
3.2.1 Plasmids carrying two replicases, repI and repIV  
Twenty- two large plasmids tested in the mPCR produced signal to the combination of repI 
and repIV (UTI, n=16; bloodstream isolates, n=4; isolates from surface waters, n=2). All of 
these repI,-IV positive plasmids except one gave also a positive signal for FIIk type replicon 
(85 kb plasmid from UTI isolate Cas671 harboured IncFII determinant); two plasmids from 
isolate Cas681 (UTI isolate; plasmids sized to 220kb and 85 kb) produced additionally 
positive signals for the IncFII determinant. Overall, the repI,-IV, FIIk plasmids fell into the 
size range of 85 kb to 230 kb.  
 
3.2.2 Plasmids producing signal for no other than repIV type replicase 
Eleven of the individually tested plasmids produced a signal in the mPCR for no other than 
repIV group (UTI, n=5; bloodstream isolates, n=3; water isolates, n=3). Overall, these repIV 
type plasmids fell into the size range from 33 kb to 230 kb. Three of these plasmids appeared 
positive for the FIIk incompatibility determinant (plasmids sized from 180kb to 229 kb and 
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located in strains C3091, Cas664 and Cas674; UTI isolates). One of the repIV positive 
plasmids was found to carry the FII determinant (100 kb, Cas681; UTI isolate).  
In the remaining (n=7) cases the repIV positive plasmids did not produce positive PCR 
signals for any of the classical incompatibility determinants tested. These plasmids represent 
the group that would possibly remain undetected if screening was performed only by means 
of the classical PBRT methods.  
 
 
 
3.2.3 Plasmids producing signal to individual repI, -IV, - VI or –VII(IncR) replicases; or 
diverse combinations of these 
The following other combinations of replicons were observed on five large plasmids based on 
the positive PCR results. In Cas673 the 121 kb plasmid harboured repVII(IncR) & FIIk  
replicons; in  Cas119 a 128 kb plasmid harboured repI, -VII(IncR) & IncFIIk replicon; in 
Cas664 a 68 kb plasmid produced signals to repIII , -VII(IncR)  replicases; two plasmids sized 
to 267 kb (Cas664) and 87 kb (Cas669) produced signals to the combination of three 
replicases repIII, -IV, -VII(IncR)  & FIIk determinant.  
Three large plasmids sized to 95 kb (Sp15), 123 kb (Sp15) and 103 kb (Cas122) produced 
positive signals to repIII replicases in the novel mPCR.  The 95 kb and the 103 kb plasmids 
repIII plasmids were also positive to FII and FIIk, respectively.  
Single cases were found of the large plasmids that produced signals in the mPCR to the 
individual replicases of repI type (68kb plasmid from Cas673, positive also to both FII and 
FIIk), repV type (377 kb plasmid from Cas122) and repVI (112 kb plasmid from Sp13, 
positive also to FIIk).  
Otherwise the following combinations of replicases were also detected on the tested 
plasmids: repI, -III, -IV & IncFII (298 kb plasmid from Sp20) and repI, -III, -IV & IncFIIk 
(180kb plasmid from Sp22) ; repI, -IV, -VI & IncFIIk ( 170 and 174 kb plasmids from Sp34 
and Sp41, respectively); repIII, -IV ( 92 kb, 142 kb and 153 kb plasmids located in Sp20) and 
repIV,-V (244 kb plasmid located in Cas127).  
3.2.4 Sequencing of the selected replicases 
The single plasmid in Sp30 (33 kb) and the largest of the three plasmids in Sp10 (113 kb) 
produced signals to no other than repIV PCR. These two products were sequenced. The repIV 
of the plasmid from Sp10 shared 99% identity with the repA sequence of pCK41 
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(HQ332785); the repIV of the plasmid from Sp30 shared 99% identity with pKCTC2242 
(CP002911); both sequences shared from 90% to 98% similarity to the repA of the reference 
plasmid pKPN3 (CP000648). 
In silico analysis of the previously sequenced plasmids with the repIV replicase indicated, 
that the DNA segments containing the repIV replicases on these plasmids share similarities 
with the IncFIA and IncFIB replicons. On the majority of fully sequenced plasmids 
harbouring the repIV replicase the sopA and sopB of IncFIA replicon were found, although 
the repIV-rep genes shared only a low level of nucleotide sequence identity with the 
repFIB (Figure 2). The repIV detected on the diverse plasmids in this study may therefore 
constitute variants of either IncFIA or IncFIB replicons. 
The repV sequences detected on a mega-plasmid in Cas122 (estimated size >300 kb) and on 
the largest of the two plasmids from Cas127 (244 kb, this plasmids was positive to both 
repIV and repV) were sequenced. These repV sequences both shared 99% identity with the 
repV of pKP187 (corresponding to the repB2 of this reference plasmid). This 
repIV, -V/ 244 kb plasmid from Cas127 (isolate from surface waters) may be closely related 
to pKP187.  
 
3.2.5 Plasmids that did not produce a signal in the novel mPCR 
For fifteen of the plasmids, no signal was observed in the mPCR. Among these, five 
produced positive signals to other classical incompatibility determinants in PBRT. An 
approximately 48 kb plasmid from Cas119 produced a positive signal for FIIk determinant 
and a plasmid of the same estimated size located in Cas671 produced a positive signal for FII 
determinant. FII and/or FIIk determinants were also detected on 110 kb plasmid from Cas123 
(FIIk), 30 kb plasmid from Cas671 (FII and FIIk), 85 kb plasmid from Cas676 (FII).  
In the remaining ten cases the plasmids turned out to be untypable both by means of the 
mPCR and by the standard PBRT methods. None of the tested plasmids or wild type strains 
produced a positive signal to repII in the mPCR. 
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4. Discussion and conclusions  
The novel mPCR allowed us for rapid detection of a broad spectrum of the different 
replicases found in this study on IncFII, IncFIIk plasmids and various plasmids non-typable 
by other classical PBRT methods from K. pneumoniae. Several combinations of replicases 
that were not observed in silico were detected in this study during screening performed by the 
mPCR method. Namely, repI, III, IV & IncFII(k) (Sp20FII and Sp22FIIk); repI, -IV, -VI & 
IncFIIk (Sp34 and Sp41) and also repIII, -IV, -VII (IncR) (Cas664). Interestingly, these 
aforementioned multi-replicon scaffolds were detected only in clinical isolates (blood-stream 
and urinary tract). Moreover, we detected individual cases of repV (377 kb, Cas122, water 
isolate) and repVI (112 kb, Sp13, blood isolate) type replicons on two of the tested plasmids. 
This is an interesting finding considering that plasmids that would harbour only these 
individual replicons are not found in the public databases. Nevertheless, these two replicase 
types seem to be present rather sporadically on the plasmids from K. pneumoniae. The repV 
was also found on a 244 kb plasmid (Cas127, water isolate) in combination with repIV type 
replicase. This pattern was observed in silico on pKP187 located in K. pneumoniae isolated 
from a plant. The two above mentioned plasmids producing signals for repV replicase in the 
mPCR (Cas122 and Cas127) and the pKP187 were all located in the environmental isolates 
of K. pneumoniae. It is therefore tempting to suggest that the repV replicons could be typical 
for large plasmids found in the external natural environments rather than in K. pneumoniae 
causing infections in humans. However, more replicon typing data on plasmids from such 
environmental K. pneumoniae strains is needed to make a definite statement about the 
distribution of these repV type replicons.  
Curiously, the repII-type replicases were not detected in this study on plasmids from the 
tested collection of K. pneumoniae. The two previously sequenced plasmids harbouring the 
repII type replicases were originally isolated from strains from Argentina (clinical isolate of 
K. pneumoniae) and China (animal isolate of Y. pestis) (Soler Bistue et al., 2008). This family 
of replicons is thus either rare or might be characteristic to some specific reservoirs or 
geographical locations that were not included in this study, which mostly covered Danish 
isolates.  
In the study we observed also that on some of the repIV- positive plasmids detected by the 
mPCR no classical determinants were detected by the standard PBRT methods. Sequence 
analysis of the plasmids found in GenBank indicated, that the repIV may constitute an 
independent replicon being an equivalent or variant of either IncFIA or IncFIB classical 
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replicons. Importantly, the mPCR proved to be a useful tool for detection of these repIV 
replicases.  
In the study we also detected possibly epidemic plasmids sized to 230 kb, positive for 
repI,-IV & IncFIIk replicons that were found among two of the blood isolates (Sp7 and Sp13) 
and nine of the urinary tracts isolates (Cas663,-665,-666,-668,-670,-671,-672,-677,-679) . 
The urinary tract K. pneumoniae isolates harbouring these similar plasmids could be clonally 
related (Stahlhut et al., 2009). However, the two blood isolates represented different capsule 
serotypes and therefore belongs to other clonal lineages than the urinary tract isolates 
(Stahlhut et al., 2009). This indicates that these repI,-IV & IncFIIk, 230 kb plasmids might 
have been circulating in different K. pneumoniae strains causing infections in Denmark.  
Another observation drawn from the study is that majority of the repVII(IncR) replicons were 
found to be hybrids with FIIk replicons. This pattern was observed both in silico and among 
the plasmids typed in the study by means of the mPCR and the standard PBRT methods. IncR 
plasmids seem to be broad host range links between K. pneumoniae and other 
Entrobacteariaceae and are apparently capable of either forming multi-replicon scaffolds 
with F-related plasmids or functioning as independent replicons. IncR plasmids do not 
encode any of the previously characterized conjugative relaxases (Garcillan-Barcia et al., 
2011). Previous study indicated that  an IncR plasmid from E. coli pK727 was not capable of 
self-transfer from a donor strain containing no other plasmids than this one (Bielak et al., 
2011). It cannot be excluded, that other proteins encoded by the IncR scaffolds that were so 
far not characterized may function as mobilization relaxases. Alternatively, IncR plasmids 
could be somehow mobilized by relaxases encoded by other co-residing plasmids. 
(Schjorring et al., 2008) demonstrated in vivo transmission of IncR pKPN5 plasmid from its 
host K. pneumoniae MGH78578 to a plasmid free recipient.  
Generally, plasmids harbouring one or more of the repI-VIII type replicases which sequences 
were found in databases were located both in K. pneumoniae as well as in other species of 
enteric bacteria. These plasmids were isolated from bacteria originating from many different 
countries (USA, China, Vietnam, Taiwan, Canada, Georgia, Slovenia, United Kingdome, 
Korea, France, Germany and Australia) and from different human and non-human sources 
(human infections, lake and sea water, plant and animals). This study showed that the 
plasmids with repIII, -IV, -V, -VI and -VII(IncR) are also prevalent in K. pneumoniae from 
infections Denmark and from the water samples from Germany (Stahlhut et al., 2009). It is 
thus evident that K. pneumoniae responsible for causing infections in humans may contain 
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plasmids similar to those found in Enterobacteriaceae from the natural environments. These 
similar plasmids may be found in different geographical locations.  
When looking on the classical determinants IncFII and IncFIIk, in this study these replicons 
were found in all three reservoirs, typically with repI (covering mainly RepFIIk), repIII 
(covering mainly RepFIA or related) or repIV replicases. Although, there were noticeable 
differences observed between replicases distribution found in different reservoirs (isolates 
from bacteraemia, urinary tract infections and surface waters). Namely, the highest ratio of 
repIII replicases or repIII combined with other rep- types was found on plasmids from blood 
infection isolates. As indicated above, in this reservoir also the highest number of replicase 
combinations not observed in silico was found on individual plasmids. Also the highest ratio 
of the blood originating plasmids turned out to be nontypable by any of the applied PCR 
methods. The blood was the only reservoir in which the repVI type replicases were detected 
on two of the plasmids. The individual repIV- type replicases were most often detected on the 
plasmids from the surface waters, while the highest frequency of occurrence of repI 
combined with repIV was observed among plasmids from the urinary tract infections.  
It should be kept in mind that the sequence data available in the public databases might be 
biased due to the focus put on plasmids encoding antibiotic resistance or conferring virulence 
factors. This might be the reason why a certain pattern was observed in silico for replicases 
found on the sequenced virulence and resistance plasmids from K. pneumoniae. This 
distribution pattern of replicases can apparently be different among plasmids selected on 
criteria other than the specific resistance or virulence conferred by these plasmids.  
Overall, the majority of plasmids from human and environmental K. pneumoniae isolates 
examined in this study belonged to the IncFII, IncFIIk and to lesser extend IncR family of 
classical replicons (Garcia-Fernandez et al., 2009; Villa et al., 2010). These plasmids often 
carried a set of different replicases which most probably allow them to overcome the 
incompatibility phenomenon in cases, when other co-resident plasmids are equipped with 
similar incompatibility determinants (Villa et al., 2010). Also the plasmids belonging to the 
broad host range families of IncR, IncN and to lesser extend also to IncL/M replicons seem to 
be characteristic for K. pneumoniae as these replicons were found on the sequenced plasmids 
available in public databases (Athanasopoulos et al., 1995; Garcia-Fernandez et al., 2011; 
Zhao et al., 2010; Zhu et al., 2009). This study underlined that there are differences between 
the distribution of replicases on plasmids originating from diverse reservoirs (blood 
infections, urinary tract infections and surface waters). Also many of the replicons still 
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remain non-typable (and thus undetectable) both by the classical PBRT methods as well as by 
the novel mPCR. This problem might be solved in the future by applying the full genome 
sequencing on a larger scale instead of or in combination with the PCR-based methods for 
plasmids detection.  
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Description of tables and figures  
 
Table 1. Summary of the in silico analysis of K. pneumoniae which replicon sequences are 
available in public databases and plasmids harbouring the similar replicases originating from 
other species (23 September 2011, date last accessed); allocation of the detected replicases 
into repI-VIII homology groups and selected features found on the listed plasmids. 
 
a- refers to the experimentally confirmed features or presence of genes on the sequenced 
plasmids encoding the putative functions; b- based on (Garcilian-Barcia et al., 2011);  c- 
multiple mismatches observed between the plasmid sequence and both primers designed for 
the given rep group; d- individual mismatches observed in silico between one of the primers 
for mPCR and its target on the given plasmid; e- marked sequences share 100% identity with 
each other at the amino acid sequence level; ab
r
-  antibiotic resistance, dis.
r 
- resistance to 
disinfectants, met.
r
- resistance to heavy metals, vir.- virulence factors; the groups highlighted 
with grey are targeted by the novel mPCR; KP- K. pneumoniae, EC- E. coli, EF- Escherichia 
fergusonii, ECL- Enterobacter cloacae, SE- S. enterica, KY- Kluyvera intermedia, CR- 
Citrobacter rodentium, PA- Pantoea agglomerans, YP- Yersinia pestis, ET- Edwardsiella 
tarda; EA- Enterobacter asburiae, n. a.-data not available; n. d. – not detected in silico; inf. – 
infection, UTI-urinary tract infection, L- Liver abscess, M- meningitis, sed.-sediment, tr. –
treatment, bac. – bacteraemia, inc.- incompatibility; replicase genes of the classical Inc 
groups are abbreviated as rep with corresponding capital letters used for naming of  that 
group (for example repA of IncN plasmids is designated as repN etc.)  
 
Table 2. Primers used in the novel multiplex PCR and the target sequences on the reference 
plasmids. 
Table 3. Summary of the results of replicon typing of plasmids from K. pneumoniae clinical 
and water isolates  
nd – not detected  
a 
the signal detected in the given PCR was significantly weaker that the control signal for that 
PCR 
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Table S1. Detailed results of detection and typing of plasmids from a collection of 
K. pneumoniae clinical and surface waters isolates. 
 
a 
results correspond to the given reference plasmids; 
b
 excluding PCR  targeting ColE-type 
replicons ( Garcia-Fernandez et al., 2009); 
c 
the signal observed in the PCR was significantly 
weaker than the corresponding signal on the control;  U- urinary tract, B- blood, W- water, P- 
plant, S- sputum, N- neonatal infection; nd- signal not detected; nt-not tested. 
 
Figure 1. Schematic representation of the IncR replicons and genetic elements downstream 
of the replicons detected on the fully or partially sequenced IncR plasmids. Black arrows 
represent open reading frames (ORFs) predicted in this study with the Vector NTI Suite 11 
software (Invitrogen, Inc.), grey arrows represent two cis origins of replication predicted for 
pGSH500 by (Silva-Tatley and Steyn, 1993), rectangle filled with slanting lines represents 
element proposed previously to be the cop/inc region of pGSH500 (Silva-Tatley and Steyn, 
1993). The figure was generated based on the sequences available in GenBank. 
 
Figure 2. Schematic overview of repIV-type replicons and their comparison with the 
classical IncFIA and IncFIB replicons. Black arrows represent open reading frames (ORFs) 
predicted in this study with the Vector NTI Suite 11 software (Invitrogen, Inc.), black 
rectangles represent regions containing direct repeats, grey arrows filled with vertical or 
slanting lines represent IncFIA and IncFIB features, respectively, that were not detected in 
this study on the repIV-type replicons. The figure was generated based on the sequences 
available in GenBank.  
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Table 1. List of large plasmids found in K. pneumoniae which replicon sequences are available in public databases and plasmids harbouring the similar replicases originating from other species (23 
September 2011, date last accessed); allocation of the detected replicases into repI-VIII homology groups and selected features found on the listed plasmids. 
 
Plasmid name 
 
Host 
 
Isolation 
source 
 
Country or 
region of 
isolation 
 
 
Size 
[kb] 
re
p
I 
 
re
p
II
 
re
p
II
I 
re
p
IV
 
re
p
V
 
re
p
V
I 
re
p
V
II
 
(R
ep
R
) 
re
p
V
II
I 
(R
ep
N
) 
R
em
ai
n
ig
  
re
p
s 
 
Other  classical  
inc. determinants 
detected 
in silico 
 
Features conferred 
by the plasmid (a) 
 
 
Genes encoding 
key relaxases
 
detected on the 
plasmid (b)
 
 
Accession 
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pKPN3 
 
KP Hum.  
 
USA 176 +   +      IncFIIk ab 
r
,  met. 
r
 traIK CP000648 - 
pOU7519 SE Hum. 
 
Taiwan 127    repFIIAs 
              (c) 
 +      IncFIIs, FIBs ab 
r
,  vir. traIS EU219534 - 
pc15-k KP Hum. 
 
China 96 +   +      IncFIIk ab 
r
 traIK HQ202266 - 
pKPN4 KP Hum.  
 
USA 108 +     +    IncFIIk ab 
r
,  met. 
r
 traIK NC009650 - 
pKpQIL KP Hum. inf. 
 
Israel 114 +     +    IncFIIk ab 
r
,  met. 
r
 traIK NC_014016 (Leavitt et al., 
2010) 
pKP91 KP Plant 
 
USA 91 +  +       IncFIIk n. d. traIK (truncated) NC_011281 
 
(Fouts et al., 2008) 
pKP048 
 
KP Hum.  
 
China 151 +      +   IncFIIk ab 
r
,  met. 
r
 traIK FJ628167 (Jiang et al., 2010) 
pLV1402 KY Lake water  
sed. 
 
UK n.a.      repFIIA 
                 α 
    β   +  
 
  repFIIA  (α ) n. a. n. a. AJ009981 (α) 
AJ009986 (β) 
(Osborn et al., 
2000) 
pGSH500 KP Hum. inf. 
 
South 
Africa 
 
107 α  +  
 
     β   +  
 
  IncFIIk ab
r
 n. a. AJ009980 (α) 
Z11775.1  (β) 
(Osborn et al., 
2000) 
pKF3-94 KP Hum. inf.  
 
China 94 +         IncFIIk ab 
r
 traIK FJ876826 (Zhao et al., 2010) 
pRMH760 KP n. a.  
 
Australia n. a. +         n. a. ab 
r
,  met. 
r
 n. d. GU553923 - 
pSLMT KP Hum. inf. 
 
UK 21 +         IncFIIk ab 
r
 n. d. HQ589350 - 
pMET1-FC1 KP Hum. inf. 
 
Argentina 42  +        n. d. ab 
r
 mobB, -C  
( Ti/ ICE related) 
EU383016 (Soler Bistue et 
al., 2008) 
pCRY YP Animal 
 
 
China 22  +        n. d. n. d. mobB, -C  
 ( Ti/ ICE related) 
AE017044 (Soler Bistue et 
al., 2008) 
pO111_1 EC Hum. inf. 
 
Japan 205   + 
 
      IncHI1 ab 
r
, met. 
r
 traIHI1 AP010961 
 
- 
R27 SE n. a. 
 
Canada 181   + 
 
      IncHI1 ab 
r
 traIHI1 AF250878 (Barton et al., 
1995) 
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pAKU_1 SE Hum. inf. 
 
Pakistan 212   +       IncHI1 ab 
r
 traIHI1 AM412236 
 
(Barton et al., 
1995) 
pHCM1 SE Hum. inf. 
 
Vietnam 218   +       IncHI1 ab 
r
 traIHI1 NC_003384 
 
(Parkhill et al., 
2001) 
pKF3-140 KP Hum. inf.  
 
China 147 repFIIA 
 
repFIA repFIB
     IncFII, repFIIA, 
IncFIA, FIB 
 
ab 
r
,  putative dis. 
r  
              traIF
 
                                 FJ876827 (Zhao et al., 2010) 
pIP1206 EC n. a.  
 
France 168 repFIIA 
 
repFIA repFIB
     repFIIA , IncFIA, 
FIB 
ab 
r
,  putative dis. 
r  
               traIF
 
                                 AM886293 - 
pU302L SE Hum. inf. 
 
USA 85  repFIA repFIB     IncFIA, FIB ab 
r
 
 
n. d. AY333434 
 
(Chen et al., 
2007a) 
pEK499 EC Hum. inf. 
 
USA 118 repFIIA                    repFIA 
 
     IncFII, repFIIA, 
IncFIA  
ab 
r
,  putative dis.
r 
                 n. d. EU935739 (Woodford et al., 
2009) 
pEC_L8 EC Hum. UTI  
 
Belgium 119 repFIIA                   repFIA 
 
     IncFII, repFIIA, 
IncFIA 
ab 
r
 
 
traIF
 
   GU371928 
 
(Smet et al., 2010) 
pEC_L46 EC Hum. UTI  
  
Belgium 145 repFIIA                  repFIA 
 
   repN  IncFII, repFIIA  
IncFIA, IncN 
 
ab 
r
  
 
traIN GU371929 (Smet et al., 2010) 
pSA1 SE Animal/ 
Hum. 
 
Slovenia
 
 n. a   repFIA 
 
     n. a n. a. n. a AF239689 
 
(Mulec et al., 
2002) 
pSFO157 EC Hum. inf. 
 
USA 121 repFIIA                  repFIA repFIB     IncFII, repFIIA, 
IncFIA, FIB 
 
vir. traIF
 
    AF401292 - 
 
pRSB107 n. a. Sewage tr. 
plant  
 
Germany 121 repFIIA                  repFIA       IncFII, repFIIA, 
IncFIA 
vir., met. 
r
 traIF
 
(truncated) AJ851089 (Szczepanowski et 
al., 2005) 
pKP245 
 
KP Hum. UTI  
 
Taiwan 98 
 
  +    +   n. d. ab 
r
  
 
n. d. DQ449578 (Chen et al., 2006) 
pKP187 KP       Plant  USA 188    + + 
 
    n. d. met. 
r
 n. d. NC_011282.1 (Fouts et al., 2008) 
pKCTC2242 KP n. a. 
 
Korea 203    +      repA (e)               n. d. vir., met. 
r
 n. d. CP002911 - 
pLVPK KP Hum. inf. 
 
Taiwan 219  
 
  +      repA (e)               n. d vir., met. r n. d. AY378100 (Chen et al., 2004) 
pK2044 KP Hum. inf.  
 
Taiwan 224    +      repA (e)               n. d met. 
r
 n. d. AP006726 
 
(Wu et al., 2009) 
pECL_A ECL Hum. inf. 
 
USA 200    (d)      repA2                 n. d. 
 (pECL_A) 
 
met. 
r
 traIECL_A/ENTAS 
 
CP001919 
 
 
(Ren et al., 2010) 
pENTAS01 EA n. a. n. a. 167    +     repA1                  n. d. 
(pENTAS01) 
 
putative dis.
r
              traIECL_A/ENTAS 
 
CP003027 - 
pCVM19633 SE Hum. inf. 
 
USA 110    +      repA2                 n. d. 
 (pCVM19633) 
 
ab 
r
,  putative dis.
r
             triK, triL  
                                 (similar to  ICEkp1) 
 
CP001125 - 
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pCK41 ET Fish 
 
Korea 73    +      n. d. ab 
r
,  putative dis.
r
             triK, triL 
                               (similar to  ICEkp1) 
HQ332785 - 
pSC138 SE Hum. inf. 
 
Taiwan 139    +      n. d. ab 
r
,  met. 
r
         nikAB 
(similar to R64)  
 
AY509004 (Chiu et al., 2005) 
pKPN5 
 
KP Hum.  
 
USA 89       +   n. d. ab 
r
,  putative dis.
r 
                 n. d. NC009651.1  - 
pEFER EF Hum. 
 
USA 55       +   n. d. ab 
r
 n. d. CU928144 
 
- 
pLV1403 PA Lake water  sed.      UK n. a.       +   n. a. n. a. n. a.   AJ009954    (Osborn et al., 2000) 
pQ19_1 KP Sea water 
 
China n. a.       +   n. d. ab r n. a. HM371193 
 
(Zhao et al., 2011) 
pK727 EC Hum. France 40       +   n. a. ab 
r
 n. a. JF708954         (Bielak et al., 2011) 
 
pCROD1 CR Mouce inf.  n. a. 55 repFIIA     (c)  IncFII, repAFII, 
IncR 
 
vir. n. d. FN543503 
 
(Petty et al., 2010) 
pKF3-70 KP Hum. inf.  
 
China 70 repFIIA        IncFII, repAFII ab 
r
 traIF FJ494913 (Zhao et al., 2010) 
pK29 KP Hum. inf. 
 
Taiwan 270        repHI2 IncHI2 ab r traIHI2 (trhI) EF382672         (Chen et al., 2007b) 
pKP96 KP Hum. inf. 
 
China 68        repN IncN ab r,  putative dis.r                 traIN EU195449.1 
 
(Garcia- 
Fernandez et al., 
2011) 
 
Plasmid 12 KP Hum. inf. 
 
USA 76        repN IncN ab 
r
 traIN NC_011385.1 
 
Plasmid 9 KP Hum. inf. 
 
USA 71        repN IncN ab r traIN NC_011383.1 
 
pNL194 KP  Hum. 
 
Greece 79        repN IncN ab r,  putative dis.r                           traIN GU585907 
pLJ1 KP Hum. 
 
Australia 65        repN IncN  ab 
r
,  putative dis.
r                          
 traIN EU880929 
pCTX-M360 KP Hum. 
 
China 68         repL/M            IncL/M ab r MOBABC, traIL/M NC_011641 (Zhu et al., 2009) 
pMU407.1 KP Hum. 
 
Australia n. a.         repL/M            IncL/M ab r                n. a.         U27345.1 (Athanasopoulos et al., 1995) 
pEI545 KP n.a. n. a. n. a.          repZ                   IncZ n. a n. a M93064.1     (Praszkier et al., 1991) 
a
-  based on the presence of genes on the sequenced plasmids encoding the putative functions; 
b
- based on (Garcilian-Barcia et al., 2011);  
c
- multiple mismatches observed between the plasmid sequence and both primers 
designed for the given rep group; 
d
- individual mismatches observed in silico between one of the primers for mPCR and its target on the given plasmid; 
e
- marked sequences share 100% identity with each other at the 
amino acid sequence level; abr-  antibiotic resistance, dis. r- resistance to disinfectants, met.r- resistance to heavy metals, vir.- virulence factors; the groups highlighted with grey are targeted by the novel mPCR; KP- K. 
pneumoniae, EC- E. coli, EF- Escherichia fergusonii, ECL- Enterobacter cloacae, SE- S. enterica, KY- Kluyvera intermedia, CR- Citrobacter rodentium, PA- Pantoea agglomerans, YP- Yersinia pestis, ET- 
Edwardsiella tarda; EA- Enterobacter asburiae, n. a.-data not available; n. d. – not detected in silico; inf. – infection, UTI-urinary tract infection, sed.-sediment, tr. –treatment, bac. – bacteraemia, inc.- incompatibility; 
replicase genes of the classical Inc groups are abbreviated as rep with corresponding capital letters used for naming of  that group (for example repA of IncN plasmids is designated as repN etc.) 
Table 2. Primers used in the novel multiplex PCR and the target sequences on the reference  
plasmids 
Primer 
name 
Primer sequence Target sequence Product 
size [bp] 
Plasmid 
accession 
repIPfw 5'-AAGCTGATGGCGAAAGC-3' repA   of pKPN3 207 CP000648 
repI Prv 5'-ACACTCGATGGCCATATTG-3'     
repII Pfw 5'-CCGGCACAACAAGTATTG-3' repA  of pMET1 264 EU383016 
repII Prv 5'-GCGTCATAAGGATTGAAGG-3'      
repIII Pfw 5'-GGCGGCATATAGTCTCTCC-3' repE of pKP91 367 NC_011281 
repIII Prv 5'-CTGCGTAAACCGGTTCTG-3'        
repIV Pfw 5'-TGTTAAGCTGGATGTCAACAG-3' repB1 of pKP187 417 NC_011282.1 
repIV Prv 5'-CCTTTGGTCTCGCTCTG-3'         
repV Pfw 5'-TTTCTCGTGGACGTCTG-3' repB2 of pKP187 499 NC_011282.1 
repV Prv  5'-TACTTCAGGGAGGGATTTCTC-3'     
repVI Pfw 5'-CTCAGGAAGGCTCTCAATG-3' repA of pKPN4 601 NC009650 
repVI Prv 5'-CATGCCTTCCAGAAACG-3'         
repVII Pfw 5'-TGGGAAAGAGGTCAAGTTC-3' repB of pKPN5 768 NC009651.1 
repVII Prv 5'-CAGGTTCCAGGAAGGTAC-3'     
 
 
 
beta replicon of pGSH500
full seq. not available
( pKPN5, pKP245, pKP048, pQ19_1, pEFER)
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     common region
Common region found on the available sequenced IncR scaffolds repB
pCROD1
(truncated)
Region with sequence 
variations on the diverse 
available IncR (repVII)
scaffolds
Figure 1. Schematic representation of the IncR replicons (corresponding to repVII in this study) and genetic 
elements downstream of the replicons detected on the fully or partially sequenced IncR (repVII) scaffolds. 
Black arrows represent open reading frames (ORFs) predicted in this study with the Vector NTI Suite 11 software
(Invitrogen, Inc.), grey arrows represent two cis origins of replication predicted for pGSH500 by 
(Silva-Tatley and Steyn, 1993), rectangle filled with slanting lines represents element proposed previously to be 
the cop/inc region of pGSH500 (Silva-Tatley and Steyn, 1993). The figure was generated based on the sequences
available in GenBank.
 target for standard IncR PCR  
 target for repVII PCR  
sopB sopA
FIA replicon (based on pKF3-140)
repA (FIA) rep. origin
repA (FIB)
repA (repIV)
organisation of the putative replicon region 
on plasmids with replicase from the repIV group 
sopB sopA
region containing
direct repeats
FIB replicon
FIA incompatibility determinant targeted by the standard PBRT
31 % similarity at nucleotide seq. level
FIB incompatibility determinant targeted by the standard PBRT
Figure 2. The schematic overview of repIV-type replicons and their comparison with the classical FIA and FIB replicons. 
Black arrows represent open reading frames (ORFs) predicted in this study with the Vector NTI Suite 11 software 
(Invitrogen, Inc.), black rectangles represent regions containing direct repeats, grey arrows filled with vertical or slanting 
lines represent IncFIA and IncFIB features, respectively, that were not detected in this study on the rep3-type replicons. 
The figure was generated based on the sequences available in GenBank.
Table S1. Results of detection and typing of plasmids from a collection of K. pneumoniae  clinical and surface waters isolates
Isolate 
name
Isolation 
source
Replicases detected by mPCR Replicons 
detected 
by PBRT
Sizes of 
plasmids 
detected 
in the 
isolate
Replicases 
detected by mPCR 
on the individual 
plasmids
Replicases 
detected by 
PBRT on the 
individual 
plasmids
Comments
C3091 U repIV FIIk 180 repIV FIIk
Sp3 B nd nt nd nt nt
Sp7 B repI, repIV FIIk 229 repI, repIV FIIk
Sp10 B repIV nd 113 repIV nd
104 nd nd
4 nd nt
Sp13 B repI, repIV, repVI FIIk 229 repI, repIV FIIk
112 repVI FIIk
95 nd nd
11 nd nd
8 nt nt
7 nt nt
6 nt nt
3 nt nt
Sp14 B nd nd 60 nd nd
Sp15 B repIII FII 123 repIII nd
95 repIII FII
4 nd nt
Sp19 B nd nd nd nt nt
Sp20 B repI, repIII, repIV FII 298 repI, repIII, repIV FII
153
d repIII, repIV FII
c
142
d repIII, repIV FII
c
92 
d repIII, repIV FII
c
29 nd nd 
26 nd nd
24 nd nd 
Sp22 B repI, repIII, repIV FIIk 180 repI, repIII, repIV FIIk
Sp25 B nd nt nd nt nt
Sp28 B repIV nd 159 repIV nd
70 nd nd
50 nd nd
6 nd nt
S29 B repI, repIV FIIk 124 repI, repIV FIIk
2 nd nt
Sp30 B repIV nd 33 repIV nd
6 nd nt
Sp31 B nd nt nd nt nt
Sp32 B repI, repIV FIIk 180 repI, repIV FIIk
Sp33 B nd nt 4 nd nt
Sp34 B repI, repIV, repVI FIIk 174 repI, repIV, repVI FIIk
Sp37 B nd nt nd nt nt
Sp39 B nd nd 110 nd nd
Sp41 B repI, repIV, repVI FIIk 170 repI, repIV, repVI FIIk
Cas119 W repI, repIV, repVII FIIk, IncR 180 repI, repIV FIIk
148 repI, repVII FIIk , IncR
48 nd FIIk
5 nd nt
3 nd nt
Cas120 W nd nt nd nt nt  
 
 
 Table S1. continued
Isolate 
name
Isolation 
source
Replicases detected by mPCR Replicons 
detected 
by PBRT
Sizes of 
plasmids 
detected 
in the 
isolate
Replicases 
detected by mPCR 
on the individual 
plasmids
Replicases 
detected by 
PBRT on the 
individual 
plasmids
Comments
Cas121 W repIV nd 220 repIV nd
23 nd nd
17 nd nd
13 nd nd 
10 nd nd 
8 nd nd 
4 nd nt
3 nd nt
Cas122 W repIII, repIV, repV FIIk 377 repV nd
188 repIV nd
103 repIII FIIk
14 nd nd
7 nd nd 
5 nd nt
3 nd nt
Cas123 W repI, repIV FIIk 224 repI, repIV FIIk
110 nd FIIk
3 nd nt
Cas124 W nd nt nd nt nt
Cas125 W repIV nd 195 repIV nd
7 nd nt
Cas126 W nd nd 110 nd nd
Cas127 W repIV, repV nd 244 repIV, repV nd
104 nd nd
Cas128 W nd nt nd nt nt
Cas663 U repI, repIV FIIk 229 repI, repIV FIIk
7 nd nt
4 nd nt 
Cas664 U repIII, repIV, repVII FIIk , IncR 267 repIII, repIV, repVII FIIkc, IncR
180 repIV FIIk
68 repIII, repVII IncR
2 nd nt
Cas665 U repI, repIV FIIk 229 repI, repIV FIIk
7 nd nt
Cas666 U repI, repIV FIIk 229 repI, repIV FIIk
7 nd nt
Cas667 U nd nt nd nt nt
Cas668 U repI, repIV FIIk 229 repI, repIV FIIk
7 nd nt
Cas669 U repIII, repIV, repVII FIIk , IncR 104 nd nd
87 repIII, repIV, repVII FIIk, IncR
Cas670 U repI, repIV FIIk 229 repI, repIV FIIk
7 nd nt
Cas671 U repI, repIV FII,  FIIk 229 repI, repIV FIIk
85 repI, repIV FII
48 nd FII
30 nd FII,  FIIk
7 nd nt
5 nd nt  
 
 
Table S1. continued
Isolate 
name
Isolation 
source
Replicases detected by mPCR Replicons 
detected 
by PBRT
Sizes of 
plasmids 
detected 
in the 
isolate
Replicases 
detected by mPCR 
on the individual 
plasmids
Replicases 
detected by 
PBRT on the 
individual 
plasmids
Comments
Cas672 U repI, repIV FIIk 229 repI, repIV FIIk
Cas673 U repI, repVII FII,  FIIk , IncR 121 repVII FIIk , IncR
68 repI FII,  FIIk
 c
7 nd nt
6 nd nt
4 nd nt
3 nd nt
Cas674 U repIV FIIk 229 repIV FIIk
Cas675 U repI, repIV FIIk 240 repI, repIV FIIk
7 nd nt
Cas676 U repI, repIV FII,  FIIk 220 repI, repIV FIIk
85 nd FII
7 nd nd
5 nd nt
Cas677 U repI, repIV FIIk 229 repI, repIV FIIk
7 nd nt
Cas678 U repI, repIV FIIk 229 repIV nd
217 repI, repIV FIIk
7 nd nt
Cas679 U repI, repIV FIIk 229 repI, repIV FIIk
7 nd nt
Cas680 U repI, repIV FIIk 220 repI, repIV FIIk
60 nd FIIk
7 nd nt
Cas681 U repI, repIV FII,  FIIk 220
d repI, repIV FII,  FIIk
100 repIVc FII
85
d repIc , repIVc FII, FIIk
7 nd nt
5 nd nt
4 nd nt
Kp342 P repI, repIII, repIV, repV FIIk 188 repIV, repV FIIk pKP187
a
FIIk 91 repI, repIII FIIk pKP91
a
MGH78578 S repI, repIV, repVI, repVII FIIk, IncR 176 repI, repIV FIIk pKPN3
a
108 repI, repVI FIIk pKPN4
a
89 repVII IncR pKPN5
a
4 nd nt pKPN6
a
3 nd nt pKPN7
a
Tomalsky N repII nd 42 repII nd pMET1
a
a 
results correspond to the given reference plasmids; b excluding PCR  targeting ColE-type replicons ( Garcia-Fernandez et al., 2009);
c  the signal observed in the PCR was significantly weaker than the corresponding signal on the control; 
d presence of the same set of incompatibility determinants on multiple plasmids in the same isolate should be further verified
 U- urinary tract, B- blood, W- water, P- plant, S- sputum, N- neonatal infection; nd- signal not detected; nt-not tested.  
 
